WO2013030818A2 - Stent-grafts with post-deployment variable axial and radial displacement - Google Patents
Stent-grafts with post-deployment variable axial and radial displacement Download PDFInfo
- Publication number
- WO2013030818A2 WO2013030818A2 PCT/IL2012/000148 IL2012000148W WO2013030818A2 WO 2013030818 A2 WO2013030818 A2 WO 2013030818A2 IL 2012000148 W IL2012000148 W IL 2012000148W WO 2013030818 A2 WO2013030818 A2 WO 2013030818A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- variable
- length section
- greatest
- stent
- radially
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/89—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements comprising two or more adjacent rings flexibly connected by separate members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2002/065—Y-shaped blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
- A61F2002/075—Stent-grafts the stent being loosely attached to the graft material, e.g. by stitching
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0057—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof stretchable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0066—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof shrinkable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0075—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements sutured, ligatured or stitched, retained or tied with a rope, string, thread, wire or cable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0063—Three-dimensional shapes
- A61F2230/0073—Quadric-shaped
- A61F2230/0078—Quadric-shaped hyperboloidal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0004—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable
- A61F2250/0007—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable for adjusting length
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0004—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable
- A61F2250/001—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable for adjusting a diameter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0004—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable
- A61F2250/0013—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof adjustable for adjusting fluid pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0039—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in diameter
Definitions
- This present application relates generally to prostheses and surgical methods, and specifically to tubular prostheses, including endovascular steni-grafts, and surgical techniques for using the prostheses to maintain patency of body passages such as blood vessels, and treating aneurysms.
- Endovascular prostheses are sometimes used to treat aortic aneurysms.
- Such treatment includes implanting a stent or stent-graft within the diseased vessel to bypass the anomaly.
- An aneurysm is a sac formed by the dilation of the wall of the artery. Aneurysms may be congenital, but are usually caused by disease or, occasionally, by trauma.
- Aortic aneurysms include abdominal aortic aneurysms ("AAAs”), which form between the renal arteries and the iliac arteries, and thoracic aortic aneurysms ("TAAs”), which may occur in one or more of the descending aorta, the ascending aorta, and the aortic arch.
- AAAs abdominal aortic aneurysms
- TAAs thoracic aortic aneurysms
- Some applications of the present invention provide endovascular stent-grafts characterized by high physiological compliance. Such high physiological compliance minimizes the effect of the stent-grafts on the pulse profile of a blood vessel in which the stent-grafts are implanted, such as the aorta.
- Large-caliber arteries, in particular the aorta provide the majority of arterial vascular compliance.
- the aorta and the branching large blood vessels thus act as a mechanical capacitor that expands during systole and contracts during diastole.
- Conventional endovascular stent-grafts often comprise substantially non- compliant graft materials, and even when such stent-grafts utilize relatively flexible medical fabrics, the stent-grafts are usually essentially fully expanded under diastolic arterial pressure. As a result, conventional stent-grafts substantially do not radially pulsate with the systolic cycle. Therefore, implantation of conventional stent-grafts results in the replacement of a large portion of a compliant aorta with a non- or low- compliant prosthesis. Conventional endovascular stent-grafts thus generally change the aortic pulse profile. Such a reduction in the overall vascular compliance may have deleterious cardiovascular effects, by increasing the load of the heart and/or decreasing the effectiveness of propagation of the systolic pulse from the heart into the smaller- caliber vasculature.
- Some applications of the present invention provide endovascular stent-grafts that have beneficial effects on the peripheral vascular load, while using well-proven, gold- standard, medical-grade textiles and metallic alloys.
- the stent-grafts are configured to provide mechanical compliance that maintains (or, in some cases, even restores) the native, healthy, physiological compliance of the arterial segment in which the stent-grafts are implanted.
- an endovascular stent-graft comprises a generally tubular body, which is configured to assume a radially-compressed delivery state and a radially-expanded deployment state.
- the body comprises a flexible stent member and a tubular fluid flow guide.
- the tubular flow guide comprises a graft material, which is generally non- or minimally-elastic.
- the body includes a compliance- restoration body portion that extends axially along a portion of the body.
- the compliance-restoration body portion When the body is in the radially-expanded deployment state, the compliance-restoration body portion is (a) characterized by a greatest diastolic outer radius when the body is internally pressurized by fluid having a pressure of 80 mmHg, typically by blood during diastole in an adult human, and (b) radially expandable to a greatest systolic outer radius when the body is internally pressurized by fluid having a pressure of 120 mmHg, typically by blood during systole in an adult human.
- the greatest systolic outer radius is typically at least 5% greater than the greatest diastolic outer radius, such as at least 10%, e.g., 15%, greater than greatest diastolic outer radius.
- This increase in outer radius at greater internal pressure occurs because the stent is heat-set to have a diameter that is substantially (e.g., 5% - 20%) less than the graft's fully-expanded (i.e., without folds) diameter, and the stent has the appropriate radial compliance such that the entire stent-graft substantially changes its radius between a state in which the stent-graft is internally pressurized by a nominal hydrostatic diastolic pressure and a state in which the stent-graft is internally pressurized by a nominal hydrostatic systolic pressure.
- the stent member may comprise a highly elastic (e.g. flexible stainless steel) or a superelastic (e.g. Nitinol) alloy that is heat-set to have a first relaxed outer diameter, e.g., 23 mm, along the compliance-restoration body portion when the body is not internally pressurized by fluid.
- the tubular flow guide is configured to have a greater, second outer diameter, e.g., 30 mm, when internally pressurized to systolic pressure, e.g., 120 mmHg.
- the compliance-restoration body portion When pressurized by fluid having a diastolic pressure, e.g., 80 mmHg, the compliance-restoration body portion assumes a diastolic outer diameter that is slightly larger than the first relaxed outer diameter, e.g., between 26 and 27 mm.
- the compliance- restoration body portion assumes a systolic outer diameter equal to the second outer diameter, e.g., 30 mm, as limited by the diameter of the non-compliant graft material.
- proximal and distal end-portions of the stent-graft have respective relaxed outer diameters that are greater than the first relaxed outer diameter, which may help provide good fixation and sealing with the blood vessel wall.
- conventional thoracic aortic stent-grafts often comprise a Nitinol stent skeleton having a heat-set diameter of 32 mm and a tubular woven PET graft cylinder having a diameter of 30 mm, sewn to the stent skeleton.
- Such conventional stent-grafts may have a relaxed diameter of 30 mm, and do not allow for further expansion during systole.
- Conventional stent-grafts thus do not provide the radial compliance provided by some applications of the present invention.
- a variable-length endovascular stent-graft comprises a generally tubular body, which comprises a fluid flow guide and a plurality of structural stent elements attached to at least a portion of the fluid flow guide.
- the body includes a variable-length section that extends axially along a portion of body.
- the body, including the variable-length section is configured to assume a radially- compressed delivery state and a radially-expanded deployment state.
- the variable-length section while radially-expanded in the deployment state, is configured to enable a change in an axial length thereof of at least 5 mm.
- This change in axial length enables the stent-graft to accommodate any elongation of the blood vessel between the ends of the stent-graft that may occur after implantation of the stent-graft.
- Such elongation often occurs after implantation of a stent-graft.
- the stent-graft excludes the aneurysm from the blood circulation, the aneurysm thromboses, decomposes and shrinks, causing the blood vessel to become longer and narrower.
- elongation occurs over a long period of time, and the stent- graft provides long-term accommodation of the elongation.
- this change in axial length provides axial compliance for reducing vascular resistance, similar to the radial compliance described above.
- variable-length section When the body is in the radially-expanded deployment state, the variable-length section is configured to assume an axially-shortest state thereof, in which state typically one or more of the structural stent elements are arranged along the variable-length section such that the variable-length section has no structural-stent-element-free axial portions having axial lengths greater than 5% of a greatest outer diameter of the fluid flow guide along the variable-length section when in its axially-shortest state; for some applications, the variable-length section has no structural-stent-element-free portions when in its axially-shortest state.
- the variable-length section is configured such that the structural stent elements thereof do not undergo plastic deformation as the axial-length changes.
- the body is configured such that elasticity of graft material of the fluid flow guide provides less than 5% of a change in an axial length of the variable-length section.
- the change in the axial length of the variable-length section is not primarily enabled by stretching of the graft material of the fluid flow guide.
- a tubular fluid flow guide which includes a graft material, and is attached to the stent member, wherein the body includes a compliance-restoration body portion, which extends axially along a portion of the body, and which includes a portion of the stent member and a portion of the fluid flow guide,
- the compliance-restoration body portion when the body is in the radially-expanded deployment state, is (a) characterized by a greatest diastolic outer radius when the body is internally pressurized by fluid having a pressure of 80 mmHg, and (b) radially expandable to a greatest systolic outer radius when the body is internally pressurized by fluid having a pressure of 120 mmHg, and
- the greatest systolic outer radius is at least 5% greater than the greatest diastolic outer radius, such as at least 10% greater than the greatest diastolic outer radius.
- the fluid flow guide of the compliance-restoration body portion is shaped so as to be expandable to a maximum greatest outer radius equal to the greatest systolic outer radius of the compliance-restoration body portion, such that the compliance-restoration body portion is limited by the fluid flow guide from assuming an outer radius that is greater than the maximum greatest outer radius.
- the stent member is heat-set to cause the compliance- restoration body portion to assume the greatest diastolic outer radius when the body is internally pressurized by the fluid having the pressure of 80 mmHg.
- the compliance-restoration body portion when the body is in the radially- expanded deployment state, the compliance-restoration body portion may be characterized by a greatest relaxed outer radius when the body is not internally pressurized by fluid, which greatest relaxed outer radius is no more than 95% of the greatest diastolic outer radius.
- the stent member is heat-set to cause the compliance- restoration body portion to assume the greatest relaxed outer radius when unconstrained.
- the graft material may include a woven graft.
- the graft material of the portion of the fluid flow guide may be at least partially folded when the body is in the radially-expanded deployment state and is internally pressured by the fluid of having the pressure of 80 mmHg.
- the fluid flow guide if not attached to the stent member, may be configured to assume first and second perimeters when internally pressurized by fluid having a pressure of 80 and 120 mmHg, respectively, the second perimeter being no more than 10% greater than the first perimeter.
- the fluid flow guide if not attached to the stent member, may be configured to assume first and second perimeters when internally pressurized by fluid having a pressure of 80 and 120 mmHg, respectively, the second perimeter being between 0.5% and 5% greater than the first perimeter.
- the stent member may include a plurality of structural stent elements that are indirectly connected to one another by the fluid flow guide.
- the stent member may include a plurality of interconnected structural stent elements.
- the greatest systolic outer radius may be no more than 30% greater than the greatest diastolic outer radius.
- the greatest diastolic outer radius may be between 7.5 mm and 25 mm, when the body is in the radially-expanded deployment state.
- the greatest systolic outer radius may be between 8.5 mm and 30 ram, when the body is in the radially-expanded deployment state.
- the body may further includes distal and proximal portions, longitudinally between which the compliance-restoration body portion is disposed,
- the distal and proximal portions when the body is in the radially-expanded deployment state, may be (a) characterized by greatest diastolic distal- and proximal-end- portion radii, respectively, when the body is internally pressurized by fluid having a pressure of 80 mmHg, and (b) radially expandable to greatest systolic distal- and proximal-end-portion radii, respectively, when the body is internally pressurized by fluid having a pressure of 120 mmHg,
- the greatest systolic distal-end-portion outer radius may be less than 2% greater than the greatest diastolic distal-end-portion outer radius
- the body may further include distal and proximal portions, longitudinally between which the compliance-restoration body portion is disposed, and respective greatest radii of the distal and the proximal portions may be each at least 5% greater than a greatest relaxed outer radius of the compliance- restoration body portion, when the body is unconstrained in the radially-expanded deployment state.
- the body may further include distal and proximal portions, longitudinally between which the compliance-restoration body portion is disposed, and respective greatest radii of the distal and the proximal portions may be each at least 5% greater than the greatest diastolic outer radius, when the body is in the radially-expanded deployment state.
- the body may further include distal and proximal portions, longitudinally between which the compliance-restoration body portion is disposed, and a greatest outer radius of the distal portion, when unconstrained, may be between 2 and 10 mm greater than the greatest systolic outer radius, when the body is in the radially-expanded deployment state.
- the graft material may include a material selected from the group of materials consisting of: Polyethylene terephthalate (PET), Dacron, Polytetrafluoroethylene (PTFE), ePTFE, and a combination of two or more of these materials.
- PET Polyethylene terephthalate
- PTFE Polytetrafluoroethylene
- ePTFE ePTFE
- the stent member may include a superelastic alloy.
- the stent-graft may be configured to self-expand from the delivery state to the deployment state.
- the flexible stent member may include a plurality of structural stent elements attached to at least a portion of the fluid flow guide,
- the body may include a variable-length section, which extends axially along a portion of the body, and which includes one or more of the structural stent elements and a portion of the fluid flow guide,
- the body including the variable-length section, may be configured to assume the radially-compressed delivery state and the radially-expanded deployment state, wherein, when the body is in the radially-expanded deployment state, the variable- length section may be configured to:
- variable-length section has no structural-stent-element-free axial portions having axial lengths greater than 5% of a greater outer diameter of the fluid flow guide along the variable-length section when in its axially-shortest state.
- apparatus including an endovascular stent-graft, which includes a generally tubular body, which body includes:
- a fluid flow guide which includes a graft material
- the body includes a variable-length section, which extends axially along a portion of the body, and which includes one or more of the structural stent elements and a portion of the fluid flow guide,
- the body including the variable-length section, is configured to assume a radially-compressed delivery state and a radially-expanded deployment state
- variable- length section when the body is in the radially-expanded deployment state, is configured to:
- variable-length section has no structural-stent-element-free axial portions having axial lengths greater than 5% of a greatest outer diameter of the fluid flow guide along the variable-length section when in its axially-shortest state.
- the one or more of the structural stent elements are arranged along the variable-length section such that the variable-length section has no structural-stent-element-free axial portions, when the variable-length section is in the axially-shortest state when the body is in the radially-expanded deployment state.
- the body is configured such that elasticity of the graft material provides less than 5% of the change in the axial length of the variable-length section.
- variable-length section is configured such that the structural stent elements thereof do not undergo plastic deformation during the change in axial length.
- variable-length section is configured such that the enabled change in the axial length is no more than 10% of a greatest outer diameter of the fluid flow guide along the variable-length section when the variable-length section is in the axially-shortest state.
- variable-length section may be configured such that the enabled change in the axial length is equal to at least 10% of a greatest outer diameter of the fluid flow guide along the variable-length section when the variable-length section is in the axially-shortest state.
- a surface coverage ratio of the one or more of the structural stent elements of the variable-length section on the fluid flow guide may be equal to at least 5% when the variable-length section is in the axially-shortest state when the body is in the radially-expanded deployment state.
- variable-length section when the body is in the radially- expanded deployment state, the variable-length section may be configured to undergo the change in the axial length in response to a change in fluid pressure within the fluid flow guide.
- variable-length section when the body is in the radially- expanded deployment state, the variable-length section may be configured to undergo an increase in the axial length, and not a decrease in the axial length.
- variable-length section when the body is in the radially- expanded deployment state, the variable-length section may be configured to cyclically undergo an increase in the axial length that alternates with a decrease in the axial length.
- variable-length section may be configured to undergo (a) an increase in the axial length in response to an increase in fluid pressure within the fluid flow guide, and (b) a decrease in the axial length in response to a decrease in the fluid pressure within the fluid flow guide.
- variable-length section may be configured to undergo (a) an increase in the axial length in response to a decrease in fluid pressure within the fluid flow guide, and (b) a decrease in the axial length in response to an increase in the fluid pressure within the fluid flow guide.
- variable-length section may be configured such that during a 5 mm change in the axial length, an average wall thickness of the graft material changes by no more than 15%.
- variable-length section may be configured to assume a folded position at least when the variable-length section is in the axially-shortest state, in which folded position a first longitudinal subsection of the fluid flow guide is radially sandwiched between second and third longitudinal subsections of the fluid flow guide.
- variable-length section may be configured such that in the folded position the second longitudinal subsection radially surrounds the first longitudinal subsection, and at least one of the one or more of the structural stent elements of the variable-length section is attached to the second longitudinal subsection.
- variable-length section is configured such that in the folded position the first longitudinal subsection radially surrounds the third longitudinal subsection, and at least one of the one or more of the structural stent elements of the variable-length section is attached to the third longitudinal subsection.
- the variable-length section is configured such that none of the structural stent elements of the body is attached to the first longitudinal subsection.
- variable-length section may be shaped so as to define, at least when the variable-length section is in the axially-shortest state, a radially-outward bulge at least partially around a perimeter of an axial site on the variable-length section, which radially-outward bulge includes the one or more of the structural elements of the variable-length section.
- the variable- length section is configured such that a radial dimension of the bulge decreases as the axial length of the variable-length section increases.
- the variable- length section when in an axially-longest state, is not shaped so as to define the bulge.
- variable-length section may be shaped so as to define, at least when the variable-length section is in the axially-shortest state, a radially-inward indentation at least partially around a perimeter of an axial site on the variable-length section, which indentation includes the one or more of the structural elements of the variable-length section.
- the variable-length section is configured such that a radial dimension of the indentation decreases as the axial length of the variable-length section increases.
- the variable-length section when in an axially-longest state, is not shaped so as to define the indentation.
- variable-length section may be configured such that when the variable-length section undergoes the change in the axial length, a proximal end of the variable-length section rotates with respect to a distal end of the variable-length section.
- variable-length section may be shaped so as to define, at least when the variable-length section is in the axially-shortest state, at least one single-sided helix, which includes the one or more of the structural elements.
- variable-length section is configured such that a step size of the at least one-single-sided helix increases as the axial length of the variable- length section increases.
- variable-length section may be shaped so as to define, at least when the variable-length section is in the axially-shortest state, at least one right-handed helix and at least one left-handed helix, which helices include the one or more of the structural elements.
- variable- length section is configured such that respective step sizes of the right- and left-handed helices either both increase, or both decrease as axial length of the variable-length section increases.
- the body may include a compliance-restoration body portion, which extends axially along a portion of the body, and which includes a portion of the structural stent elements and a portion of the fluid flow guide,
- the compliance- restoration body portion when the body is in the radially-expanded deployment state, may be (a) characterized by a greatest diastolic outer radius when the body is internally pressurized by fluid having a pressure of 80 mmHg, and (b) radially expandable to a greatest systolic outer radius when the body is internally pressurized by fluid having a pressure of 120 mmHg, and
- the greatest systolic outer radius may be at least 5% greater than the greatest diastolic outer radius.
- an endovascular stent-graft which includes a generally tubular body, which includes a flexible stent member, and a tubular fluid flow guide, which includes a graft material, and is attached to the stent member, wherein the body includes a compliance-restoration body portion, which extends axially along a portion of the body, and which includes a portion of the stent member and a portion of the fluid flow guide; transvascularly introducing the stent-graft into a blood vessel of a human subject while the body is in a radially-compressed delivery state; and
- the compliance-restoration body portion is characterized by (a) a greatest diastolic outer radius when the body is internally pressurized by blood of the subject during diastole, and (b) a greatest systolic outer radius when the body is internally pressurized by blood of the subject during systole, which greatest systolic outer radius is at least 5% greater than the greatest diastolic outer radius.
- transitioning the body to the deployment state includes allowing the body to self-expand.
- the greatest systolic outer radius is at least 10% greater than the greatest diastolic outer radius.
- providing the stent-graft includes providing the stent-graft in which the fluid flow guide of the compliance-restoration body portion is shaped so as to be expandable to a maximum greatest outer radius equal to the greatest systolic outer radius of the compliance-restoration body portion, such that the compliance-restoration body portion is limited by the fluid flow guide from assuming an outer radius that is greater than the maximum greatest outer radius.
- providing the stent-graft includes providing the stent-graft in which the fluid flow guide, if not attached to the stent member, is configured to assume first and second perimeters when internally pressurized by fluid having a pressure of 80 and 120 mmHg, respectively, the second perimeter being no more than 10% greater than the first perimeter.
- the body further includes distal and proximal portions, longitudinally between which the compliance-restoration body portion is disposed,
- the distal and proximal portions are characterized by (a) greatest diastolic distal- and proximal-end- portion radii, respectively, when the body is internally pressurized by the blood during diastole, and (b) greatest systolic distal- and proximal-end-portion radii, respectively, when the body is internally pressurized by the blood during systole,
- the greatest systolic distal-end-portion outer radius is less than 2% greater than the greatest diastolic distal-end-portion outer radius
- the greatest systolic proximal-end-portion outer radius is less than 2% greater than the greatest diastolic proximal-end-portion outer radius.
- the greatest systolic outer radius is no more than 30% greater than the greatest diastolic outer radius.
- the flexible stent member includes a plurality of structural stent elements attached to at least a portion of the fluid flow guide,
- the body includes a variable-length section, which extends axially along a portion of the body, and which includes one or more of the structural stent elements and a portion of the fluid flow guide,
- the body including the variable-length section, is configured to assume the radially-compressed delivery state and the radially-expanded deployment state
- variable-length section is configured to enable a change in an axial length thereof of at least 5 mm
- variable-length section assumes an axially-shortest state thereof while the body is in the radially-expanded deployment state
- the one or more of the structural stent elements are arranged along the variable-length section such that the variable-length section has no structural-stent-element-free axial portions having axial lengths greater than 5% of a greatest outer diameter of the fluid flow guide along the variable-length section when in its axially-shortest state.
- an endovascular stent-graft which includes a generally tubular body, which includes a fluid flow guide, which includes a graft material, and a plurality of structural stent elements attached to at least a portion of the fluid flow guide, wherein the body includes a variable-length section, which extends axially along a portion of the body, and which includes one or more of the structural stent elements and a portion of the fluid flow guide,
- variable-length section is configured to enable a change in an axial length thereof of at least 5 mm
- variable-length section assumes an axially- shortest state thereof while the body is in the radially-expanded deployment state
- the one or more of the structural stent elements are arranged along the variable-length section such that the variable-length section has no structural-stent-element-free axial portions having axial lengths greater than 5% of a greatest outer diameter of the fluid flow guide along the variable-length section when in its axially-shortest state.
- variable-length section assumes an axially-shortest state thereof while the body is in the radially-expanded deployment state
- the one or more of the structural stent elements are arranged along the variable-length section such that the variable-length section has no structural-stent-element-free axial portions.
- providing the stent-graft includes providing the stent-graft in which the body is configured such that elasticity of the graft material provides less than 5% of the change in the axial length of the variable-length section.
- providing the stent-graft includes providing the stent-graft in which the variable-length section is configured such that the structural stent elements thereof do not undergo plastic deformation during the change in axial length.
- providing the stent-graft includes providing the stent-graft in which the variable-length section is configured such that the enabled change in the axial length is no more than 10% of a greatest outer diameter of the fluid flow guide along the variable-length section when the variable-length section is in the axially-shortest state.
- variable-length section when the body is in the radially-expanded deployment state, the variable-length section is configured to undergo the change in the axial length in response to a change in fluid pressure within the fluid flow guide.
- variable-length section when the body is in the radially-expanded deployment state, the variable-length section is configured to undergo an increase in the axial length, and not a decrease in the axial length.
- variable-length section when the body is in the radially-expanded deployment state, the variable-length section is configured to cyclically undergo an increase in the axial length that alternates with a decrease in the axial length.
- the variable-length section is configured to undergo (a) an increase in the axial length in response to an increase in fluid pressure within the fluid flow guide, and (b) a decrease in the axial length in response to a decrease in the fluid pressure within the fluid flow guide.
- variable-length section is configured such that during a
- an average wall thickness of the graft material changes by no more than 15%.
- variable-length section is configured to assume a folded position at least when the variable-length section is in the axially-shortest state, in which folded position a first longitudinal subsection of the fluid flow guide is radially sandwiched between second and third longitudinal subsections of the fluid flow guide.
- variable-length section is shaped so as to define, at least when the variable-length section is in the axially-shortest state, a radially-outward bulge at least partially around a perimeter of an axial site on the variable-length section, which radially-outward bulge includes the one or more of the structural elements of the variable- length section.
- variable-length section is shaped so as to define, at least when the variable-length section is in the axially-shortest state, a radially-inward indentation at least partially around a perimeter of an axial site on the variable-length section, which indentation includes the one or more of the structural elements of the variable-length section.
- the body includes a compliance-restoration body portion, which extends axially along a portion of the body, and which includes a portion of the structural stent elements and a portion of the fluid flow guide; and after the body is transitioned to the radially-expanded deployment state, the compliance-restoration body portion is characterized by (a) a greatest diastolic outer radius when the body is internally pressurized by blood flow of the subject during diastole, and (b) a greatest systolic outer radius when the body is internally pressurized by blood of the subject during systole, which greatest systolic outer radius is at least 5% greater than the greatest diastolic outer radius.
- FIGs. 1A and IB are schematic illustrations of an endovascuiar stent-graft, in accordance with an application of the present invention
- FIGS. 2A and 2B are schematic illustrations of another configuration of the endovascuiar stent-graft of Figs. 1A and IB, in accordance with an application of the present invention
- FIGS. 3A-C are schematic illustrations of yet another configuration of the endovascuiar stent-graft of Figs. 1A and IB, in accordance with an application of the present invention
- Fig. 4 is a schematic illustration of still another configuration of the endovascuiar stent-graft of Figs. 1A and IB, in accordance with an application of the present invention
- Fig. 5 is a graph that schematically illustrates the stent-graft caliber of a compliance-restoration body portion of the endovascuiar stent-graft of Figs. 1A-4 vs. internal fluid pressure, in accordance with an application of the present invention
- Fig. 6 is a schematic illustration of a variable-length stent-graft, in accordance with an application of the present invention.
- Fig. 7 is a schematic illustration of the variable-length stent-graft of Fig. 6 coupled to a bifurcated fixation stent-graft, in accordance with an application of the present invention
- Figs. 8 A and 8B are schematic illustrations of the variable-length stent-graft of Fig. 6 in exemplary axially-shorter and axially-longer states, respectively, in accordance with an application of the present invention
- Figs. 9A and 9B are schematic illustrations of additional variable-length stent- grafts, in accordance with respective applications of the present invention.
- Figs. 10A and 10B are schematic illustrations of the variable-length stent-graft of Fig. 9A in exemplary axially-shorter and axially-longer states, respectively, in accordance with an application of the present invention
- Figs. 11 is a schematic illustration of yet another variable-length stent-graft, in accordance with an application of the present invention.
- Figs. 12A and 12B are schematic illustrations of the variable-length stent-graft of Fig. 11 in exemplary axially-shorter and axially-longer states, respectively, in accordance with an application of the present invention.
- Fig. 13 is a schematic illustration of another stent-graft, which combines certain features of the stent-grafts of Figs. 1A-B and 6, in accordance with an application of the present invention.
- Figs. 1A and IB are schematic illustrations of an endovascular stent-graft 20, in accordance with an application of the present invention.
- Stent-graft 20 comprises a generally tubular body 22 having a central longitudinal axis 23.
- Body 22 is configured to assume (a) a radially-compressed delivery state, typically when the body is initially positioned in a delivery catheter, and (b) a radially-expanded deployment state, upon deployment from the delivery catheter.
- Both Figs. 1A and IB show the stent-graft with body 22 in its radially-expanded deployment state.
- Body 22 is shown during diastole of an adult human in Fig. 1 A, and during systole of the adult human in Fig. IB.
- Body 22 comprises a flexible stent member 24, and a tubular fluid flow guide 26.
- the fluid flow guide is attached to the stent member, such as by suturing or stitching.
- the flexible stent member may be attached to an internal and/or an external surface of the fluid flow guide.
- a portion of the structural stent elements may be attached (e.g., sutured) to the internal surface of the fluid flow guide, and another portion to the external surface of the fluid flow guide.
- Flexible stent member 24 comprises a plurality of structural stent elements 28, which are either indirectly connected to one another by the fluid flow guide (as shown), and/or interconnected with one another (configuration not shown).
- structural stent elements 24 comprise a metal.
- the structural stent elements comprise a self-expanding material, such that body 22 (and, optionally, stent- graft 20) is self-expandable.
- the structural stent elements comprise one or more metallic alloys, such as one or more superelastic metal alloys, a shape memory metallic alloy, and/or Nitinol.
- Fluid flow guide 26 comprises a graft material, i.e., at least one biologically- compatible substantially blood-impervious flexible sheet.
- the flexible sheet may comprise, for example, a polyester, a polyethylene (e.g., a poly-ethylene-terephthalate), a polymeric film material (such as a fluoropolymer, e.g., polytetrafluoroethylene), a polymeric textile material (e.g., woven polyethylene terephthalate (PET)), natural tissue graft (e.g., saphenous vein or collagen), Polytetrafluoroethylene (PTFE), ePTFE, Dacron, or a combination of two or more of these materials.
- the graft material optionally is woven.
- the graft material of fluid flow guide 26 is generally non- or minimally-elastic.
- stent-graft 20 is configured to self-expand from the delivery state to the deployment state.
- stent member 24 may be heat-set to cause stent-graft 20 to self-expand from the delivery state to the deployment state.
- Body 22 includes a compliance-restoration body portion 34, which extends axially along a portion of body 22, and which comprises a portion of stent member 24 and a portion of fluid flow guide 26.
- compliance-restoration body portion 34 is:
- compliance-restoration body portion 34 expands to greatest systolic outer radius Rg even when the body is internally pressured by fluid having a pressure of greater than 120 mmHg.
- Greatest systolic outer radius Rg is typically at least 5% greater than greatest diastolic outer radius Rrj>, such as at least 10% greater than greatest diastolic outer radius R j, e.g., at least 15% greater than greatest diastolic outer radius Rj Alternatively or additionally, greatest systolic outer radius Rg is no more than 30% greater than the greatest diastolic outer radius R This increase in outer radius at greater internal pressure occurs because the stent is heat-set to have a diameter that is substantially (e.g., 5% - 20%) less than the graft's fully-expanded (i.e., without folds) diameter, and the stent has the appropriate radial compliance such that the entire stent-graft substantially changes its radius between a state in which the stent-graft is internally pressurized by a nominal hydrostatic diastolic pressure and a state in which the stent-graft is internally pressurized by a nominal hydrostatic sy
- fluid flow guide 26 of compliance-restoration body portion 34 is shaped so as to be expandable to a maximum greatest outer radius R equal to greatest systolic outer radius Rg of compliance-restoration body portion 34, such that the compliance-restoration body portion is limited by the fluid flow guide from assuming an outer radius that is greater than the maximum greatest outer radius Rjyj.
- maximum greatest outer radius R]y j of fluid flow guide 26 is greater than the greatest diastolic outer radius of stent member 24, such as at least 5%, at least 10%, or at least 20% greater than greatest diastolic outer radius Rj) of stent member 24.
- the inward compressive force applied by stent-member 24 is countered by the outward force applied by the internally pressurizing fluid (typically, diastoHcally-pressurized blood).
- greatest diastolic outer radius Rj is at least 7.5 mm, no more than 25 mm, and/or between 7.5 mm and 25 mm
- greatest systolic outer radius Rg is at least 8.5 mm, no more than 30 mm, and/or between 8.5 mm and 30 mm.
- the graft material of fluid flow guide 26 is generally non- or minimally-elastic.
- the graft material of the compliance-restoration portion is at least partially folded.
- the outer radius of compliance-restoration body portion 34 is less than the maximum outer radius of the fluid flow guide (though the actual circumference of the fluid flow guide remains essentially the same, so the graft material of the fluid flow guide must assume small folds to accommodate this state).
- the actual circumference is to be understood as measuring the actual length of the fabric's wall if the fabric were to be flattened to remove any folds, invaginations, or bulges caused by the radial contraction of the fluid flow guide.
- Fluid flow guide 26, if not attached to stent member 24 is configured to assume first and second perimeters when internally pressurized by fluid having a pressure of 80 and 120 mmHg, respectively.
- the second perimeter is no more than 10% greater than the first perimeter, such as no more than 5% greater than the first perimeter.
- the second perimeter is between 0.5% and 5% greater than the first perimeter.
- body 22 further includes distal and proximal portions 40 and 42, longitudinally between which compliance-restoration body portion 34 is disposed.
- distal and proximal portions 40 and 42 are:
- RDD ⁇ RpD' respectively, when body 22 is internally pressurized by fluid having a pressure of 80 mmHg, typically by blood during diastole in an adult human, as shown in Fig. 1A;
- greatest systolic distal-end-portion outer radius R $ s is less than 2% greater than greatest diastolic distal-end-portion outer radius RDD' an d ° r greatest systolic proximal-end-portion outer radius Rpg is less than 2% greater than greatest diastolic proximal-end-portion outer radius Rpj> hi other words, the radii of distal and proximal portions 40 and 42 change only slightly, or not at all, during the transition between diastole and systole. (In contrast, the outer radius of compliance-restoration body portion 34 changes substantially (e.g., by at least 5%), during the transition between diastole and systole, as described
- FIGS. 1A and IB are schematic illustrations of another configuration of endovascular stent- graft 20, in accordance with an application of the present invention.
- FIGs. 2A and 2B show the stent-graft with body 22 in its radially-expanded deployment state.
- Body 22 is shown during diastole of an adult human in Fig. 2A, and during systole of the adult human in Fig. 2B.
- stent-graft 20 is configured such that:
- ⁇ greatest systolic outer radius Rg is greater than (e.g., at least 5% greater
- stent-graft 20 is configured such that:
- At least 5% greater than, such as at least 10% greater than) greatest diastolic outer radius Rj ⁇ , and/or greatest diastolic proximal-end-portion outer radius Rprj is greater than (e.g., at least 5% greater than, such as at least 10% greater than) greatest diastolic outer radius Rj and ⁇ greatest systolic outer radius R ⁇ j is approximately equal to (e.g., within +/- 20% of) greatest systolic distal-end-portion outer radius Rpg and/or greatest systolic proximal-end-portion outer radius Rps-
- stent-graft 20 is configured such that:
- greatest diastolic outer radius Rp is less than (e.g., at least 10% less than, such as at least 15% less than) greatest diastolic distal-end-portion outer radius DD and/or greatest diastolic proximal-end-portion outer radius Rppj;
- greatest systolic outer radius R ⁇ j is greater than (e.g., at least 10% greater than, such as at least 15% greater than) greatest systolic distal-end-portion outer radius RrjS ⁇ /or greatest systolic proximal-end-portion outer radius Rps-
- FIGs. 3A-C are schematic illustrations of yet another configuration of endovascular stent-graft 20, in accordance with an application of the present invention. This configuration may be implemented in combination with any of the three configurations described immediately hereinabove with reference to Figs. 1A- B and 2A-B. All of Figs. 3A, 3B, and 3C show stent-graft 20 with body 22 in its radially- expanded deployment state.
- compliance-restoration body portion 34 when not internally pressured by fluid, is characterized by a greatest relaxed outer radius RR that is less than greatest diastolic outer radius Rj) (and thus also less than even greater greatest systolic outer radius Rg).
- This greatest relaxed outer radius RR occurs only during manufacture and does not occur in vivo (except perhaps briefly during the implantation procedure), because upon deployment and radial expansion of body 22 to its radially-expanded deployment state, the body is internally subjected to at least diastolic blood pressure.
- stent member 24 is heat- set to cause compliance-restoration body portion 34 to assume greatest relaxed outer radius RR when unconstrained, i.e., when no forces are applied to the compliance-restoration body portion by a delivery tool, walls of a blood vessel, or otherwise.
- an "unconstrained" element is an element to which no forces are applied by a delivery tool, walls of a blood vessel, or otherwise.
- body 22 is shown internally pressurized by fluid having a pressure of 80 mmHg, typically by blood during diastole in an adult human.
- compliance-restoration body portion 34 is characterized by greatest diastolic outer radius RQ.
- RQ diastolic outer radius
- body 22 is shown internally pressurized by fluid having a pressure of 120 mmHg, typically by blood during systole in an adult human.
- compliance-restoration body portion 34 is characterized by greatest diastolic outer radius Rg.
- distal and proximal portions 40 and 42 are characterized by greatest relaxed distal- and proximal-end-portion radii RTJ>R and RpR, respectively, when body 22 is not internally pressurized by fluid.
- greatest relaxed distal-end-portion outer radius RDR is at least 5% greater than greatest relaxed outer radius RR of compliance-restoration body portion 34
- greatest relaxed proximal- end-portion outer radius RpR is at least 5% greater than greatest relaxed outer radius RR.
- Such greater radii may help provide proper fixation to and sealing with the blood vessel wall.
- FIG. 4 is a schematic illustration of yet another configuration of endovascular stent-graft 20, in accordance with an application of the present invention.
- Fig. 4 shows the stent-graft with body 22 in its radially-expanded deployment state during systole, with distal and proximal portions 40 and 42 shown by way of illustration in a radially-expanded state while unconstrained, i.e., while no forces are applied to these portions by a delivery tool, walls of a blood vessel, or otherwise.
- the shape of compliance-restoration body portion 34 during diastole is also shown by dashed lines.
- stent-graft 20 is configured such that:
- greatest systolic outer radius Rg such as at least 5% greater than, e.g., as at least 15% greater than, and/or at least 2 mm greater than, no more than 10 mm greater than, or between 2 and 10 mm greater than greatest systolic outer radius Rg; and/or
- greatest systolic outer radius Rg such as at least 5% greater than, e.g., as at least 15% greater than, and/or at least 2 mm greater than, no more than 10 mm greater than, or between 2 and 10 mm greater than greatest systolic outer radius Rg.
- greatest systolic outer radius Rg is greater than greatest diastolic outer radius Rrj (e.g., at least 3% greater than, such as at least 5% greater than).
- each of greatest unconstrained distal- and proximal-end-portion radii R jU and R u is at least 5 mm, no more than 20 mm, and/or between 10 and 30 mm, e.g., at least 11 mm, no more than 25 mm, and/or between 11 and 25 mm.
- endovascular stent-graft 20 may be deployed in an aneurysmatic blood vessel, such as an aneurysmatic aorta, such as described hereinabove with reference to Figs. 1A-3C.
- endovascular stent-graft 20 may be deployed in a non-aneurysmatic blood vessel.
- the stent-graft may be configured to provide (passive, that is, by means of storage of mechanical energy) counterpulsation, by being configured to absorb and store blood pressure during systole and release and apply blood pressure during diastole.
- Counterpulsation is a technique for assisting the circulation by decreasing the afterload of the left ventricle and augmenting the diastolic pressure. Counterpulsation increases stroke volume by decreasing afterload, reduces heart workload, and maintains or increase coronary perfusion.
- Stent-graft 20 may thus be used, for example, for treating sclerotic disease in order to restore radial compliance of a blood vessel.
- Fig. 5 is a graph that schematically illustrates the stent-graft caliber of compliance-restoration body portion 34 vs. internal fluid pressure, in accordance with an application of the present invention.
- Stent-graft caliber of compliance-restoration body portion 34 is expressed as a percentage of maximum graft caliber (i.e., the graft caliber at burst pressure).
- maximum graft caliber i.e., the graft caliber at burst pressure
- the caliber of compliance-restoration body portion 34 varies between about 70% and 100% of the maximum graft caliber as the internal fluid pressure changes.
- conventional stents-grafts that comprise polyethylene terephthalate (PET) or polytetrafluoroethylene (ePTFE, available under the trademark Gore-Tex®) maintain approximately 100% and 95%, respectively, of their maximum graft caliber as internal pressure varies in a physiologically-normal range. It is noted that even conventional stent-grafts that comprise graft material that allows a 5% change in graft caliber cannot increase by at least 5% in radius, because the stent elements of conventional stent-grafts are heat-set to hold the stent-graft in its maximum graft caliber even when not pressurized by physiological blood pressure from the inside.
- PET polyethylene terephthalate
- ePTFE polytetrafluoroethylene
- Figs. 6-12B are schematic illustrations of a variable-length endovascular stent-graft 90, in accordance with respective applications of the present invention.
- Fig. 6 is a schematic illustration of a variable-length stent-graft 100, in accordance with an application of the present invention.
- Variable- length stent-graft 100 is one implementation of variable-length-stent graft 90, described herein with reference to Figs. 6-12B.
- Stent-graft 100 comprises a generally tubular body 110, which comprises a fluid flow guide 112 and a plurality of structural stent elements 114 attached to at least a portion of the fluid flow guide.
- Body 110 includes a variable- length section 120 that extends axially along a portion of body 110.
- Body 110, including variable-length section 120 is configured to assume a radially-compressed delivery state and a radially-expanded deployment state.
- body 110 is configured to self- expand from the delivery state to the deployment state upon being deployed from a delivery catheter.
- Body 110 is shown in Figs. 6-12B in the radially-expanded deployment state.
- Variable-length section 120 while radially-expanded in the deployment state, is configured to enable a change in an axial length thereof of at least 5 mm, such as at least 8 mm, e.g., at least 10 mm, and/or no more than 30 mm, e.g., no more than 25 mm.
- variable-length section 120 is configured such that the enabled change in the axial length is equal to at least 10%, e.g., at least 20%, and/or no more than 30%, e.g., no more than 10%, of outer diameter D of the fluid flow guide along the variable-length section when in its axially-shortest state ("greatest diameter" means the diameter at the longitudinal site having the greatest diameter).
- variable-length section 120 is to be understood as being that portion of the stent-graft that actually facilitates the change in axial length, as labeled in Figs. 6-12B.
- variable-length section 120 When body 110 is in the radially-expanded deployment state, variable-length section 120 is configured to assume an axially-shortest state thereof. Typically, at least when variable-length section 120 is in this axially-shortest state, one or more of structural stent elements 114 are arranged along the variable-length section such that the variable- length section has no structural-stent-element-free axial portions having axial lengths greater than 5%, e.g., greater than 10%, of greatest outer diameter D of the fluid flow guide along the variable-length section when in its axially-shortest state; for some applications, the variable-length section has no structural-stent-element-free portions when in its axially-shortest state. Typically, variable-length section 120 is configured such that structural stent elements 114 thereof do not undergo plastic deformation as the axial length changes.
- Fluid flow guide 112 comprises a graft material, i.e., at least one biologically- compatible substantially blood-impervious flexible sheet.
- the flexible sheet may comprise, for example, a polyester, a polyethylene (e.g., a poly-ethylene-terephthalate), a polymeric film material (such as a fluoropolymer, e.g., polytetrafluoroethylene), a polymeric textile material (e.g., woven polyethylene terephthalate (PET)), natural tissue graft (e.g., saphenous vein or collagen), Polytetrafluoroethylene (PTFE), ePTFE, Dacron, or a combination of two or more of these materials.
- the graft material optionally is woven.
- the graft material is not accordion-pleated.
- structural stent elements 114 comprise a metal.
- the structural stent elements comprise a self -expanding material, such that body 110 (and, optionally, stent-graft 90) is self-expandable.
- the structural stent elements comprise one or more metallic alloys, such as one or more superelastic metal alloys, a shape memory metallic alloy, and/or Nitinol.
- variable-length stent- graft 100 is configured to define at least one generally tubular foldable section 130.
- variable-length section 120 is configured to assume a folded position at least when variable-length section 120 is in the axially-shortest state.
- a first longitudinal subsection 132 of fluid flow guide 112 is radially sandwiched between second and third longitudinal subsections 134 and 136 of fluid flow guide 112.
- the variable-length section is typically configured to gradually unfold as the axial length thereof increases.
- second longitudinal subsection 134 radially surrounds the first longitudinal subsection 132, and first longitudinal subsection 132 radially surrounds third longitudinal subsection 136, such that first longitudinal subsection 132 is radially sandwiched between second and third longitudinal subsections 134 and 136.
- second subsection 134 at least partially longitudinally overlaps with both first and third longitudinal subsections 132 and 136.
- At least one of structural stent elements 114 is attached to second longitudinal subsection 134. Alternatively or additionally, for some applications, at least one of structural stent elements 114 is attached to third longitudinal subsection 136. Further alternatively or additionally, for some applications, an average surface coverage ratio of structural stent elements 114 on fluid flow guide 112 along first subsection 132 is no more than 20%, such as no more than 10%, of the greater of (a) an average surface coverage ratio on fluid flow guide 112 along second longitudinal subsection 134 and (b) an average surface coverage ratio on fluid flow guide 112 along third longitudinal subsection 136. For some applications, variable-length section 120 is configured such that none of structural stent elements 114 of body 110 is attached to first longitudinal subsection 132.
- This lower average surface coverage ratio (such as no surface coverage) provides greater evertibility to first longitudinal subsection 132, thereby enabling the transition of foldable section 130 from the folded state to the unfolded state.
- first longitudinal subsection 132 is everted, i.e., turned inside-out.
- the average surface coverage ratio of structural stent elements 114 on fluid flow guide 112 along first longitudinal subsection 132 is not necessarily no more than 20%.
- second and third longitudinal subsections 134 and 136 may be provided by:
- the structural stent elements extend around less than 360 degrees of the circumference of the stent-graft, i.e., are circumferentially incomplete, in order to increase the evertibility of the first longitudinal subsection.
- a first subgroup of structural stent elements 114 is attached (e.g., sutured) to second longitudinal subsection 134, and a second subgroup of structural stent elements 114 is attached (e.g., sutured) to third longitudinal subsection 136.
- one of the first and second subgroups of structural stent elements 114 is attached (e.g., sutured) to an internal surface of fluid flow guide 112, and the other of the first and second subgroups is attached (e.g., sutured) to an external surface of fluid flow guide 112.
- structural stent elements 114 are arranged as a plurality of generally circumferential bands. Longitudinal adjacent ones of the bands may or may not be joined to one another.
- one or more of the circumferential bands is attached (e.g., sutured) to fluid flow guide 112 along second longitudinal subsection 134 (either to an external surface and/or to an internal surface thereof), and one or more of the circumferential bands is attached (e.g., sutured) to fluid flow guide 112 along third longitudinal subsection 136 (either to an external surface and/or to an internal surface thereof).
- one or more of the circumferential bands is attached to fluid flow guide 112 along first longitudinal subsection 132 (either to an external surface and/or to an internal surface thereof).
- a surface coverage ratio of the one or more of structural stent elements 114 of variable-length section 120 on fluid flow guide 112 is at least 5%, such as at least 10%, when variable-length section 120 is the axially-shortest state when body 110 is in the radially-expanded deployment state.
- foldable section 130 comprises exactly three subsections, in which case the foldable section may be considered a triple-collar section.
- foldable section 130 comprises more than three subsections, such as described with reference to Fig. 7 of above- mentioned US Provisional Application 61/553,209, which is incorporated herein by reference.
- Fig. 7 is a schematic illustration of variable- length stent-graft 100 coupled to a bifurcated fixation stent-graft 150, in accordance with an application of the present invention.
- bifurcated fixation stent- graft 150 facilitates long-term anchoring of variable-length stent-graft 100 at a bifurcation.
- bifurcated fixation stent-graft 150 may comprise a bi-iliac self-expandable stent that is deployed in the iliac arteries, in order to facilitate long-term anchoring of stent-graft 100 at the aorto-iliac bifurcation.
- Stent-grafts 100 and 150 may be deployed and/or coupled to each other using techniques described in one or more of the following patent application publications, all of which are assigned to the assignee of the present application and are incorporated herein by reference: (a) PCT Publication WO 08/107885, (b) PCT Publication WO 2011/007354, (c) PCT Publication WO 2010/150208, e.g., with reference to Figs. 14D-E, 20B, and/or 21B thereof, and (d) US Patent Application Publication 201 1/0208289.
- Figs. 8A and 8B are schematic illustrations of variable-length stent-graft 100 in exemplary axially- shorter and axially-longer states, respectively, in accordance with an application of the present invention.
- Stent-graft 100 is configured to assume a plurality of axially-shorter states (including the axially-shortest state described hereinabove with reference to Fig. 6).
- Fig. 8 A shows stent-graft 100 in one of these axially-shorter states, in which variable-length section 120 has axial length LJJ, and variable-length section 120 is in the folded position, as described hereinabove with reference to the blow-up of Fig. 6.
- Fig. 8A are schematic illustrations of variable-length stent-graft 100 in exemplary axially- shorter and axially-longer states, respectively, in accordance with an application of the present invention.
- Stent-graft 100 is configured to assume a plurality of axially-shorter states (including the axial
- variable-length section 120 has axial length LL, and variable-length section 120 is nearly entirely unfolded.
- the stent- graft may assume a slightly longer state, in which it is entirely unfolded (state not shown).
- Figs. 9A-B and 10A-B are schematic illustrations of variable-length stent-grafts 200 and 202, in accordance with respective applications of the present invention.
- Variable-length stent-grafts 200 and 202 are respective implementations of variable-length-stent graft 90, described herein with reference to Figs. 6-12B.
- Stent-grafts 200 and 202 comprise generally tubular body 110, which comprises fluid flow guide 112 and structural stent elements 114 attached to at least a portion of the fluid flow guide.
- Body 110 includes variable-length section 120 that extends axially along a portion of body 110.
- Body 110, including variable-length section 120, is configured to assume a radially-compressed delivery state and a radially-expanded deployment state.
- Body 110 is shown in Figs. 9A-B and 10A-B in the radially-expanded deployment state.
- Variable-length section 120 of stent-grafts 200 and 202 are configured to change length by means of rotation of a proximal end 206 of variable-length section 120 with respect to a distal end 208 of variable-length section 120. Such rotation causes structural elements 114 to twist. Variable-length section 120 shortens as structural elements 114 twist, and the graft material circumferentially folds around the more acutely curved structural elements.
- variable-length section 120 is configured to cyclically undergo an increase in the axial length that alternates with a decrease in the axial length.
- the length of the variable-length section increase and decreases every heartbeat.
- variable-section 120 shortens during diastole and lengthens during systole.
- variable-length section 120 of stent-graft 200 is shaped so as to define, at least when the variable-length section is in the axially-shortest state, at least one single- sided helix 204, which comprises the one or more of structural elements 114.
- variable-length section 120 is configured such that a step size of the at least one-single-sided helix increases as the axial length of the variable-length section increases.
- variable-length section 120 of stent- graft 202 is shaped so as to define, at least when the variable-length section is in the axially-shortest state, at least one right-handed helix and at least one left-handed helix, which helices comprise the one or more of structural elements 114.
- variable-length section 120 is configured such that respective step sizes of the right- and left-handed helices either both increase, or both decrease, as axial length of the variable-length section increases.
- Figs. 10A and 10B show variable-length stent-graft 200 of Fig. 9A in exemplary axially-shorter and axially-longer states, respectively.
- Fig. 10A shows stent-graft 200 in one of its axially-shorter states, in which variable-length section 120 has axial length L ⁇ .
- variable-length section 120 is relaxed in the axially-shorter state.
- Fig. 10B shows stent-graft 200 in one of its axially-longer states, in which variable-length section 120 has axial length LL.
- the one or more of structural stent elements 1 14 are configured to be elastically deformed at least when variable-length section 120 is in an axially- shortest of the axially-shorter states, such that the stent elements protrude radially outwardly (as shown in Fig. 10A) or radially inwardly (configuration not shown).
- the portions of these stent elements that protrude are attached (e.g., sutured) to fluid flow guide 1 12.
- variable- length section 120 is shaped so as to define, at least when the variable-length section is in the axially-shortest state, a radially- outward bulge 210 at least partially around a perimeter of an axial site on variable-length section 120.
- Radially-outward bulge 210 comprises the one or more of structural elements 1 14 of variable-length section 120, and, typically, a portion of the graft material of fluid flow guide 1 12.
- the variable- length section is configured such that a radial dimension of the bulge decreases as the axial length of the variable-length section increases.
- variable-length section 120 is configured such that structural stent elements 1 14 thereof do not undergo plastic deformation as the axial length changes.
- variable-length section 120 when variable-length section 120 is in an axially-longest state (for example, as shown in Fig. 10B, and Figs. 9A and 9B), the stent elements that define the bulge generally do not protrude radially outwardly or radially inwardly.
- the variable- length section when in an axially-longest state, thus is not shaped so as to define bulge 210.
- structural elements 1 14 are relaxed in the axially-shortest state.
- a surface coverage ratio of the one or more of structural stent elements 114 of variable-length section 120 on fluid flow guide 112 is at least 5%, such as at least 10%.
- variable-length section 120 When body 110 is in the radially-expanded deployment state (as shown in Figs. 9 and 10A-B), variable-length section 120 is configured to assume an axially-shortest state thereof (which might, for example, be the state shown in Fig. 10A). In this state the one or more of structural stent elements 114 are arranged along the variable-length section such that the variable-length section has no structural-stent-element-free axial portions having axial lengths greater than 5% of greatest outer diameter D of the fluid flow guide along the variable-length section when in its axially-shortest state. In this configuration, the variable-length section typically has no structural-stent-element free axial portions, when the variable-length section is in the axially-shortest state.
- Figs. 11 and 12A-B are schematic illustrations of a variable-length stent-graft 300, in accordance with an application of the present invention.
- Variable-length stent-graft 300 is one implementation of variable-length- stent graft 90, described herein with reference to Figs. 6-12B.
- Stent-graft 300 comprises generally tubular body 110, which comprises fluid flow guide 112 and structural stent elements 114 attached to at least a portion of the fluid flow guide.
- Body 110 includes variable-length section 120 that extends axially along a portion of body 110.
- Body 110, including variable-length section 120 is configured to assume a radially-compressed delivery state and a radially-expanded deployment state.
- Body 110 is shown in Figs. 11 and 12A-B in the radially-expanded deployment state.
- Figs. 12A and 12B show variable-length stent-graft 300 in exemplary axially- shorter and axially-longer states, respectively.
- Fig. 12A shows stent-graft 300 in one of its axially-shorter states, in which variable-length section 120 has axial length Lg. Typically, variable-length section 120 is relaxed in the axially-shorter state.
- Fig. 12B shows stent-graft 300 in one of its axially-longer states, in which variable-length section 120 has axial length LL.
- the one or more of structural stent elements 114 are configured to be elastically deformed at least when variable-length section 120 is in the axially- shortest state, such that the stent elements protrude radially outwardly (as shown in Fig. 10A) or radially inwardly (configuration not shown).
- the portions of the stent elements that protrude radially outward are not attached (e.g., sutured) to fluid flow guide 112.
- the graft material of fluid flow guide 112 along the variable-length section folds as the variable-length section axially shortens, as shown in Fig. 12A.
- variable- length section 120 is shaped so as to define, at least when the variable-length section is in the axially-shortest state, a radially-outward bulge 310 at least partially around a perimeter of an axial site on variable-length section 120.
- Radially-outward bulge 310 comprises the one or more of structural elements 114 of variable-length section 120.
- the variable-length section is configured such that a radial dimension of the bulge decreases as the axial length of the variable-length section increases.
- variable-length section 120 is configured such that structural stent elements 114 thereof do not undergo plastic deformation as the axial length changes.
- Bulge 310 radially protrudes less when the variable-length section is in an axially- longer state than when in an axially-shorter state.
- variable-length section 120 is relaxed in the axially-shorter state.
- a surface coverage ratio of the one or more of structural stent elements 114 of variable-length section 120 on fluid flow guide 112 is at least 5%, such as at least 10%.
- variable-length section 120 When body 110 is in the radially-expanded deployment state (as shown in Figs. 12A and 12B), variable-length section 120 is configured to assume an axially-shortest state thereof (which might, for example, be the state shown in Fig. 12A). In this state the one or more of structural stent elements 114 are arranged along the variable-length section such that the variable-length section has no structural-stent-element-free axial portions having axial lengths greater than 5% of greatest outer diameter D of the fluid flow guide along the variable-length section when in its axially-shortest state. In this configuration, the variable-length section typically has no structural-stent-element free axial portions, when the variable-length section is in the axially-shortest state.
- variable-length section 120 is shaped so as to define, at least when the variable-length section is in the axially-shortest state, a radially-inward indentation at least partially around a perimeter of an axial site on the variable-length section.
- the indentation comprises the one or more of structural elements 114 of variable-length section 120.
- the variable-length section is configured such that a radial dimension of the indentation decreases as the axial length of the variable-length section increases.
- the variable-length section when in an axially-longest state, is not shaped so as to define the indentation.
- body 110 is configured such that elasticity of the graft material of fluid flow guide 112 provides less than 5%, such as less than 3% of a change in an axial length of variable-length section 120.
- the change in the axial length of variable-length section 120 is not primarily enabled by stretching of the graft material of the fluid flow guide.
- an average wall thickness T of the graft material (labeled in Figs. 6, 9, and 11) does not decrease, or decreases only slightly, as the axial length increases.
- average wall thickness T of the graft material changes by no more than 15%, such as by no more than 10%.
- variable-length section 120 when body 110 is in the radially-expanded deployment state, variable-length section 120 is configured to undergo an increase in the axial length, and not a decrease in the axial length. For some applications, such an increase occurs gradually after implantation, such as over months or years, enabling variable-length endovascular stent-graft 90 to accommodate the gradual lengthening of the aorta that sometimes occurs. Such accommodation decreases the risk that the stent-graft might become dislodged and decreases the risk of endoleak.
- variable-length section 120 when body 110 is in the radially-expanded deployment state, variable-length section 120 is configured to cyclically undergo an increase in the axial length that alternates with a decrease in the axial length. For some applications, the length of the variable-length section increase and decreases every heartbeat. This repeated change in axial length provides axial compliance for reducing vascular resistance, similar to the radial compliance described above. For some applications, variable-section 120 shortens during diastole and lengthens during systole.
- variable-length section 120 when body 110 is in the radially-expanded deployment state, variable-length section 120 is configured to undergo the change in axial length in response to a change in fluid pressure within fluid flow guide 112, such as every heartbeat as pressure increases and decreases during systole and diastole. This repeated change in axial length provides axial compliance for reducing vascular resistance, similar to the radial compliance described above. Therefore, for these applications, the variable-length section typically is not configured to lock upon elongation.
- variable-length section 120 is configured to undergo (a) an increase in the axial length in response to an increase in fluid pressure within the fluid flow guide, and (b) a decrease in the axial length in response to a decrease in the fluid pressure within the fluid flow guide.
- variable-length section 120 is configured to undergo (a) an increase in the axial length in response to a decrease in fluid pressure within the fluid flow guide, and (b) a decrease in the axial length in response to an increase in the fluid pressure within the fluid flow guide.
- stent-graft 90 further comprises one or more fixation members 330, such as barbs or hooks, located proximally and/or distally to variable-length section 120.
- the fixation members are configured to provide secured positioning between at least an end of the stent-graft and an internal circumference of the lumen.
- fixation members 330 are shown only in Fig. 7, they may also be provided in the other configurations of stent-graft 90 described herein with reference to Figs.
- the fixation members are configured to provide secured positioning between at least an end of the stent-graft and an internal circumference of at least a branch of the lumen (e.g., a renal artery branching from the aorta).
- the fixation members may comprises atraumatic arms that are configured to extend into the branch.
- fixation members are configured to provide secured positioning between at least an end of the stent-graft and an external or internal circumference of another tubular stent-graft, e.g., are configured to allow telescopic anchoring of stent-graft 90 inside another stent-graft.
- Fig. 13 is a schematic illustration of a stent-graft 400, in accordance with an application of the present invention.
- Stent-graft 400 combines certain features of stent-graft 20, described hereinabove with reference to Figs. 1A-5, and certain features of stent-graft 90, described hereinabove with reference to Figs. 6-12B.
- Stent-graft 400 includes both compliance-restoration body portion 34 and variable-length section 120. Stent-graft 400 thus provides both the axial and radial compliance described hereinabove.
- Stent-graft 400 may implement the configuration of compliance-restoration body portion 34 described hereinabove with reference to Figs. 1A-B (as shown in Fig. 13), or any of the other configurations of compliance-restoration body portion 34 described hereinabove with reference to Figs. 2A-4.
- stent-graft 400 may implement the configuration of variable-length section 120 described hereinabove with reference to Figs. 6, 7, and 8A-B (as shown in Fig. 13), or any of the other configurations of variable-length section 120 described hereinabove with reference to 9- 12B.
- tubular means having the form of an elongated hollow object that defines a conduit therethrough.
- a “tubular” structure may have varied cross-sections therealong, and the cross-sections are not necessarily circular.
- one or more of the cross-sections may be generally circular, or generally elliptical but not circular, or circular.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Prostheses (AREA)
Abstract
An endovascular stent-graft (20) includes a generally tubular body (22), which is configured to assume a radially-compressed delivery state and a radially-expanded deployment state. The body (22) includes a flexible stent member (24), and a tubular fluid flow guide (26) attached to the stent member (24). The body (22) includes a compliance-restoration body portion (34), which extends axially along a portion of the body, and which comprises a portion of the stent member (24) and a portion of the fluid flow guide (26). When the body (22) is in the radially-expanded deployment state, the compliance-restoration body portion (34) is (a) characterized by a greatest diastolic outer radius (RD) when the body (22) is internally pressurized by fluid having a pressure of 80 mmHg, and (b) radially expandable to a greatest systolic outer radius (RS) when the body (22) is internally pressurized by fluid having a pressure of 120 mmHg. The greatest systolic outer radius (RS) is at least 5% greater than the greatest diastolic outer radius (RD).
Description
STENT-GRAFTS WITH POST-DEPLOYMENT VARIABLE AXIAL AND RADIAL
DISPLACEMENT
CROSS-REFERENCE TO RELATED APPLICATIONS
The present application claims priority from US Provisional Application 61/528,242, filed August 28, 2011, and US Provisional Application 61/553,209, filed October 30, 2011, both of which are assigned to the assignee of the present application and are incorporated herein by reference.
FIELD OF THE APPLICATION
This present application relates generally to prostheses and surgical methods, and specifically to tubular prostheses, including endovascular steni-grafts, and surgical techniques for using the prostheses to maintain patency of body passages such as blood vessels, and treating aneurysms.
BACKGROUND OF THE APPLICATION
Endovascular prostheses are sometimes used to treat aortic aneurysms. Such treatment includes implanting a stent or stent-graft within the diseased vessel to bypass the anomaly. An aneurysm is a sac formed by the dilation of the wall of the artery. Aneurysms may be congenital, but are usually caused by disease or, occasionally, by trauma. Aortic aneurysms include abdominal aortic aneurysms ("AAAs"), which form between the renal arteries and the iliac arteries, and thoracic aortic aneurysms ("TAAs"), which may occur in one or more of the descending aorta, the ascending aorta, and the aortic arch.
SUMMARY OF APPLICATIONS
Some applications of the present invention provide endovascular stent-grafts characterized by high physiological compliance. Such high physiological compliance minimizes the effect of the stent-grafts on the pulse profile of a blood vessel in which the stent-grafts are implanted, such as the aorta. Large-caliber arteries, in particular the aorta, provide the majority of arterial vascular compliance. The aorta and the branching large blood vessels thus act as a mechanical capacitor that expands during systole and contracts during diastole. Conventional endovascular stent-grafts often comprise substantially non-
compliant graft materials, and even when such stent-grafts utilize relatively flexible medical fabrics, the stent-grafts are usually essentially fully expanded under diastolic arterial pressure. As a result, conventional stent-grafts substantially do not radially pulsate with the systolic cycle. Therefore, implantation of conventional stent-grafts results in the replacement of a large portion of a compliant aorta with a non- or low- compliant prosthesis. Conventional endovascular stent-grafts thus generally change the aortic pulse profile. Such a reduction in the overall vascular compliance may have deleterious cardiovascular effects, by increasing the load of the heart and/or decreasing the effectiveness of propagation of the systolic pulse from the heart into the smaller- caliber vasculature.
Some applications of the present invention provide endovascular stent-grafts that have beneficial effects on the peripheral vascular load, while using well-proven, gold- standard, medical-grade textiles and metallic alloys. The stent-grafts are configured to provide mechanical compliance that maintains (or, in some cases, even restores) the native, healthy, physiological compliance of the arterial segment in which the stent-grafts are implanted.
In some applications of the present invention, an endovascular stent-graft comprises a generally tubular body, which is configured to assume a radially-compressed delivery state and a radially-expanded deployment state. The body comprises a flexible stent member and a tubular fluid flow guide. The tubular flow guide comprises a graft material, which is generally non- or minimally-elastic. The body includes a compliance- restoration body portion that extends axially along a portion of the body. When the body is in the radially-expanded deployment state, the compliance-restoration body portion is (a) characterized by a greatest diastolic outer radius when the body is internally pressurized by fluid having a pressure of 80 mmHg, typically by blood during diastole in an adult human, and (b) radially expandable to a greatest systolic outer radius when the body is internally pressurized by fluid having a pressure of 120 mmHg, typically by blood during systole in an adult human. The greatest systolic outer radius is typically at least 5% greater than the greatest diastolic outer radius, such as at least 10%, e.g., 15%, greater than greatest diastolic outer radius. This increase in outer radius at greater internal pressure occurs because the stent is heat-set to have a diameter that is substantially (e.g., 5% - 20%) less than the graft's fully-expanded (i.e., without folds) diameter, and the stent has the appropriate radial compliance such that the entire stent-graft substantially changes
its radius between a state in which the stent-graft is internally pressurized by a nominal hydrostatic diastolic pressure and a state in which the stent-graft is internally pressurized by a nominal hydrostatic systolic pressure.
For example, the stent member may comprise a highly elastic (e.g. flexible stainless steel) or a superelastic (e.g. Nitinol) alloy that is heat-set to have a first relaxed outer diameter, e.g., 23 mm, along the compliance-restoration body portion when the body is not internally pressurized by fluid. The tubular flow guide is configured to have a greater, second outer diameter, e.g., 30 mm, when internally pressurized to systolic pressure, e.g., 120 mmHg. When pressurized by fluid having a diastolic pressure, e.g., 80 mmHg, the compliance-restoration body portion assumes a diastolic outer diameter that is slightly larger than the first relaxed outer diameter, e.g., between 26 and 27 mm. When pressurized by the fluid having systolic pressure, e.g., 120 mmHg, the compliance- restoration body portion assumes a systolic outer diameter equal to the second outer diameter, e.g., 30 mm, as limited by the diameter of the non-compliant graft material. For some applications, proximal and distal end-portions of the stent-graft have respective relaxed outer diameters that are greater than the first relaxed outer diameter, which may help provide good fixation and sealing with the blood vessel wall.
In contrast, conventional thoracic aortic stent-grafts often comprise a Nitinol stent skeleton having a heat-set diameter of 32 mm and a tubular woven PET graft cylinder having a diameter of 30 mm, sewn to the stent skeleton. Such conventional stent-grafts may have a relaxed diameter of 30 mm, and do not allow for further expansion during systole. Conventional stent-grafts thus do not provide the radial compliance provided by some applications of the present invention.
In some applications of the present invention, a variable-length endovascular stent-graft comprises a generally tubular body, which comprises a fluid flow guide and a plurality of structural stent elements attached to at least a portion of the fluid flow guide. The body includes a variable-length section that extends axially along a portion of body. The body, including the variable-length section, is configured to assume a radially- compressed delivery state and a radially-expanded deployment state. The variable-length section, while radially-expanded in the deployment state, is configured to enable a change in an axial length thereof of at least 5 mm.
This change in axial length enables the stent-graft to accommodate any elongation
of the blood vessel between the ends of the stent-graft that may occur after implantation of the stent-graft. Such elongation often occurs after implantation of a stent-graft. Because the stent-graft excludes the aneurysm from the blood circulation, the aneurysm thromboses, decomposes and shrinks, causing the blood vessel to become longer and narrower. Typically, such elongation occurs over a long period of time, and the stent- graft provides long-term accommodation of the elongation. Such accommodation decreases the risk of the stent-graft becoming dislodged, and decreases the risk of endoleak. Alternatively or additionally, this change in axial length provides axial compliance for reducing vascular resistance, similar to the radial compliance described above.
When the body is in the radially-expanded deployment state, the variable-length section is configured to assume an axially-shortest state thereof, in which state typically one or more of the structural stent elements are arranged along the variable-length section such that the variable-length section has no structural-stent-element-free axial portions having axial lengths greater than 5% of a greatest outer diameter of the fluid flow guide along the variable-length section when in its axially-shortest state; for some applications, the variable-length section has no structural-stent-element-free portions when in its axially-shortest state. Typically, the variable-length section is configured such that the structural stent elements thereof do not undergo plastic deformation as the axial-length changes.
Typically, the body is configured such that elasticity of graft material of the fluid flow guide provides less than 5% of a change in an axial length of the variable-length section. In other words, the change in the axial length of the variable-length section is not primarily enabled by stretching of the graft material of the fluid flow guide. There is therefore provided, in accordance with an application of the present invention, apparatus including an endovascular stent-graft, which includes a generally tubular body, which body (a) is configured to assume a radially-compressed delivery state and a radially-expanded deployment state, and (b) includes:
a flexible stent member; and
a tubular fluid flow guide, which includes a graft material, and is attached to the stent member,
wherein the body includes a compliance-restoration body portion, which extends axially along a portion of the body, and which includes a portion of the stent member and a portion of the fluid flow guide,
wherein, when the body is in the radially-expanded deployment state, the compliance-restoration body portion is (a) characterized by a greatest diastolic outer radius when the body is internally pressurized by fluid having a pressure of 80 mmHg, and (b) radially expandable to a greatest systolic outer radius when the body is internally pressurized by fluid having a pressure of 120 mmHg, and
wherein the greatest systolic outer radius is at least 5% greater than the greatest diastolic outer radius, such as at least 10% greater than the greatest diastolic outer radius.
For some applications, the fluid flow guide of the compliance-restoration body portion is shaped so as to be expandable to a maximum greatest outer radius equal to the greatest systolic outer radius of the compliance-restoration body portion, such that the compliance-restoration body portion is limited by the fluid flow guide from assuming an outer radius that is greater than the maximum greatest outer radius.
For some applications, the stent member is heat-set to cause the compliance- restoration body portion to assume the greatest diastolic outer radius when the body is internally pressurized by the fluid having the pressure of 80 mmHg.
For any of the applications described above, when the body is in the radially- expanded deployment state, the compliance-restoration body portion may be characterized by a greatest relaxed outer radius when the body is not internally pressurized by fluid, which greatest relaxed outer radius is no more than 95% of the greatest diastolic outer radius. For some applications, the stent member is heat-set to cause the compliance- restoration body portion to assume the greatest relaxed outer radius when unconstrained.
For any of the applications described above, the graft material may include a woven graft.
For any of the applications described above, the graft material of the portion of the fluid flow guide may be at least partially folded when the body is in the radially-expanded deployment state and is internally pressured by the fluid of having the pressure of 80 mmHg.
For any of the applications described above, the fluid flow guide, if not attached to the stent member, may be configured to assume first and second perimeters when
internally pressurized by fluid having a pressure of 80 and 120 mmHg, respectively, the second perimeter being no more than 10% greater than the first perimeter.
For any of the applications described above, the fluid flow guide, if not attached to the stent member, may be configured to assume first and second perimeters when internally pressurized by fluid having a pressure of 80 and 120 mmHg, respectively, the second perimeter being between 0.5% and 5% greater than the first perimeter.
For any of the applications described above, the stent member may include a plurality of structural stent elements that are indirectly connected to one another by the fluid flow guide.
For any of the applications described above, the stent member may include a plurality of interconnected structural stent elements.
For any of the applications described above, the greatest systolic outer radius may be no more than 30% greater than the greatest diastolic outer radius.
For any of the applications described above, the greatest diastolic outer radius may be between 7.5 mm and 25 mm, when the body is in the radially-expanded deployment state.
For any of the applications described above, the greatest systolic outer radius may be between 8.5 mm and 30 ram, when the body is in the radially-expanded deployment state.
For any of the applications described above, the body may further includes distal and proximal portions, longitudinally between which the compliance-restoration body portion is disposed,
when the body is in the radially-expanded deployment state, the distal and proximal portions may be (a) characterized by greatest diastolic distal- and proximal-end- portion radii, respectively, when the body is internally pressurized by fluid having a pressure of 80 mmHg, and (b) radially expandable to greatest systolic distal- and proximal-end-portion radii, respectively, when the body is internally pressurized by fluid having a pressure of 120 mmHg,
the greatest systolic distal-end-portion outer radius may be less than 2% greater than the greatest diastolic distal-end-portion outer radius, and
the greatest systolic proximal-end-portion outer radius may be less than 2% greater than the greatest diastolic proximal-end-portion outer radius.
For any of the applications described above, the body may further include distal and proximal portions, longitudinally between which the compliance-restoration body portion is disposed, and respective greatest radii of the distal and the proximal portions may be each at least 5% greater than a greatest relaxed outer radius of the compliance- restoration body portion, when the body is unconstrained in the radially-expanded deployment state.
For any of the applications described above, the body may further include distal and proximal portions, longitudinally between which the compliance-restoration body portion is disposed, and respective greatest radii of the distal and the proximal portions may be each at least 5% greater than the greatest diastolic outer radius, when the body is in the radially-expanded deployment state.
For any of the applications described above, the body may further include distal and proximal portions, longitudinally between which the compliance-restoration body portion is disposed, and a greatest outer radius of the distal portion, when unconstrained, may be between 2 and 10 mm greater than the greatest systolic outer radius, when the body is in the radially-expanded deployment state.
For any of the applications described above, the graft material may include a material selected from the group of materials consisting of: Polyethylene terephthalate (PET), Dacron, Polytetrafluoroethylene (PTFE), ePTFE, and a combination of two or more of these materials.
For any of the applications described above, the stent member may include a superelastic alloy.
For any of the applications described above, the stent-graft may be configured to self-expand from the delivery state to the deployment state.
For any of the applications described above:
the flexible stent member may include a plurality of structural stent elements attached to at least a portion of the fluid flow guide,
the body may include a variable-length section, which extends axially along a portion of the body, and which includes one or more of the structural stent elements and a portion of the fluid flow guide,
the body, including the variable-length section, may be configured to assume the radially-compressed delivery state and the radially-expanded deployment state,
wherein, when the body is in the radially-expanded deployment state, the variable- length section may be configured to:
enable a change in an axial length thereof of at least 5 mm, and assume an axially-shortest state thereof, in which state the one or more of the structural stent elements are arranged along the variable-length section such that the variable-length section has no structural-stent-element-free axial portions having axial lengths greater than 5% of a greater outer diameter of the fluid flow guide along the variable-length section when in its axially-shortest state.
There is further provided, in accordance with an application of the present invention, apparatus including an endovascular stent-graft, which includes a generally tubular body, which body includes:
a fluid flow guide, which includes a graft material; and
a plurality of structural stent elements attached to at least a portion of the fluid flow guide,
wherein the body includes a variable-length section, which extends axially along a portion of the body, and which includes one or more of the structural stent elements and a portion of the fluid flow guide,
wherein the body, including the variable-length section, is configured to assume a radially-compressed delivery state and a radially-expanded deployment state,
wherein, when the body is in the radially-expanded deployment state, the variable- length section is configured to:
enable a change in an axial length thereof of at least 5 mm, and assume an axially-shortest state thereof, in which state the one or more of the structural stent elements are arranged along the variable-length section such that the variable-length section has no structural-stent-element-free axial portions having axial lengths greater than 5% of a greatest outer diameter of the fluid flow guide along the variable-length section when in its axially-shortest state.
For some applications, the one or more of the structural stent elements are arranged along the variable-length section such that the variable-length section has no structural-stent-element-free axial portions, when the variable-length section is in the axially-shortest state when the body is in the radially-expanded deployment state.
For some applications, the body is configured such that elasticity of the graft material provides less than 5% of the change in the axial length of the variable-length section.
For some applications, the variable-length section is configured such that the structural stent elements thereof do not undergo plastic deformation during the change in axial length.
For some applications, the variable-length section is configured such that the enabled change in the axial length is no more than 10% of a greatest outer diameter of the fluid flow guide along the variable-length section when the variable-length section is in the axially-shortest state.
For any of the applications described above, the variable-length section may be configured such that the enabled change in the axial length is equal to at least 10% of a greatest outer diameter of the fluid flow guide along the variable-length section when the variable-length section is in the axially-shortest state.
For any of the applications described above, a surface coverage ratio of the one or more of the structural stent elements of the variable-length section on the fluid flow guide may be equal to at least 5% when the variable-length section is in the axially-shortest state when the body is in the radially-expanded deployment state.
For any of the applications described above, when the body is in the radially- expanded deployment state, the variable-length section may be configured to undergo the change in the axial length in response to a change in fluid pressure within the fluid flow guide.
For any of the applications described above, when the body is in the radially- expanded deployment state, the variable-length section may be configured to undergo an increase in the axial length, and not a decrease in the axial length.
For any of the applications described above, when the body is in the radially- expanded deployment state, the variable-length section may be configured to cyclically undergo an increase in the axial length that alternates with a decrease in the axial length.
For any of the applications described above, the variable-length section may be configured to undergo (a) an increase in the axial length in response to an increase in fluid
pressure within the fluid flow guide, and (b) a decrease in the axial length in response to a decrease in the fluid pressure within the fluid flow guide.
For any of the applications described above, the variable-length section may be configured to undergo (a) an increase in the axial length in response to a decrease in fluid pressure within the fluid flow guide, and (b) a decrease in the axial length in response to an increase in the fluid pressure within the fluid flow guide.
For any of the applications described above, the variable-length section may be configured such that during a 5 mm change in the axial length, an average wall thickness of the graft material changes by no more than 15%.
For any of the applications described above, the variable-length section may be configured to assume a folded position at least when the variable-length section is in the axially-shortest state, in which folded position a first longitudinal subsection of the fluid flow guide is radially sandwiched between second and third longitudinal subsections of the fluid flow guide.
For any of the applications described above, the variable-length section may be configured such that in the folded position the second longitudinal subsection radially surrounds the first longitudinal subsection, and at least one of the one or more of the structural stent elements of the variable-length section is attached to the second longitudinal subsection. For some applications, the variable-length section is configured such that in the folded position the first longitudinal subsection radially surrounds the third longitudinal subsection, and at least one of the one or more of the structural stent elements of the variable-length section is attached to the third longitudinal subsection. For some applications, the variable-length section is configured such that none of the structural stent elements of the body is attached to the first longitudinal subsection.
For any of the applications described above, the variable-length section may be shaped so as to define, at least when the variable-length section is in the axially-shortest state, a radially-outward bulge at least partially around a perimeter of an axial site on the variable-length section, which radially-outward bulge includes the one or more of the structural elements of the variable-length section. For some applications, the variable- length section is configured such that a radial dimension of the bulge decreases as the axial length of the variable-length section increases. For some applications, the variable- length section, when in an axially-longest state, is not shaped so as to define the bulge.
For any of the applications described above, the variable-length section may be shaped so as to define, at least when the variable-length section is in the axially-shortest state, a radially-inward indentation at least partially around a perimeter of an axial site on the variable-length section, which indentation includes the one or more of the structural elements of the variable-length section. For some applications, the variable-length section is configured such that a radial dimension of the indentation decreases as the axial length of the variable-length section increases. For some applications, the variable-length section, when in an axially-longest state, is not shaped so as to define the indentation.
For any of the applications described above, the variable-length section may be configured such that when the variable-length section undergoes the change in the axial length, a proximal end of the variable-length section rotates with respect to a distal end of the variable-length section.
For any of the applications described above, the variable-length section may be shaped so as to define, at least when the variable-length section is in the axially-shortest state, at least one single-sided helix, which includes the one or more of the structural elements. For some applications, the variable-length section is configured such that a step size of the at least one-single-sided helix increases as the axial length of the variable- length section increases.
For any of the applications described above, the variable-length section may be shaped so as to define, at least when the variable-length section is in the axially-shortest state, at least one right-handed helix and at least one left-handed helix, which helices include the one or more of the structural elements. For some applications, the variable- length section is configured such that respective step sizes of the right- and left-handed helices either both increase, or both decrease as axial length of the variable-length section increases.
For any of the applications described above:
the body may include a compliance-restoration body portion, which extends axially along a portion of the body, and which includes a portion of the structural stent elements and a portion of the fluid flow guide,
when the body is in the radially-expanded deployment state, the compliance- restoration body portion may be (a) characterized by a greatest diastolic outer radius when the body is internally pressurized by fluid having a pressure of 80 mmHg, and (b) radially
expandable to a greatest systolic outer radius when the body is internally pressurized by fluid having a pressure of 120 mmHg, and
the greatest systolic outer radius may be at least 5% greater than the greatest diastolic outer radius. There is still further provided, in accordance with an application of the present invention, a method including:
providing an endovascular stent-graft, which includes a generally tubular body, which includes a flexible stent member, and a tubular fluid flow guide, which includes a graft material, and is attached to the stent member, wherein the body includes a compliance-restoration body portion, which extends axially along a portion of the body, and which includes a portion of the stent member and a portion of the fluid flow guide; transvascularly introducing the stent-graft into a blood vessel of a human subject while the body is in a radially-compressed delivery state; and
thereafter, transitioning the body to a radially-expanded deployment state in the blood vessel, in which state the compliance-restoration body portion is characterized by (a) a greatest diastolic outer radius when the body is internally pressurized by blood of the subject during diastole, and (b) a greatest systolic outer radius when the body is internally pressurized by blood of the subject during systole, which greatest systolic outer radius is at least 5% greater than the greatest diastolic outer radius.
For some applications, transitioning the body to the deployment state includes allowing the body to self-expand.
For some applications, the greatest systolic outer radius is at least 10% greater than the greatest diastolic outer radius.
For some applications, providing the stent-graft includes providing the stent-graft in which the fluid flow guide of the compliance-restoration body portion is shaped so as to be expandable to a maximum greatest outer radius equal to the greatest systolic outer radius of the compliance-restoration body portion, such that the compliance-restoration body portion is limited by the fluid flow guide from assuming an outer radius that is greater than the maximum greatest outer radius.
For some applications, providing the stent-graft includes providing the stent-graft in which the fluid flow guide, if not attached to the stent member, is configured to assume first and second perimeters when internally pressurized by fluid having a pressure of 80
and 120 mmHg, respectively, the second perimeter being no more than 10% greater than the first perimeter.
For some applications:
the body further includes distal and proximal portions, longitudinally between which the compliance-restoration body portion is disposed,
when the body is in the radially-expanded deployment state, the distal and proximal portions are characterized by (a) greatest diastolic distal- and proximal-end- portion radii, respectively, when the body is internally pressurized by the blood during diastole, and (b) greatest systolic distal- and proximal-end-portion radii, respectively, when the body is internally pressurized by the blood during systole,
the greatest systolic distal-end-portion outer radius is less than 2% greater than the greatest diastolic distal-end-portion outer radius, and
the greatest systolic proximal-end-portion outer radius is less than 2% greater than the greatest diastolic proximal-end-portion outer radius.
For some applications, the greatest systolic outer radius is no more than 30% greater than the greatest diastolic outer radius.
For some applications:
the flexible stent member includes a plurality of structural stent elements attached to at least a portion of the fluid flow guide,
the body includes a variable-length section, which extends axially along a portion of the body, and which includes one or more of the structural stent elements and a portion of the fluid flow guide,
the body, including the variable-length section, is configured to assume the radially-compressed delivery state and the radially-expanded deployment state,
after the body is transitioned to the radially-expanded deployment state, the variable-length section is configured to enable a change in an axial length thereof of at least 5 mm, and
if the variable-length section assumes an axially-shortest state thereof while the body is in the radially-expanded deployment state, the one or more of the structural stent elements are arranged along the variable-length section such that the variable-length section has no structural-stent-element-free axial portions having axial lengths greater than 5% of a greatest outer diameter of the fluid flow guide along the variable-length section when in its axially-shortest state.
There is additionally provided, in accordance with an application of the present invention, a method including:
providing an endovascular stent-graft, which includes a generally tubular body, which includes a fluid flow guide, which includes a graft material, and a plurality of structural stent elements attached to at least a portion of the fluid flow guide, wherein the body includes a variable-length section, which extends axially along a portion of the body, and which includes one or more of the structural stent elements and a portion of the fluid flow guide,
transvascularly introducing the stent-graft into a blood vessel of a human subject while the body, including the variable-length section, is in a radially-compressed delivery state; and
thereafter, transitioning the body to a radially-expanded deployment state in the blood vessel, in which state the variable-length section is configured to enable a change in an axial length thereof of at least 5 mm,
wherein, if the variable-length section assumes an axially- shortest state thereof while the body is in the radially-expanded deployment state, the one or more of the structural stent elements are arranged along the variable-length section such that the variable-length section has no structural-stent-element-free axial portions having axial lengths greater than 5% of a greatest outer diameter of the fluid flow guide along the variable-length section when in its axially-shortest state.
For some applications, if the variable-length section assumes an axially-shortest state thereof while the body is in the radially-expanded deployment state, the one or more of the structural stent elements are arranged along the variable-length section such that the variable-length section has no structural-stent-element-free axial portions.
For some applications, providing the stent-graft includes providing the stent-graft in which the body is configured such that elasticity of the graft material provides less than 5% of the change in the axial length of the variable-length section.
For some applications, providing the stent-graft includes providing the stent-graft in which the variable-length section is configured such that the structural stent elements thereof do not undergo plastic deformation during the change in axial length.
For some applications, providing the stent-graft includes providing the stent-graft in which the variable-length section is configured such that the enabled change in the
axial length is no more than 10% of a greatest outer diameter of the fluid flow guide along the variable-length section when the variable-length section is in the axially-shortest state.
For some applications, when the body is in the radially-expanded deployment state, the variable-length section is configured to undergo the change in the axial length in response to a change in fluid pressure within the fluid flow guide.
For some applications, when the body is in the radially-expanded deployment state, the variable-length section is configured to undergo an increase in the axial length, and not a decrease in the axial length.
For some applications, when the body is in the radially-expanded deployment state, the variable-length section is configured to cyclically undergo an increase in the axial length that alternates with a decrease in the axial length. For some appHcations, the variable-length section is configured to undergo (a) an increase in the axial length in response to an increase in fluid pressure within the fluid flow guide, and (b) a decrease in the axial length in response to a decrease in the fluid pressure within the fluid flow guide.
For some applications, the variable-length section is configured such that during a
5 mm change in the axial length, an average wall thickness of the graft material changes by no more than 15%.
For some applications, the variable-length section is configured to assume a folded position at least when the variable-length section is in the axially-shortest state, in which folded position a first longitudinal subsection of the fluid flow guide is radially sandwiched between second and third longitudinal subsections of the fluid flow guide.
For some applications, the variable-length section is shaped so as to define, at least when the variable-length section is in the axially-shortest state, a radially-outward bulge at least partially around a perimeter of an axial site on the variable-length section, which radially-outward bulge includes the one or more of the structural elements of the variable- length section.
For some applications, the variable-length section is shaped so as to define, at least when the variable-length section is in the axially-shortest state, a radially-inward indentation at least partially around a perimeter of an axial site on the variable-length section, which indentation includes the one or more of the structural elements of the variable-length section.
For some applications, the body includes a compliance-restoration body portion, which extends axially along a portion of the body, and which includes a portion of the structural stent elements and a portion of the fluid flow guide; and after the body is transitioned to the radially-expanded deployment state, the compliance-restoration body portion is characterized by (a) a greatest diastolic outer radius when the body is internally pressurized by blood flow of the subject during diastole, and (b) a greatest systolic outer radius when the body is internally pressurized by blood of the subject during systole, which greatest systolic outer radius is at least 5% greater than the greatest diastolic outer radius. The present invention will be more fully understood from the following detailed description of applications thereof, taken together with the drawings, in which:
BRIEF DESCRIPTION OF THE DRAWINGS
Figs. 1A and IB are schematic illustrations of an endovascuiar stent-graft, in accordance with an application of the present invention;
Figs. 2A and 2B are schematic illustrations of another configuration of the endovascuiar stent-graft of Figs. 1A and IB, in accordance with an application of the present invention;
Figs. 3A-C are schematic illustrations of yet another configuration of the endovascuiar stent-graft of Figs. 1A and IB, in accordance with an application of the present invention;
Fig. 4 is a schematic illustration of still another configuration of the endovascuiar stent-graft of Figs. 1A and IB, in accordance with an application of the present invention;
Fig. 5 is a graph that schematically illustrates the stent-graft caliber of a compliance-restoration body portion of the endovascuiar stent-graft of Figs. 1A-4 vs. internal fluid pressure, in accordance with an application of the present invention;
Fig. 6 is a schematic illustration of a variable-length stent-graft, in accordance with an application of the present invention;
Fig. 7 is a schematic illustration of the variable-length stent-graft of Fig. 6 coupled to a bifurcated fixation stent-graft, in accordance with an application of the present invention;
Figs. 8 A and 8B are schematic illustrations of the variable-length stent-graft of Fig. 6 in exemplary axially-shorter and axially-longer states, respectively, in accordance with an application of the present invention;
Figs. 9A and 9B are schematic illustrations of additional variable-length stent- grafts, in accordance with respective applications of the present invention;
Figs. 10A and 10B are schematic illustrations of the variable-length stent-graft of Fig. 9A in exemplary axially-shorter and axially-longer states, respectively, in accordance with an application of the present invention;
Figs. 11 is a schematic illustration of yet another variable-length stent-graft, in accordance with an application of the present invention;
Figs. 12A and 12B are schematic illustrations of the variable-length stent-graft of Fig. 11 in exemplary axially-shorter and axially-longer states, respectively, in accordance with an application of the present invention; and
Fig. 13 is a schematic illustration of another stent-graft, which combines certain features of the stent-grafts of Figs. 1A-B and 6, in accordance with an application of the present invention.
DETAILED DESCRIPTION OF APPLICATIONS
Figs. 1A and IB are schematic illustrations of an endovascular stent-graft 20, in accordance with an application of the present invention. Stent-graft 20 comprises a generally tubular body 22 having a central longitudinal axis 23. Body 22 is configured to assume (a) a radially-compressed delivery state, typically when the body is initially positioned in a delivery catheter, and (b) a radially-expanded deployment state, upon deployment from the delivery catheter. Both Figs. 1A and IB show the stent-graft with body 22 in its radially-expanded deployment state. Body 22 is shown during diastole of an adult human in Fig. 1 A, and during systole of the adult human in Fig. IB.
Body 22 comprises a flexible stent member 24, and a tubular fluid flow guide 26. The fluid flow guide is attached to the stent member, such as by suturing or stitching. The flexible stent member may be attached to an internal and/or an external surface of the fluid flow guide. Optionally, a portion of the structural stent elements may be attached (e.g., sutured) to the internal surface of the fluid flow guide, and another portion to the external surface of the fluid flow guide. Flexible stent member 24 comprises a plurality
of structural stent elements 28, which are either indirectly connected to one another by the fluid flow guide (as shown), and/or interconnected with one another (configuration not shown). For some applications, structural stent elements 24 comprise a metal. Alternatively or additionally, the structural stent elements comprise a self-expanding material, such that body 22 (and, optionally, stent- graft 20) is self-expandable. Alternatively or additionally, the structural stent elements comprise one or more metallic alloys, such as one or more superelastic metal alloys, a shape memory metallic alloy, and/or Nitinol.
Fluid flow guide 26 comprises a graft material, i.e., at least one biologically- compatible substantially blood-impervious flexible sheet. The flexible sheet may comprise, for example, a polyester, a polyethylene (e.g., a poly-ethylene-terephthalate), a polymeric film material (such as a fluoropolymer, e.g., polytetrafluoroethylene), a polymeric textile material (e.g., woven polyethylene terephthalate (PET)), natural tissue graft (e.g., saphenous vein or collagen), Polytetrafluoroethylene (PTFE), ePTFE, Dacron, or a combination of two or more of these materials. The graft material optionally is woven. The graft material of fluid flow guide 26 is generally non- or minimally-elastic.
Typically, stent-graft 20 is configured to self-expand from the delivery state to the deployment state. For example, stent member 24 may be heat-set to cause stent-graft 20 to self-expand from the delivery state to the deployment state.
Body 22 includes a compliance-restoration body portion 34, which extends axially along a portion of body 22, and which comprises a portion of stent member 24 and a portion of fluid flow guide 26. When body 22 is in the radially-expanded deployment state, as shown in Figs. 1A and IB, compliance-restoration body portion 34 is:
• characterized by a greatest diastolic outer radius Rj) when body 22 is
internally pressurized by fluid having a pressure of 80 mmHg, typically by blood during diastole in an adult human, as shown in Fig. 1A (and also by dashed lines in Fig. IB); and
• radially expandable to a greatest systolic outer radius Rs when body 22 is
internally pressurized by fluid having a pressure of 120 mmHg, typically by blood during systole in an adult human, as shown in Fig. IB. For some applications, compliance-restoration body portion 34 expands to greatest
systolic outer radius Rg even when the body is internally pressured by fluid having a pressure of greater than 120 mmHg.
Greatest systolic outer radius Rg is typically at least 5% greater than greatest diastolic outer radius Rrj>, such as at least 10% greater than greatest diastolic outer radius R j, e.g., at least 15% greater than greatest diastolic outer radius Rj Alternatively or additionally, greatest systolic outer radius Rg is no more than 30% greater than the greatest diastolic outer radius R This increase in outer radius at greater internal pressure occurs because the stent is heat-set to have a diameter that is substantially (e.g., 5% - 20%) less than the graft's fully-expanded (i.e., without folds) diameter, and the stent has the appropriate radial compliance such that the entire stent-graft substantially changes its radius between a state in which the stent-graft is internally pressurized by a nominal hydrostatic diastolic pressure and a state in which the stent-graft is internally pressurized by a nominal hydrostatic systolic pressure.
For some applications, fluid flow guide 26 of compliance-restoration body portion 34 is shaped so as to be expandable to a maximum greatest outer radius R equal to greatest systolic outer radius Rg of compliance-restoration body portion 34, such that the compliance-restoration body portion is limited by the fluid flow guide from assuming an outer radius that is greater than the maximum greatest outer radius Rjyj. (The outer radius might not otherwise be limited by stent member 24, which is typically highly compliant and deformable, e.g., initially highly elastically deformable and subsequently, plastically deformable.) Typically, maximum greatest outer radius R]yj of fluid flow guide 26 is greater than the greatest diastolic outer radius of stent member 24, such as at least 5%, at least 10%, or at least 20% greater than greatest diastolic outer radius Rj) of stent member 24. During diastole, the inward compressive force applied by stent-member 24 is countered by the outward force applied by the internally pressurizing fluid (typically, diastoHcally-pressurized blood). These opposing forces jointly retain the fluid flow guide (and thus the entire compliance-restoration body portion 34) at greatest diastolic outer radius Rr
For some applications, when body 22 is in the radially-expanded deployment state: (a) greatest diastolic outer radius Rj) is at least 7.5 mm, no more than 25 mm, and/or between 7.5 mm and 25 mm, and/or (b) greatest systolic outer radius Rg is at least 8.5 mm, no more than 30 mm, and/or between 8.5 mm and 30 mm.
As mentioned above, the graft material of fluid flow guide 26 is generally non- or minimally-elastic. Therefore, when compliance-restoration body portion 34 is internally pressured by diastolic pressure, and is thus characterized greatest diastolic outer radius R j (which is less than maximum greatest outer radius Rj j of fluid flow guide 26), the graft material of the compliance-restoration portion is at least partially folded. In other words, during diastole, the outer radius of compliance-restoration body portion 34 is less than the maximum outer radius of the fluid flow guide (though the actual circumference of the fluid flow guide remains essentially the same, so the graft material of the fluid flow guide must assume small folds to accommodate this state). (The actual circumference is to be understood as measuring the actual length of the fabric's wall if the fabric were to be flattened to remove any folds, invaginations, or bulges caused by the radial contraction of the fluid flow guide.)
Fluid flow guide 26, if not attached to stent member 24 (e.g., before completion of manufacture of stent-graft 20), is configured to assume first and second perimeters when internally pressurized by fluid having a pressure of 80 and 120 mmHg, respectively. For some applications, the second perimeter is no more than 10% greater than the first perimeter, such as no more than 5% greater than the first perimeter. Alternatively or additionally, for some applications, the second perimeter is between 0.5% and 5% greater than the first perimeter.
For some applications, body 22 further includes distal and proximal portions 40 and 42, longitudinally between which compliance-restoration body portion 34 is disposed. When body 22 is in the radially-expanded deployment state, distal and proximal portions 40 and 42 are:
• characterized by greatest diastolic distal- and proximal-end-portion radii
RDD ^ RpD' respectively, when body 22 is internally pressurized by fluid having a pressure of 80 mmHg, typically by blood during diastole in an adult human, as shown in Fig. 1A; and
• radially expandable to greatest systolic distal- and proximal-end-portion
radii Rj^g and Rps> respectively, when body 22 is internally pressurized by fluid having a pressure of 120 mmHg, typically by blood during systole in an adult human, as shown in Fig. IB.
For some applications, greatest systolic distal-end-portion outer radius R$s is less than 2% greater than greatest diastolic distal-end-portion outer radius RDD' and °r greatest systolic proximal-end-portion outer radius Rpg is less than 2% greater than greatest diastolic proximal-end-portion outer radius Rpj> hi other words, the radii of distal and proximal portions 40 and 42 change only slightly, or not at all, during the transition between diastole and systole. (In contrast, the outer radius of compliance-restoration body portion 34 changes substantially (e.g., by at least 5%), during the transition between diastole and systole, as described above.)
Reference is still made to Figs. 1A and IB, and is additionally made to Figs. 2A and 2B, which are schematic illustrations of another configuration of endovascular stent- graft 20, in accordance with an application of the present invention. Both Figs. 2A and 2B show the stent-graft with body 22 in its radially-expanded deployment state. Body 22 is shown during diastole of an adult human in Fig. 2A, and during systole of the adult human in Fig. 2B.
In a first configuration, as shown in Figs. 1A and IB, stent-graft 20 is configured such that:
• greatest diastolic outer radius Rj) is approximately equal to (e.g., within
+/- 20% of) greatest diastolic distal-end-portion outer radius RDD and/or greatest diastolic proximal-end-portion outer radius RpD! aa^
· greatest systolic outer radius Rg is greater than (e.g., at least 5% greater
than, such as at least 15% greater than) greatest systolic distal-end-portion outer radius R jg and or greatest systolic proximal-end-portion outer radius Rpg.
In a second configuration, as shown in Figs. 2A and 2B, stent-graft 20 is configured such that:
• greatest diastolic distal-end-portion outer radius RDD is greater than (e.g.,
at least 5% greater than, such as at least 10% greater than) greatest diastolic outer radius Rj}, and/or greatest diastolic proximal-end-portion outer radius Rprj is greater than (e.g., at least 5% greater than, such as at least 10% greater than) greatest diastolic outer radius Rj and
Φ greatest systolic outer radius R<j is approximately equal to (e.g., within +/- 20% of) greatest systolic distal-end-portion outer radius Rpg and/or greatest systolic proximal-end-portion outer radius Rps-
In a third configuration (not shown), stent-graft 20 is configured such that:
greatest diastolic outer radius Rp is less than (e.g., at least 10% less than, such as at least 15% less than) greatest diastolic distal-end-portion outer radius DD and/or greatest diastolic proximal-end-portion outer radius Rppj; and
greatest systolic outer radius R<j is greater than (e.g., at least 10% greater than, such as at least 15% greater than) greatest systolic distal-end-portion outer radius RrjS ^ /or greatest systolic proximal-end-portion outer radius Rps-
Reference is now made to Figs. 3A-C, which are schematic illustrations of yet another configuration of endovascular stent-graft 20, in accordance with an application of the present invention. This configuration may be implemented in combination with any of the three configurations described immediately hereinabove with reference to Figs. 1A- B and 2A-B. All of Figs. 3A, 3B, and 3C show stent-graft 20 with body 22 in its radially- expanded deployment state. In this configuration, when body 22 is in its radially- expanded deployment state, compliance-restoration body portion 34, when not internally pressured by fluid, is characterized by a greatest relaxed outer radius RR that is less than greatest diastolic outer radius Rj) (and thus also less than even greater greatest systolic outer radius Rg). This greatest relaxed outer radius RR occurs only during manufacture and does not occur in vivo (except perhaps briefly during the implantation procedure), because upon deployment and radial expansion of body 22 to its radially-expanded deployment state, the body is internally subjected to at least diastolic blood pressure.
In Fig. 3A, body 22 is shown when it is not internally pressured by fluid. In this non-pressurized state, compliance-restoration body portion 34 is characterized by a greatest relaxed outer radius RR that is no more than 95% of greatest diastolic outer radius Rrj>, such as no more than 90% of greatest diastolic outer radius Rj . Typically, stent member 24 is heat- set to cause compliance-restoration body portion 34 to assume greatest relaxed outer radius RR when unconstrained, i.e., when no forces are applied to the compliance-restoration body portion by a delivery tool, walls of a blood vessel, or
otherwise. As used in the present application, including in the claims, an "unconstrained" element is an element to which no forces are applied by a delivery tool, walls of a blood vessel, or otherwise.
In Fig. 3B, body 22 is shown internally pressurized by fluid having a pressure of 80 mmHg, typically by blood during diastole in an adult human. In this diastolically- pressurized state, compliance-restoration body portion 34 is characterized by greatest diastolic outer radius RQ. AS described hereinabove with reference to Figs. 1A-B, during diastole, the inward compressive force applied by stent-member 24 is countered by the outward force applied by the internally pressurizing fluid (typically, diastolically- pressurized blood). These opposing forces jointly retain the fluid flow guide (and thus the entire compliance-restoration body portion 34) at greatest diastolic outer radius Rr
In Fig. 3C, body 22 is shown internally pressurized by fluid having a pressure of 120 mmHg, typically by blood during systole in an adult human. In this systolically- pressurized state, compliance-restoration body portion 34 is characterized by greatest diastolic outer radius Rg.
Reference is again made to Fig. 3A. For some applications, when body 22 is unconstrained in the radially-expanded deployment state, distal and proximal portions 40 and 42 are characterized by greatest relaxed distal- and proximal-end-portion radii RTJ>R and RpR, respectively, when body 22 is not internally pressurized by fluid. For some applications, when body 22 is in the radially-expanded deployment state, greatest relaxed distal-end-portion outer radius RDR is at least 5% greater than greatest relaxed outer radius RR of compliance-restoration body portion 34, and or greatest relaxed proximal- end-portion outer radius RpR is at least 5% greater than greatest relaxed outer radius RR. Such greater radii may help provide proper fixation to and sealing with the blood vessel wall.
Reference is now made to Fig. 4, which is a schematic illustration of yet another configuration of endovascular stent-graft 20, in accordance with an application of the present invention. Fig. 4 shows the stent-graft with body 22 in its radially-expanded deployment state during systole, with distal and proximal portions 40 and 42 shown by way of illustration in a radially-expanded state while unconstrained, i.e., while no forces are applied to these portions by a delivery tool, walls of a blood vessel, or otherwise. The
shape of compliance-restoration body portion 34 during diastole is also shown by dashed lines.
In this configuration, stent-graft 20 is configured such that:
• a greatest unconstrained distal-end-portion outer radius Rpu *s greater
than greatest systolic outer radius Rg, such as at least 5% greater than, e.g., as at least 15% greater than, and/or at least 2 mm greater than, no more than 10 mm greater than, or between 2 and 10 mm greater than greatest systolic outer radius Rg; and/or
• a greatest unconstrained proximal-end-portion outer radius Rpu is greater
than greatest systolic outer radius Rg, such as at least 5% greater than, e.g., as at least 15% greater than, and/or at least 2 mm greater than, no more than 10 mm greater than, or between 2 and 10 mm greater than greatest systolic outer radius Rg.
In addition, greatest systolic outer radius Rg is greater than greatest diastolic outer radius Rrj (e.g., at least 3% greater than, such as at least 5% greater than). For some applications, each of greatest unconstrained distal- and proximal-end-portion radii R jU and R u is at least 5 mm, no more than 20 mm, and/or between 10 and 30 mm, e.g., at least 11 mm, no more than 25 mm, and/or between 11 and 25 mm.
In this configuration, endovascular stent-graft 20 may be deployed in an aneurysmatic blood vessel, such as an aneurysmatic aorta, such as described hereinabove with reference to Figs. 1A-3C. Alternatively, endovascular stent-graft 20 may be deployed in a non-aneurysmatic blood vessel. In either case, the stent-graft may be configured to provide (passive, that is, by means of storage of mechanical energy) counterpulsation, by being configured to absorb and store blood pressure during systole and release and apply blood pressure during diastole. Counterpulsation is a technique for assisting the circulation by decreasing the afterload of the left ventricle and augmenting the diastolic pressure. Counterpulsation increases stroke volume by decreasing afterload, reduces heart workload, and maintains or increase coronary perfusion. Stent-graft 20 may thus be used, for example, for treating sclerotic disease in order to restore radial compliance of a blood vessel.
Reference is now made to Fig. 5, which is a graph that schematically illustrates the stent-graft caliber of compliance-restoration body portion 34 vs. internal fluid pressure, in
accordance with an application of the present invention. Stent-graft caliber of compliance-restoration body portion 34 is expressed as a percentage of maximum graft caliber (i.e., the graft caliber at burst pressure). As can be seen, while the caliber of distal and proximal portions 40 and 42 of body 22 of stent-graft 20 remain the same as internal fluid (e.g., blood) pressure increases and decreases, the caliber of compliance-restoration body portion 34 varies between about 70% and 100% of the maximum graft caliber as the internal fluid pressure changes.
In contrast, conventional stents-grafts that comprise polyethylene terephthalate (PET) or polytetrafluoroethylene (ePTFE, available under the trademark Gore-Tex®) maintain approximately 100% and 95%, respectively, of their maximum graft caliber as internal pressure varies in a physiologically-normal range. It is noted that even conventional stent-grafts that comprise graft material that allows a 5% change in graft caliber cannot increase by at least 5% in radius, because the stent elements of conventional stent-grafts are heat-set to hold the stent-graft in its maximum graft caliber even when not pressurized by physiological blood pressure from the inside.
Reference is now made to Figs. 6-12B, which are schematic illustrations of a variable-length endovascular stent-graft 90, in accordance with respective applications of the present invention.
Reference is made to Fig. 6, which is a schematic illustration of a variable-length stent-graft 100, in accordance with an application of the present invention. Variable- length stent-graft 100 is one implementation of variable-length-stent graft 90, described herein with reference to Figs. 6-12B. Stent-graft 100 comprises a generally tubular body 110, which comprises a fluid flow guide 112 and a plurality of structural stent elements 114 attached to at least a portion of the fluid flow guide. Body 110 includes a variable- length section 120 that extends axially along a portion of body 110. Body 110, including variable-length section 120, is configured to assume a radially-compressed delivery state and a radially-expanded deployment state. Typically, body 110 is configured to self- expand from the delivery state to the deployment state upon being deployed from a delivery catheter. Body 110 is shown in Figs. 6-12B in the radially-expanded deployment state.
Variable-length section 120, while radially-expanded in the deployment state, is configured to enable a change in an axial length thereof of at least 5 mm, such as at least 8
mm, e.g., at least 10 mm, and/or no more than 30 mm, e.g., no more than 25 mm. Alternatively or additionally, variable-length section 120 is configured such that the enabled change in the axial length is equal to at least 10%, e.g., at least 20%, and/or no more than 30%, e.g., no more than 10%, of outer diameter D of the fluid flow guide along the variable-length section when in its axially-shortest state ("greatest diameter" means the diameter at the longitudinal site having the greatest diameter). It is noted that even though the entire length of the stent-graft somewhat changes as the length of the variable- length section changes, the variable-length section should not be construed as including the entire length of the stent-graft. Instead, variable-length section 120 is to be understood as being that portion of the stent-graft that actually facilitates the change in axial length, as labeled in Figs. 6-12B.
When body 110 is in the radially-expanded deployment state, variable-length section 120 is configured to assume an axially-shortest state thereof. Typically, at least when variable-length section 120 is in this axially-shortest state, one or more of structural stent elements 114 are arranged along the variable-length section such that the variable- length section has no structural-stent-element-free axial portions having axial lengths greater than 5%, e.g., greater than 10%, of greatest outer diameter D of the fluid flow guide along the variable-length section when in its axially-shortest state; for some applications, the variable-length section has no structural-stent-element-free portions when in its axially-shortest state. Typically, variable-length section 120 is configured such that structural stent elements 114 thereof do not undergo plastic deformation as the axial length changes.
Fluid flow guide 112 comprises a graft material, i.e., at least one biologically- compatible substantially blood-impervious flexible sheet. The flexible sheet may comprise, for example, a polyester, a polyethylene (e.g., a poly-ethylene-terephthalate), a polymeric film material (such as a fluoropolymer, e.g., polytetrafluoroethylene), a polymeric textile material (e.g., woven polyethylene terephthalate (PET)), natural tissue graft (e.g., saphenous vein or collagen), Polytetrafluoroethylene (PTFE), ePTFE, Dacron, or a combination of two or more of these materials. The graft material optionally is woven. Typically, the graft material is not accordion-pleated. For some applications, structural stent elements 114 comprise a metal. Alternatively or additionally, the structural stent elements comprise a self -expanding material, such that body 110 (and, optionally, stent-graft 90) is self-expandable. Alternatively or additionally, the structural
stent elements comprise one or more metallic alloys, such as one or more superelastic metal alloys, a shape memory metallic alloy, and/or Nitinol.
For some applications, as shown in the blow-up in Fig. 6, variable-length stent- graft 100 is configured to define at least one generally tubular foldable section 130. For these applications, variable-length section 120 is configured to assume a folded position at least when variable-length section 120 is in the axially-shortest state. When the variable- length section is in which folded position, a first longitudinal subsection 132 of fluid flow guide 112 is radially sandwiched between second and third longitudinal subsections 134 and 136 of fluid flow guide 112. The variable-length section is typically configured to gradually unfold as the axial length thereof increases. In the folded position, second longitudinal subsection 134 radially surrounds the first longitudinal subsection 132, and first longitudinal subsection 132 radially surrounds third longitudinal subsection 136, such that first longitudinal subsection 132 is radially sandwiched between second and third longitudinal subsections 134 and 136. As a result, second subsection 134 at least partially longitudinally overlaps with both first and third longitudinal subsections 132 and 136.
For some applications, at least one of structural stent elements 114 is attached to second longitudinal subsection 134. Alternatively or additionally, for some applications, at least one of structural stent elements 114 is attached to third longitudinal subsection 136. Further alternatively or additionally, for some applications, an average surface coverage ratio of structural stent elements 114 on fluid flow guide 112 along first subsection 132 is no more than 20%, such as no more than 10%, of the greater of (a) an average surface coverage ratio on fluid flow guide 112 along second longitudinal subsection 134 and (b) an average surface coverage ratio on fluid flow guide 112 along third longitudinal subsection 136. For some applications, variable-length section 120 is configured such that none of structural stent elements 114 of body 110 is attached to first longitudinal subsection 132. This lower average surface coverage ratio (such as no surface coverage) provides greater evertibility to first longitudinal subsection 132, thereby enabling the transition of foldable section 130 from the folded state to the unfolded state. During this transition, first longitudinal subsection 132 is everted, i.e., turned inside-out.
Alternatively or additionally, the average surface coverage ratio of structural stent elements 114 on fluid flow guide 112 along first longitudinal subsection 132 is not necessarily no more than 20%. The greater evertibility of first longitudinal subsection
132 compared to second and third longitudinal subsections 134 and 136 may be provided
by:
• configuring the structural stent elements along the first longitudinal
subsection to be softer and/or thinner than the structural stent elements along the second and/or the third longitudinal subsections; and/or
· configuring the structural stent elements along the first longitudinal
subsection to be longitudinally short, e.g., as simple circles disposed circumferentially around the stent-graft. Optionally, the structural stent elements extend around less than 360 degrees of the circumference of the stent-graft, i.e., are circumferentially incomplete, in order to increase the evertibility of the first longitudinal subsection.
For some applications, a first subgroup of structural stent elements 114 is attached (e.g., sutured) to second longitudinal subsection 134, and a second subgroup of structural stent elements 114 is attached (e.g., sutured) to third longitudinal subsection 136. For some applications, one of the first and second subgroups of structural stent elements 114 is attached (e.g., sutured) to an internal surface of fluid flow guide 112, and the other of the first and second subgroups is attached (e.g., sutured) to an external surface of fluid flow guide 112.
For some applications, as shown in Fig. 6, structural stent elements 114 are arranged as a plurality of generally circumferential bands. Longitudinal adjacent ones of the bands may or may not be joined to one another. For some applications, one or more of the circumferential bands is attached (e.g., sutured) to fluid flow guide 112 along second longitudinal subsection 134 (either to an external surface and/or to an internal surface thereof), and one or more of the circumferential bands is attached (e.g., sutured) to fluid flow guide 112 along third longitudinal subsection 136 (either to an external surface and/or to an internal surface thereof). Optionally, in addition, one or more of the circumferential bands is attached to fluid flow guide 112 along first longitudinal subsection 132 (either to an external surface and/or to an internal surface thereof).
For some applications, a surface coverage ratio of the one or more of structural stent elements 114 of variable-length section 120 on fluid flow guide 112 is at least 5%, such as at least 10%, when variable-length section 120 is the axially-shortest state when body 110 is in the radially-expanded deployment state.
For some applications, such as shown in the blow-up of Fig. 6, foldable section
130 comprises exactly three subsections, in which case the foldable section may be considered a triple-collar section. For other applications, foldable section 130 comprises more than three subsections, such as described with reference to Fig. 7 of above- mentioned US Provisional Application 61/553,209, which is incorporated herein by reference.
Reference is now made to Fig. 7, which is a schematic illustration of variable- length stent-graft 100 coupled to a bifurcated fixation stent-graft 150, in accordance with an application of the present invention. In this configuration, bifurcated fixation stent- graft 150 facilitates long-term anchoring of variable-length stent-graft 100 at a bifurcation. For example, as shown, bifurcated fixation stent-graft 150 may comprise a bi-iliac self-expandable stent that is deployed in the iliac arteries, in order to facilitate long-term anchoring of stent-graft 100 at the aorto-iliac bifurcation. Stent-grafts 100 and 150 may be deployed and/or coupled to each other using techniques described in one or more of the following patent application publications, all of which are assigned to the assignee of the present application and are incorporated herein by reference: (a) PCT Publication WO 08/107885, (b) PCT Publication WO 2011/007354, (c) PCT Publication WO 2010/150208, e.g., with reference to Figs. 14D-E, 20B, and/or 21B thereof, and (d) US Patent Application Publication 201 1/0208289.
Reference is now made to Figs. 8A and 8B, which are schematic illustrations of variable-length stent-graft 100 in exemplary axially- shorter and axially-longer states, respectively, in accordance with an application of the present invention. Stent-graft 100 is configured to assume a plurality of axially-shorter states (including the axially-shortest state described hereinabove with reference to Fig. 6). Fig. 8 A shows stent-graft 100 in one of these axially-shorter states, in which variable-length section 120 has axial length LJJ, and variable-length section 120 is in the folded position, as described hereinabove with reference to the blow-up of Fig. 6. Fig. 8B shows stent-graft 100 in one of the axially-longer states, in which variable-length section 120 has axial length LL, and variable-length section 120 is nearly entirely unfolded. For some applications, the stent- graft may assume a slightly longer state, in which it is entirely unfolded (state not shown). Reference is now made to Figs. 9A-B and 10A-B, which are schematic illustrations of variable-length stent-grafts 200 and 202, in accordance with respective applications of the present invention. Variable-length stent-grafts 200 and 202 are respective implementations of variable-length-stent graft 90, described herein with
reference to Figs. 6-12B. Stent-grafts 200 and 202 comprise generally tubular body 110, which comprises fluid flow guide 112 and structural stent elements 114 attached to at least a portion of the fluid flow guide. Body 110 includes variable-length section 120 that extends axially along a portion of body 110. Body 110, including variable-length section 120, is configured to assume a radially-compressed delivery state and a radially-expanded deployment state. Body 110 is shown in Figs. 9A-B and 10A-B in the radially-expanded deployment state.
Variable-length section 120 of stent-grafts 200 and 202 are configured to change length by means of rotation of a proximal end 206 of variable-length section 120 with respect to a distal end 208 of variable-length section 120. Such rotation causes structural elements 114 to twist. Variable-length section 120 shortens as structural elements 114 twist, and the graft material circumferentially folds around the more acutely curved structural elements.
For some applications, variable-length section 120 is configured to cyclically undergo an increase in the axial length that alternates with a decrease in the axial length. For some applications, the length of the variable-length section increase and decreases every heartbeat. For some applications, variable-section 120 shortens during diastole and lengthens during systole.
For some applications, as shown in Figs. 9A and 10A-B, variable-length section 120 of stent-graft 200 is shaped so as to define, at least when the variable-length section is in the axially-shortest state, at least one single- sided helix 204, which comprises the one or more of structural elements 114. For some applications, variable-length section 120 is configured such that a step size of the at least one-single-sided helix increases as the axial length of the variable-length section increases.
For some applications, as shown in Fig. 9B, variable-length section 120 of stent- graft 202 is shaped so as to define, at least when the variable-length section is in the axially-shortest state, at least one right-handed helix and at least one left-handed helix, which helices comprise the one or more of structural elements 114. For some applications, variable-length section 120 is configured such that respective step sizes of the right- and left-handed helices either both increase, or both decrease, as axial length of the variable-length section increases.
Figs. 10A and 10B show variable-length stent-graft 200 of Fig. 9A in exemplary
axially-shorter and axially-longer states, respectively. Fig. 10A shows stent-graft 200 in one of its axially-shorter states, in which variable-length section 120 has axial length L§. Typically, variable-length section 120 is relaxed in the axially-shorter state. Fig. 10B shows stent-graft 200 in one of its axially-longer states, in which variable-length section 120 has axial length LL. The one or more of structural stent elements 1 14 are configured to be elastically deformed at least when variable-length section 120 is in an axially- shortest of the axially-shorter states, such that the stent elements protrude radially outwardly (as shown in Fig. 10A) or radially inwardly (configuration not shown). Typically, the portions of these stent elements that protrude are attached (e.g., sutured) to fluid flow guide 1 12.
For configurations in which the stent elements protrude radially outward, variable- length section 120 is shaped so as to define, at least when the variable-length section is in the axially-shortest state, a radially- outward bulge 210 at least partially around a perimeter of an axial site on variable-length section 120. Radially-outward bulge 210 comprises the one or more of structural elements 1 14 of variable-length section 120, and, typically, a portion of the graft material of fluid flow guide 1 12. Typically, the variable- length section is configured such that a radial dimension of the bulge decreases as the axial length of the variable-length section increases. Typically, variable-length section 120 is configured such that structural stent elements 1 14 thereof do not undergo plastic deformation as the axial length changes.
Typically, when variable-length section 120 is in an axially-longest state (for example, as shown in Fig. 10B, and Figs. 9A and 9B), the stent elements that define the bulge generally do not protrude radially outwardly or radially inwardly. The variable- length section, when in an axially-longest state, thus is not shaped so as to define bulge 210. Typically, structural elements 1 14 are relaxed in the axially-shortest state. For some applications, a surface coverage ratio of the one or more of structural stent elements 114 of variable-length section 120 on fluid flow guide 112 is at least 5%, such as at least 10%.
When body 110 is in the radially-expanded deployment state (as shown in Figs. 9 and 10A-B), variable-length section 120 is configured to assume an axially-shortest state thereof (which might, for example, be the state shown in Fig. 10A). In this state the one or more of structural stent elements 114 are arranged along the variable-length section such that the variable-length section has no structural-stent-element-free axial portions having axial lengths greater than 5% of greatest outer diameter D of the fluid flow guide
along the variable-length section when in its axially-shortest state. In this configuration, the variable-length section typically has no structural-stent-element free axial portions, when the variable-length section is in the axially-shortest state.
Reference is made to Figs. 11 and 12A-B, which are schematic illustrations of a variable-length stent-graft 300, in accordance with an application of the present invention. Variable-length stent-graft 300 is one implementation of variable-length- stent graft 90, described herein with reference to Figs. 6-12B. Stent-graft 300 comprises generally tubular body 110, which comprises fluid flow guide 112 and structural stent elements 114 attached to at least a portion of the fluid flow guide. Body 110 includes variable-length section 120 that extends axially along a portion of body 110. Body 110, including variable-length section 120, is configured to assume a radially-compressed delivery state and a radially-expanded deployment state. Body 110 is shown in Figs. 11 and 12A-B in the radially-expanded deployment state.
Figs. 12A and 12B show variable-length stent-graft 300 in exemplary axially- shorter and axially-longer states, respectively. Fig. 12A shows stent-graft 300 in one of its axially-shorter states, in which variable-length section 120 has axial length Lg. Typically, variable-length section 120 is relaxed in the axially-shorter state. Fig. 12B shows stent-graft 300 in one of its axially-longer states, in which variable-length section 120 has axial length LL. The one or more of structural stent elements 114 are configured to be elastically deformed at least when variable-length section 120 is in the axially- shortest state, such that the stent elements protrude radially outwardly (as shown in Fig. 10A) or radially inwardly (configuration not shown). Unlike the configuration shown in Figs. 9 and 10A-B, in the configuration shown in Figs. 11 and 12A-B the portions of the stent elements that protrude radially outward are not attached (e.g., sutured) to fluid flow guide 112. Typically, the graft material of fluid flow guide 112 along the variable-length section folds as the variable-length section axially shortens, as shown in Fig. 12A.
For configurations in which the stent elements protrude radially outward, variable- length section 120 is shaped so as to define, at least when the variable-length section is in the axially-shortest state, a radially-outward bulge 310 at least partially around a perimeter of an axial site on variable-length section 120. Radially-outward bulge 310 comprises the one or more of structural elements 114 of variable-length section 120. Typically, the variable-length section is configured such that a radial dimension of the bulge decreases as the axial length of the variable-length section increases. Typically,
variable-length section 120 is configured such that structural stent elements 114 thereof do not undergo plastic deformation as the axial length changes.
Bulge 310 radially protrudes less when the variable-length section is in an axially- longer state than when in an axially-shorter state. Typically, variable-length section 120 is relaxed in the axially-shorter state. For some applications, a surface coverage ratio of the one or more of structural stent elements 114 of variable-length section 120 on fluid flow guide 112 is at least 5%, such as at least 10%.
When body 110 is in the radially-expanded deployment state (as shown in Figs. 12A and 12B), variable-length section 120 is configured to assume an axially-shortest state thereof (which might, for example, be the state shown in Fig. 12A). In this state the one or more of structural stent elements 114 are arranged along the variable-length section such that the variable-length section has no structural-stent-element-free axial portions having axial lengths greater than 5% of greatest outer diameter D of the fluid flow guide along the variable-length section when in its axially-shortest state. In this configuration, the variable-length section typically has no structural-stent-element free axial portions, when the variable-length section is in the axially-shortest state.
Reference is made to Figs. 9-10B and 11-12B. Alternatively, for some applications, variable-length section 120 is shaped so as to define, at least when the variable-length section is in the axially-shortest state, a radially-inward indentation at least partially around a perimeter of an axial site on the variable-length section. The indentation comprises the one or more of structural elements 114 of variable-length section 120. The variable-length section is configured such that a radial dimension of the indentation decreases as the axial length of the variable-length section increases. Typically, the variable-length section, when in an axially-longest state, is not shaped so as to define the indentation.
Reference is again made to Figs. 6-12B. Typically, body 110 is configured such that elasticity of the graft material of fluid flow guide 112 provides less than 5%, such as less than 3% of a change in an axial length of variable-length section 120. In other words, the change in the axial length of variable-length section 120 is not primarily enabled by stretching of the graft material of the fluid flow guide. As a result, an average wall thickness T of the graft material (labeled in Figs. 6, 9, and 11) does not decrease, or decreases only slightly, as the axial length increases. For some applications, during a 5
mm change in axial length of variable-length section 120, average wall thickness T of the graft material changes by no more than 15%, such as by no more than 10%.
Reference is still made to Figs. 6-12B. For some applications, when body 110 is in the radially-expanded deployment state, variable-length section 120 is configured to undergo an increase in the axial length, and not a decrease in the axial length. For some applications, such an increase occurs gradually after implantation, such as over months or years, enabling variable-length endovascular stent-graft 90 to accommodate the gradual lengthening of the aorta that sometimes occurs. Such accommodation decreases the risk that the stent-graft might become dislodged and decreases the risk of endoleak.
Reference is still made to Figs. 6-12B. For some applications, when body 110 is in the radially-expanded deployment state, variable-length section 120 is configured to cyclically undergo an increase in the axial length that alternates with a decrease in the axial length. For some applications, the length of the variable-length section increase and decreases every heartbeat. This repeated change in axial length provides axial compliance for reducing vascular resistance, similar to the radial compliance described above. For some applications, variable-section 120 shortens during diastole and lengthens during systole.
Reference is still made to Figs. 6-12B. For some applications, when body 110 is in the radially-expanded deployment state, variable-length section 120 is configured to undergo the change in axial length in response to a change in fluid pressure within fluid flow guide 112, such as every heartbeat as pressure increases and decreases during systole and diastole. This repeated change in axial length provides axial compliance for reducing vascular resistance, similar to the radial compliance described above. Therefore, for these applications, the variable-length section typically is not configured to lock upon elongation.
For some applications in which structural stent elements 114 comprises a shape memory alloy, such as Nitinol, the spring-like properties of the alloy enable this repeated change in length of the variable-length section. Typically, variable-length section 120 is configured to undergo (a) an increase in the axial length in response to an increase in fluid pressure within the fluid flow guide, and (b) a decrease in the axial length in response to a decrease in the fluid pressure within the fluid flow guide. Alternatively, variable-length section 120 is configured to undergo (a) an increase in the axial length in response to a
decrease in fluid pressure within the fluid flow guide, and (b) a decrease in the axial length in response to an increase in the fluid pressure within the fluid flow guide.
Reference is again made to Fig. 7. For some applications, stent-graft 90 further comprises one or more fixation members 330, such as barbs or hooks, located proximally and/or distally to variable-length section 120. The fixation members are configured to provide secured positioning between at least an end of the stent-graft and an internal circumference of the lumen. (Although fixation members 330 are shown only in Fig. 7, they may also be provided in the other configurations of stent-graft 90 described herein with reference to Figs. 6 and 8A-12B.) For some applications, the fixation members are configured to provide secured positioning between at least an end of the stent-graft and an internal circumference of at least a branch of the lumen (e.g., a renal artery branching from the aorta). For example, the fixation members may comprises atraumatic arms that are configured to extend into the branch. For some applications, fixation members are configured to provide secured positioning between at least an end of the stent-graft and an external or internal circumference of another tubular stent-graft, e.g., are configured to allow telescopic anchoring of stent-graft 90 inside another stent-graft.
Reference is now made to Fig. 13, which is a schematic illustration of a stent-graft 400, in accordance with an application of the present invention. Stent-graft 400 combines certain features of stent-graft 20, described hereinabove with reference to Figs. 1A-5, and certain features of stent-graft 90, described hereinabove with reference to Figs. 6-12B. Stent-graft 400 includes both compliance-restoration body portion 34 and variable-length section 120. Stent-graft 400 thus provides both the axial and radial compliance described hereinabove.
Stent-graft 400 may implement the configuration of compliance-restoration body portion 34 described hereinabove with reference to Figs. 1A-B (as shown in Fig. 13), or any of the other configurations of compliance-restoration body portion 34 described hereinabove with reference to Figs. 2A-4. Similarly, stent-graft 400 may implement the configuration of variable-length section 120 described hereinabove with reference to Figs. 6, 7, and 8A-B (as shown in Fig. 13), or any of the other configurations of variable-length section 120 described hereinabove with reference to 9- 12B.
As used in the present application, including in the claims, "tubular" means having the form of an elongated hollow object that defines a conduit therethrough. A "tubular"
structure may have varied cross-sections therealong, and the cross-sections are not necessarily circular. For example, one or more of the cross-sections may be generally circular, or generally elliptical but not circular, or circular.
The scope of the present invention includes embodiments described in the following applications, which are assigned to the assignee of the present application and are incorporated herein by reference. In an embodiment, techniques and apparatus described in one or more of the following applications are combined with techniques and apparatus described herein:
• PCT Application PCT/TL2008/000287, filed March 5, 2008, which published as PCT Publication WO 2008/107885 to Shalev et al., and US Application 12/529,936 in the national stage thereof, which published as US Patent Application Publication 2010/0063575 to Shalev et al.
• US Provisional Application 60/892,885, filed March 5, 2007
• PCT Application PCT/IL2007/001312, filed October 29, 2007, which published as PCT Publication WO/2008/053469 to Shalev, and US Application 12/447,684 in the national stage thereof, which published as US Patent Application Publication 2010/0070019 to Shalev
• US Provisional Application 60/991 ,726, filed December 2, 2007
• PCT Application PCT IL2008/001621, filed December 15, 2008, which published as PCT Publication WO 2009/078010, and US Application 12/808,037 in the national stage thereof, which published as US Patent Application Publication 2010/0292774
• US Provisional Application 61/219,758, filed June 23, 2009
• US Provisional Application 61/221 ,074, filed June 28, 2009
• PCT Application PCT/TB2010/052861, filed June 23, 2010, which published as PCT Publication WO 2010/150208, and US Application 13/380,278 in the national stage thereof
• PCT Application PCT/IL2010/000549, filed July 8, 2010, which published as PCT Publication WO 20Π/004374
• PCT Application PCML2010/000564, filed July 14, 2010, which published as
PCT Publication WO 2011/007354, and US Application 13/384,075 in the national stage thereof
• PCT Application PCT 1L2010/000917, filed November 4, 2010, which published as PCT Publication WO 2011/055364
· PCT Application PCT/IL2010/000999, filed November 30, 2010, which published as PCT Publication WO 2011/064782
• PCT Application PCT IL2010/001018, filed December 2, 2010, which published as PCT Publication WO 2011/067764
• PCT Application PCT/IL2010/001037, filed December 8, 2010, which published as PCT Publication WO 2011/070576
• PCT Application PCT IL2010/001087, filed December 27, 2010, which published as PCT Publication WO 2011/080738
• PCT Application PCT IL2011/000135, filed February 8, 2011, which published as PCT Publication WO 2011/095979 · PCT Application PCT/IL2011/000801 , filed October 10, 2011
• US Application 13/031,871, filed February 22, 2011, which published as US Patent Application Publication 2011/0208289
• US Provisional Application 61/496,613, filed June 14, 2011
• US Provisional Application 61/505,132, filed July 7, 2011 · US Provisional Application 61/529,931 , filed September 1, 2011
It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.
Claims
1. Apparatus comprising an endovascular stent-graft, which comprises a generally tubular body, which body (a) is configured to assume a radially-compressed delivery state and a radially-expanded deployment state, and (b) comprises:
a flexible stent member; and
a tubular fluid flow guide, which comprises a graft material, and is attached to the stent member,
wherein the body includes a compliance-restoration body portion, which extends axially along a portion of the body, and which comprises a portion of the stent member and a portion of the fluid flow guide,
wherein, when the body is in the radially-expanded deployment state, the compliance-restoration body portion is (a) characterized by a greatest diastolic outer radius when the body is internally pressurized by fluid having a pressure of 80 mmHg, and (b) radially expandable to a greatest systolic outer radius when the body is internally pressurized by fluid having a pressure of 120 mmHg, and
wherein the greatest systolic outer radius is at least 5% greater than the greatest diastolic outer radius.
2. The apparatus according to claim 1, wherein the greatest systolic outer radius is at least 10% greater than the greatest diastolic outer radius.
3. The apparatus according to claim 1, wherein the fluid flow guide of the compliance-restoration body portion is shaped so as to be expandable to a maximum greatest outer radius equal to the greatest systolic outer radius of the compliance- restoration body portion, such that the compliance-restoration body portion is limited by the fluid flow guide from assuming an outer radius that is greater than the maximum greatest outer radius.
4. The apparatus according to claim 1, wherein the stent member is heat- set to cause the compliance-restoration body portion to assume the greatest diastolic outer radius when the body is internally pressurized by the fluid having the pressure of 80 mmHg.
5. The apparatus according to any one of claims 1-4, wherein, when the body is in the radially-expanded deployment state, the compliance-restoration body portion is characterized by a greatest relaxed outer radius when the body is not internally pressurized by fluid, which greatest relaxed outer radius is no more than 95% of the greatest diastolic outer radius.
6. The apparatus according to claim 5, wherein the stent member is heat-set to cause the compliance-restoration body portion to assume the greatest relaxed outer radius when unconstrained.
7. The apparatus according to any one of claims 1-4, wherein the graft material comprises a woven graft.
8. The apparatus according to any one of claims 1-4, wherein the graft material of the portion of the fluid flow guide is at least partially folded when the body is in the radialiy- expanded deployment state and is internally pressured by the fluid of having the pressure of 80 mraHg.
9. The apparatus according to any one of claims 1-4, wherein the fluid flow guide, if not attached to the stent member, is configured to assume first and second perimeters when internally pressurized by fluid having a pressure of 80 and 120 mmHg, respectively, the second perimeter being no more than 10% greater than the first perimeter.
10. The apparatus according to any one of claims 1-4, wherein the fluid flow guide, if not attached to the stent member, is configured to assume first and second perimeters when internally pressurized by fluid having a pressure of 80 and 120 mmHg, respectively, the second perimeter being between 0.5% and 5% greater than the first perimeter.
11. The apparatus according to any one of claims 1-4, wherein the greatest systolic outer radius is no more than 30% greater than the greatest diastolic outer radius.
12. The apparatus according to any one of claims 1-4, wherein the greatest diastolic outer radius is between 7.5 mm and 25 mm, when the body is in the radially-expanded deployment state.
13. The apparatus according to any one of claims 1-4, wherein the greatest systolic outer radius is between 8.5 mm and 30 mm, when the body is in the radially-expanded deployment state.
14. The apparatus according to any one of claims 1-4,
wherein the body further includes distal and proximal portions, longitudinally between which the compliance-restoration body portion is disposed, wherein, when the body is in the radially-expanded deployment state, the distal and proximal portions are (a) characterized by greatest diastolic distal- and proximal-end- portion radii, respectively, when the body is internally pressurized by fluid having a pressure of 80 mmHg, and (b) radially expandable to greatest systolic distal- and proximal-end-portion radii, respectively, when the body is internally pressurized by fluid having a pressure of 120 mmHg,
wherein the greatest systolic distal-end-portion outer radius is less than 2% greater than the greatest diastolic distal-end-portion outer radius, and
wherein the greatest systolic proximal-end-portion outer radius is less than 1% greater than the greatest diastolic proximal-end-portion outer radius.
15. The apparatus according to any one of claims 1-4, wherein the body further includes distal and proximal portions, longitudinally between which the compliance- restoration body portion is disposed, and wherein respective greatest radii of the distal and the proximal portions are each at least 5% greater than a greatest relaxed outer radius of the compliance-restoration body portion, when the body is unconstrained in the radially- expanded deployment state.
16. The apparatus according to any one of claims 1-4, wherein the body further includes distal and proximal portions, longitudinally between which the compliance- restoration body portion is disposed, and wherein respective greatest radii of the distal and the proximal portions are each at least 5% greater than the greatest diastolic outer radius, when the body is in the radially-expanded deployment state.
17. The apparatus according to any one of claims 1-4, wherein the body further includes distal and proximal portions, longitudinally between which the compliance- restoration body portion is disposed, and wherein a greatest outer radius of the distal portion, when unconstrained, is between 2 and 10 mm greater than the greatest systolic outer radius, when the body is in the radially-expanded deployment state.
18. The apparatus according to any one of claims 1-4, wherein the graft material comprises a material selected from the group of materials consisting of: Polyethylene terephthalate (PET), Dacron, Polytetrafluoroethylene (PTFE), ePTFE, and a combination of two or more of these materials.
19. The apparatus according to any one of claims 1-4, wherein the stent member comprises a superelastic alloy.
20. The apparatus according to any one of claims 1-4, wherein the stent-graft is configured to self -expand from the delivery state to the deployment state.
21. The apparatus according to any one of claims 1-4,
wherein the flexible stent member comprises a plurality of structural stent elements attached to at least a portion of the fluid flow guide,
wherein the body includes a variable-length section, which extends axially along a portion of the body, and which comprises one or more of the structural stent elements and a portion of the fluid flow guide,
wherein the body, including the variable-length section, is configured to assume the radially-compressed delivery state and the radially-expanded deployment state,
wherein, when the body is in the radially-expanded deployment state, the variable- length section is configured to:
enable a change in an axial length thereof of at least 5 mm, and assume an axially-shortest state thereof, in which state the one or more of the structural stent elements are arranged along the variable-length section such that the variable-length section has no structural-stent-element-free axial portions having axial lengths greater than 5% of a greater outer diameter of the fluid flow guide along the variable-length section when in its axially-shortest state.
22. Apparatus comprising an endovascular stent-graft, which comprises a generally tubular body, which body comprises:
a fluid flow guide, which comprises a graft material; and
a plurality of structural stent elements attached to at least a portion of the fluid flow guide,
wherein the body includes a variable-length section, which extends axially along a portion of the body, and which comprises one or more of the structural stent elements and a portion of the fluid flow guide,
wherein the body, including the variable-length section, is configured to assume a radially-compressed delivery state and a radially-expanded deployment state,
wherein, when the body is in the radially-expanded deployment state, the variable- length section is configured to:
enable a change in an axial length thereof of at least 5 mm, and assume an axially-shortest state thereof, in which state the one or more of the structural stent elements are arranged along the variable-length section such that the variable-length section has no structural-stent-element-free axial portions having axial lengths greater than 5% of a greatest outer diameter of the fluid flow guide along the variable-length section when in its axially-shortest state.
23. The apparatus according to claim 22, wherein the one or more of the structural stent elements are arranged along the variable-length section such that the variable-length section has no structural-stent-element-free axial portions, when the variable-length section is in the axially- shortest state when the body is in the radially-expanded deployment state.
24. The apparatus according to claim 22, wherein the body is configured such that elasticity of the graft material provides less than 5% of the change in the axial length of the variable-length section.
25. The apparatus according to claim 22, wherein the variable-length section is configured such that the structural stent elements thereof do not undergo plastic deformation during the change in axial length.
26. The apparatus according to claim 22, wherein the variable-length section is configured such that the enabled change in the axial length is no more than 10% of a greatest outer diameter of the fluid flow guide along the variable-length section when the variable-length section is in the axially-shortest state.
27. The apparatus according to any one of claims 22-26, wherein the variable-length section is configured such that the enabled change in the axial length is equal to at least
10% of a greatest outer diameter of the fluid flow guide along the variable-length section when the variable-length section is in the axially-shortest state.
28. The apparatus according to any one of claims 22-26, wherein a surface coverage ratio of the one or more of the structural stent elements of the variable-length section on the fluid flow guide is equal to at least 5% when the variable-length section is in the axially-shortest state when the body is in the radially-expanded deployment state.
29. The apparatus according to any one of claims 22-26, wherein, when the body is in the radially-expanded deployment state, the variable-length section is configured to undergo the change in the axial length in response to a change in fluid pressure within the fluid flow guide.
30. The apparatus according to any one of claims 22-26, wherein, when the body is in the radially-expanded deployment state, the variable-length section is configured to undergo an increase in the axial length, and not a decrease in the axial length.
31. The apparatus according to any one of claims 22-26, wherein, when the body is in the radially-expanded deployment state, the variable-length section is configured to cyclically undergo an increase in the axial length that alternates with a decrease in the axial length.
32. The apparatus according to claim 31, wherein the variable-length section is configured to undergo (a) an increase in the axial length in response to an increase in fluid pressure within the fluid flow guide, and (b) a decrease in the axial length in response to a decrease in the fluid pressure within the fluid flow guide.
33. The apparatus according to claim 31, wherein the variable-length section is configured to undergo (a) an increase in the axial length in response to a decrease in fluid pressure within the fluid flow guide, and (b) a decrease in the axial length in response to an increase in the fluid pressure within the fluid flow guide.
34. The apparatus according to any one of claims 22-26, wherein the variable-length section is configured such that during a 5 mm change in the axial length, an average wall thickness of the graft material changes by no more than 15%.
35. The apparatus according to any one of claims 22-26, wherein the variable-length section is configured to assume a folded position at least when the variable-length section is in the axially-shortest state, in which folded position a first longitudinal subsection of the fluid flow guide is radially sandwiched between second and third longitudinal subsections of the fluid flow guide.
36. The apparatus according to claim 35, wherein the variable-length section is configured such that in the folded position the second longitudinal subsection radially surrounds the first longitudinal subsection, and at least one of the one or more of the structural stent elements of the variable-length section is attached to the second longitudinal subsection.
37. The apparatus according to claim 36, wherein the variable-length section is configured such that in the folded position the first longitudinal subsection radially surrounds the third longitudinal subsection, and wherein at least one of the one or more of the structural stent elements of the variable-length section is attached to the third longitudinal subsection.
38. The apparatus according to claim 37, wherein the variable-length section is configured such that none of the structural stent elements of the body is attached to the first longitudinal subsection.
39. The apparatus according to any one of claims 22-26, wherein the variable-length section is shaped so as to define, at least when the variable-length section is in the axially- shortest state, a radially- outward bulge at least partially around a perimeter of an axial site on the variable-length section, which radially-outward bulge comprises the one or more of the structural elements of the variable-length section.
40. The apparatus according to claim 39, wherein the variable-length section is configured such that a radial dimension of the bulge decreases as the axial length of the variable-length section increases.
41. The apparatus according to claim 40, wherein the variable-length section, when in an axially-longest state, is not shaped so as to define the bulge.
42. The apparatus according to any one of claims 22-26, wherein the variable-length section is shaped so as to define, at least when the variable-length section is in the axially- shortest state, a radially-inward indentation at least partially around a perimeter of an axial site on the variable-length section, which indentation comprises the one or more of the structural elements of the variable-length section.
43. The apparatus according to claim 42, wherein the variable-length section is configured such that a radial dimension of the indentation decreases as the axial length of the variable-length section increases.
44. The apparatus according to claim 43, wherein the variable-length section, when in an axially-longest state, is not shaped so as to define the indentation.
45. The apparatus according to any one of claims 22-26, wherein the variable-length section is configured such that when the variable-length section undergoes the change in the axial length, a proximal end of the variable-length section rotates with respect to a distal end of the variable-length section.
46. The apparatus according to any one of claims 22-26, wherein the variable-length section is shaped so as to define, at least when the variable-length section is in the axially- shortest state, at least one single-sided helix, which comprises the one or more of the structural elements.
47. The apparatus according to claim 46, wherein the variable-length section is configured such that a step size of the at least one-single-sided helix increases as the axial length of the variable-length section increases.
48. The apparatus according to any one of claims 22-26, wherein the variable-length section is shaped so as to define, at least when the variable-length section is in the axially- shortest state, at least one right-handed helix and at least one left-handed helix, which helices comprise the one or more of the structural elements.
49. The apparatus according to claim 48, wherein the variable-length section is configured such that respective step sizes of the right- and left-handed helices either both increase, or both decrease as axial length of the variable-length section increases.
50. The apparatus according to any one of claims 22-26,
wherein the body includes a compliance-restoration body portion, which extends axially along a portion of the body, and which comprises a portion of the structural stent elements and a portion of the fluid flow guide,
wherein, when the body is in the radially-expanded deployment state, the compliance-restoration body portion is (a) characterized by a greatest diastolic outer radius when the body is internally pressurized by fluid having a pressure of 80 mmHg, and (b) radially expandable to a greatest systolic outer radius when the body is internally pressurized by fluid having a pressure of 120 mmHg, and
wherein the greatest systolic outer radius is at least 5% greater than the greatest diastolic outer radius.
51. A method comprising :
providing an endovascular stent-graft, which includes a generally tubular body, which includes a flexible stent member, and a tubular fluid flow guide, which includes a graft material, and is attached to the stent member, wherein the body includes a compliance-restoration body portion, which extends axially along a portion of the body, and which includes a portion of the stent member and a portion of the fluid flow guide; trans vascularly introducing the stent-graft into a blood vessel of a human subject while the body is in a radially-compressed delivery state; and thereafter, transitioning the body to a radially-expanded deployment state in the blood vessel, in which state the compliance-restoration body portion is characterized by (a) a greatest diastolic outer radius when the body is internally pressurized by blood of the subject during diastole, and (b) a greatest systolic outer radius when the body is internally pressurized by blood of the subject during systole, which greatest systolic outer radius is at least 5% greater than the greatest diastolic outer radius.
52. The method according to claim 51, wherein transitioning the body to the deployment state comprises allowing the body to self-expand.
53. The method according to claim 51, wherein the greatest systolic outer radius is at least 10% greater than the greatest diastolic outer radius.
54. The method according to claim 51, wherein providing the stent-graft comprises providing the stent-graft in which the fluid flow guide of the compliance-restoration body portion is shaped so as to be expandable to a maximum greatest outer radius equal to the greatest systolic outer radius of the compliance-restoration body portion, such that the compliance-restoration body portion is limited by the fluid flow guide from assuming an outer radius that is greater than the maximum greatest outer radius.
55. The method according to claim 51, wherein providing the stent-graft comprises providing the stent-graft in which the fluid flow guide, if not attached to the stent member, is configured to assume first and second perimeters when internally pressurized by fluid having a pressure of 80 and 120 mmHg, respectively, the second perimeter being no more than 10% greater than the first perimeter.
56. The method according to claim 51 ,
wherein the body further includes distal and proximal portions, longitudinally between which the compliance-restoration body portion is disposed,
wherein, when the body is in the radially-expanded deployment state, the distal and proximal portions are characterized by (a) greatest diastolic distal- and proximal-end- portion radii, respectively, when the body is internally pressurized by the blood during diastole, and (b) greatest systolic distal- and proximal-end-portion radii, respectively, when the body is internally pressurized by the blood during systole,
wherein the greatest systolic distal-end-portion outer radius is less than 2% greater than the greatest diastolic distal-end-portion outer radius, and wherein the greatest systolic proximal-end-portion outer radius is less than 2% greater than the greatest diastolic proximal-end-portion outer radius.
57. The method according to claim 51, wherein the greatest systolic outer radius is no more than 30% greater than the greatest diastolic outer radius.
58. The method according to claim 51 ,
wherein the flexible stent member includes a plurality of structural stent elements attached to at least a portion of the fluid flow guide,
wherein the body includes a variable-length section, which extends axially along a portion of the body, and which comprises one or more of the structural stent elements and a portion of the fluid flow guide,
wherein the body, including the variable-length section, is configured to assume the radially-compressed delivery state and the radially-expanded deployment state,
wherein, after the body is transitioned to the radially-expanded deployment state, the variable-length section is configured to enable a change in an axial length thereof of at least 5 mm, and
wherein, if the variable-length section assumes an axially-shortest state thereof while the body is in the radially-expanded deployment state, the one or more of the structural stent elements are arranged along the variable-length section such that the variable-length section has no structural-stent-element-free axial portions having axial lengths greater than 5% of a greatest outer diameter of the fluid flow guide along the variable-length section when in its axially-shortest state.
59. A method comprising:
providing an endovascular stent-graft, which includes a generally tubular body, which includes a fluid flow guide, which includes a graft material, and a plurality of structural stent elements attached to at least a portion of the fluid flow guide, wherein the body includes a variable-length section, which extends axially along a portion of the body, and which comprises one or more of the structural stent elements and a portion of the fluid flow guide,
transvascularly introducing the stent-graft into a blood vessel of a human subject while the body, including the variable-length section, is in a radially-compressed delivery state; and thereafter, transitioning the body to a radially-expanded deployment state in the blood vessel, in which state the variable-length section is configured to enable a change in an axial length thereof of at least 5 mm,
wherein, if the variable-length section assumes an axially-shortest state thereof while the body is in the radially-expanded deployment state, the one or more of the structural stent elements are arranged along the variable-length section such that the variable-length section has no structural-stent-element-free axial portions having axial lengths greater than 5% of a greatest outer diameter of the fluid flow guide along the variable-length section when in its axially-shortest state.
60. The method according to claim 59, wherein, if the variable-length section assumes an axially-shortest state thereof while the body is in the radially-expanded deployment state, the one or more of the structural stent elements are arranged along the variable- length section such that the variable-length section has no structural-stent-element-free axial portions.
61. The method according to claim 59, wherein providing the stent-graft comprises providing the stent-graft in which the body is configured such that elasticity of the graft material provides less than 5% of the change in the axial length of the variable-length section.
62. The method according to claim 59, wherein providing the stent-graft comprises providing the stent-graft in which the variable-length section is configured such that the structural stent elements thereof do not undergo plastic deformation during the change in axial length.
63. The method according to claim 59, wherein providing the stent-graft comprises providing the stent-graft in which the variable-length section is configured such that the enabled change in the axial length is no more than 10% of a greatest outer diameter of the fluid flow guide along the variable-length section when the variable-length section is in the axially-shortest state.
64. The method according to claim 59, wherein, when the body is in the radially- expanded deployment state, the variable-length section is configured to undergo the change in the axial length in response to a change in fluid pressure within the fluid flow guide.
65. The method according to claim 59, wherein, when the body is in the radially- expanded deployment state, the variable-length section is configured to undergo an increase in the axial length, and not a decrease in the axial length.
66. The method according to claim 59, wherein, when the body is in the radially- expanded deployment state, the variable-length section is configured to cyclically undergo an increase in the axial length that alternates with a decrease in the axial length.
67. The method according to claim 66, wherein the variable-length section is configured to undergo (a) an increase in the axial length in response to an increase in fluid pressure within the fluid flow guide, and (b) a decrease in the axial length in response to a decrease in the fluid pressure within the fluid flow guide.
68. The method according to claim 59, wherein the variable-length section is configured such that during a 5 mm change in the axial length, an average wall thickness of the graft material changes by no more than 15%.
69. The method according to claim 59, wherein the variable-length section is configured to assume a folded position at least when the variable-length section is in the axially-shortest state, in which folded position a first longitudinal subsection of the fluid flow guide is radially sandwiched between second and third longitudinal subsections of the fluid flow guide.
70. The method according to claim 59, wherein the variable-length section is shaped so as to define, at least when the variable-length section is in the axially-shortest state, a radially-outward bulge at least partially around a perimeter of an axial site on the variable- length section, which radially-outward bulge comprises the one or more of the structural elements of the variable-length section.
71. The method according to claim 59, wherein the variable-length section is shaped so as to define, at least when the variable-length section is in the axially-shortest state, a radially-inward indentation at least partially around a perimeter of an axial site on the variable-length section, which indentation comprises the one or more of the structural elements of the variable-length section.
72. The method according to claim 59,
wherein the body includes a compliance-restoration body portion, which extends axially along a portion of the body, and which comprises a portion of the structural stent elements and a portion of the fluid flow guide, and wherein, after the body is transitioned to the radially-expanded deployment state, the compliance-restoration body portion is characterized by (a) a greatest diastolic outer radius when the body is internally pressurized by blood flow of the subject during diastole, and (b) a greatest systolic outer radius when the body is internally pressurized by blood of the subject during systole, which greatest systolic outer radius is at least 5% greater than the greatest diastolic outer radius.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/240,600 US9839510B2 (en) | 2011-08-28 | 2012-04-04 | Stent-grafts with post-deployment variable radial displacement |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161528242P | 2011-08-28 | 2011-08-28 | |
US61/528,242 | 2011-08-28 | ||
US201161553209P | 2011-10-30 | 2011-10-30 | |
US61/553,209 | 2011-10-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2013030818A2 true WO2013030818A2 (en) | 2013-03-07 |
WO2013030818A3 WO2013030818A3 (en) | 2015-06-18 |
Family
ID=47756994
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IL2012/000148 WO2013030818A2 (en) | 2011-08-28 | 2012-04-04 | Stent-grafts with post-deployment variable axial and radial displacement |
Country Status (2)
Country | Link |
---|---|
US (1) | US9839510B2 (en) |
WO (1) | WO2013030818A2 (en) |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013084235A2 (en) | 2011-12-04 | 2013-06-13 | Endospan Ltd. | Branched stent-graft system |
WO2014108895A2 (en) | 2013-01-08 | 2014-07-17 | Endospan Ltd. | Minimization of stent-graft migration during implantation |
EP2777609A1 (en) * | 2013-03-12 | 2014-09-17 | Cook Medical Technologies LLC | Device for treating vascular dissections |
WO2016098113A1 (en) | 2014-12-18 | 2016-06-23 | Endospan Ltd. | Endovascular stent-graft with fatigue-resistant lateral tube |
WO2016113731A1 (en) | 2015-01-12 | 2016-07-21 | Endospan Ltd. | Self-curving stent-graft |
WO2016125137A1 (en) | 2015-02-02 | 2016-08-11 | Endospan Ltd. | Self-orienting endovascular delivery system |
US9427339B2 (en) | 2011-10-30 | 2016-08-30 | Endospan Ltd. | Triple-collar stent-graft |
WO2016145391A1 (en) * | 2015-03-11 | 2016-09-15 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Expansible cardiovascular graft system |
US9486341B2 (en) | 2011-03-02 | 2016-11-08 | Endospan Ltd. | Reduced-strain extra-vascular ring for treating aortic aneurysm |
WO2017081679A1 (en) | 2015-11-12 | 2017-05-18 | Endospan Ltd. | Stent-grafts systems with skirt |
US9668892B2 (en) | 2013-03-11 | 2017-06-06 | Endospan Ltd. | Multi-component stent-graft system for aortic dissections |
US9770350B2 (en) | 2012-05-15 | 2017-09-26 | Endospan Ltd. | Stent-graft with fixation elements that are radially confined for delivery |
US9839510B2 (en) | 2011-08-28 | 2017-12-12 | Endospan Ltd. | Stent-grafts with post-deployment variable radial displacement |
US9855046B2 (en) | 2011-02-17 | 2018-01-02 | Endospan Ltd. | Vascular bands and delivery systems therefor |
US9918825B2 (en) | 2009-06-23 | 2018-03-20 | Endospan Ltd. | Vascular prosthesis for treating aneurysms |
WO2018173056A1 (en) | 2017-03-21 | 2018-09-27 | Endospan Ltd. | Stent-grafts for sealing around external disturbances |
CN108712891A (en) * | 2016-02-29 | 2018-10-26 | 爱德华兹生命科学公司 | Compliance based on vacuum is restored |
US10603197B2 (en) | 2013-11-19 | 2020-03-31 | Endospan Ltd. | Stent system with radial-expansion locking |
US20210077283A1 (en) * | 2013-04-24 | 2021-03-18 | Vascular Dynamics, Inc. | Implantable vascular device having longitudinal struts |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9579187B1 (en) * | 2016-02-10 | 2017-02-28 | Stanislaw L Zukowski | Radially compliant pressure indicating stent graft |
US11395726B2 (en) * | 2017-09-11 | 2022-07-26 | Incubar Llc | Conduit vascular implant sealing device for reducing endoleaks |
US10912664B2 (en) * | 2017-11-21 | 2021-02-09 | Cook Medical Technologies, LLC | Stent with induction responsive muscles that facilitate implantation adjustments |
WO2019245624A1 (en) * | 2018-06-19 | 2019-12-26 | Medtronic Vascular, Inc. | Modular stent device for multiple vessels and method |
US11911259B2 (en) * | 2020-07-31 | 2024-02-27 | DePuy Synthes Products, Inc. | Multi-layer folding flow diverters |
WO2023028279A2 (en) * | 2021-08-25 | 2023-03-02 | Parodi Juan C | Compliant endovascular device for thoracic and the thoraco-abdominal aorta |
WO2024009265A1 (en) | 2022-07-08 | 2024-01-11 | Ecole Polytechnique Federale De Lausanne (Epfl) | Compliant vascular grafts and methods of use |
WO2024158627A1 (en) * | 2023-01-23 | 2024-08-02 | Edwards Lifesciences Corporation | Compliant devices |
Family Cites Families (503)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4281669A (en) | 1975-05-09 | 1981-08-04 | Macgregor David C | Pacemaker electrode with porous system |
US4180613A (en) | 1977-09-01 | 1979-12-25 | E. I. Du Pont De Nemours And Company | Craze-resistant polysiloxane resin coatings and coating compositions containing a discontinuous phase |
US4665906A (en) | 1983-10-14 | 1987-05-19 | Raychem Corporation | Medical devices incorporating sim alloy elements |
US4505767A (en) | 1983-10-14 | 1985-03-19 | Raychem Corporation | Nickel/titanium/vanadium shape memory alloy |
US4787899A (en) | 1983-12-09 | 1988-11-29 | Lazarus Harrison M | Intraluminal graft device, system and method |
US4562596A (en) | 1984-04-25 | 1986-01-07 | Elliot Kornberg | Aortic graft, device and method for performing an intraluminal abdominal aortic aneurysm repair |
US4617932A (en) | 1984-04-25 | 1986-10-21 | Elliot Kornberg | Device and method for performing an intraluminal abdominal aortic aneurysm repair |
US4577631A (en) | 1984-11-16 | 1986-03-25 | Kreamer Jeffry W | Aneurysm repair apparatus and method |
US4733665C2 (en) | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
US4878906A (en) | 1986-03-25 | 1989-11-07 | Servetus Partnership | Endoprosthesis for repairing a damaged vessel |
US4816339A (en) | 1987-04-28 | 1989-03-28 | Baxter International Inc. | Multi-layered poly(tetrafluoroethylene)/elastomer materials useful for in vivo implantation |
US4969458A (en) | 1987-07-06 | 1990-11-13 | Medtronic, Inc. | Intracoronary stent and method of simultaneous angioplasty and stent implant |
US4886062A (en) | 1987-10-19 | 1989-12-12 | Medtronic, Inc. | Intravascular radially expandable stent and method of implant |
US5782903A (en) | 1987-10-19 | 1998-07-21 | Medtronic, Inc. | Intravascular stent and method |
US5133732A (en) | 1987-10-19 | 1992-07-28 | Medtronic, Inc. | Intravascular stent |
US4938740A (en) | 1988-05-25 | 1990-07-03 | Trustees Of The University Of Pennsylvania | Reducing stress at vascular graft anastomoses |
US5632746A (en) | 1989-08-16 | 1997-05-27 | Medtronic, Inc. | Device or apparatus for manipulating matter |
US6004330A (en) | 1989-08-16 | 1999-12-21 | Medtronic, Inc. | Device or apparatus for manipulating matter |
US5749879A (en) | 1989-08-16 | 1998-05-12 | Medtronic, Inc. | Device or apparatus for manipulating matter |
US5509923A (en) | 1989-08-16 | 1996-04-23 | Raychem Corporation | Device for dissecting, grasping, or cutting an object |
IE73670B1 (en) | 1989-10-02 | 1997-07-02 | Medtronic Inc | Articulated stent |
US5122136A (en) | 1990-03-13 | 1992-06-16 | The Regents Of The University Of California | Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas |
US5360443A (en) | 1990-06-11 | 1994-11-01 | Barone Hector D | Aortic graft for repairing an abdominal aortic aneurysm |
US5064435A (en) | 1990-06-28 | 1991-11-12 | Schneider (Usa) Inc. | Self-expanding prosthesis having stable axial length |
JP3256540B2 (en) | 1990-10-09 | 2002-02-12 | メッドトロニック・インコーポレイテッド | Device or device for manipulating the target object |
US5042707A (en) | 1990-10-16 | 1991-08-27 | Taheri Syde A | Intravascular stapler, and method of operating same |
US5192256A (en) | 1991-01-22 | 1993-03-09 | Ryan William T | Swim exercise or training apparatus |
US5192286A (en) | 1991-07-26 | 1993-03-09 | Regents Of The University Of California | Method and device for retrieving materials from body lumens |
EP0539237A1 (en) | 1991-10-25 | 1993-04-28 | Cook Incorporated | Expandable transluminal graft prosthesis for repair of aneurysm and method for implanting |
US5693084A (en) | 1991-10-25 | 1997-12-02 | Cook Incorporated | Expandable transluminal graft prosthesis for repair of aneurysm |
US5234448A (en) | 1992-02-28 | 1993-08-10 | Shadyside Hospital | Method and apparatus for connecting and closing severed blood vessels |
US5342387A (en) | 1992-06-18 | 1994-08-30 | American Biomed, Inc. | Artificial support for a blood vessel |
US5383926A (en) | 1992-11-23 | 1995-01-24 | Children's Medical Center Corporation | Re-expandable endoprosthesis |
US5417699A (en) | 1992-12-10 | 1995-05-23 | Perclose Incorporated | Device and method for the percutaneous suturing of a vascular puncture site |
US5639278A (en) | 1993-10-21 | 1997-06-17 | Corvita Corporation | Expandable supportive bifurcated endoluminal grafts |
US5723004A (en) | 1993-10-21 | 1998-03-03 | Corvita Corporation | Expandable supportive endoluminal grafts |
US5632772A (en) | 1993-10-21 | 1997-05-27 | Corvita Corporation | Expandable supportive branched endoluminal grafts |
US5527322A (en) | 1993-11-08 | 1996-06-18 | Perclose, Inc. | Device and method for suturing of internal puncture sites |
DE9319267U1 (en) | 1993-12-15 | 1994-02-24 | Günther, Rudolf W., Prof. Dr., 52074 Aachen | Aortic endoprosthesis |
US5507769A (en) | 1994-10-18 | 1996-04-16 | Stentco, Inc. | Method and apparatus for forming an endoluminal bifurcated graft |
US5556413A (en) * | 1994-03-11 | 1996-09-17 | Advanced Cardiovascular Systems, Inc. | Coiled stent with locking ends |
US5449373A (en) | 1994-03-17 | 1995-09-12 | Medinol Ltd. | Articulated stent |
US6165210A (en) | 1994-04-01 | 2000-12-26 | Gore Enterprise Holdings, Inc. | Self-expandable helical intravascular stent and stent-graft |
EP0754017B1 (en) | 1994-04-29 | 2002-06-19 | SciMed Life Systems, Inc. | Stent with collagen |
US5554181A (en) | 1994-05-04 | 1996-09-10 | Regents Of The University Of Minnesota | Stent |
US5456694A (en) | 1994-05-13 | 1995-10-10 | Stentco, Inc. | Device for delivering and deploying intraluminal devices |
WO1995032671A1 (en) | 1994-06-01 | 1995-12-07 | Perclose, Inc. | Method and device for providing vascular hemostasis |
EP0689805B1 (en) * | 1994-06-27 | 2003-05-28 | Corvita Corporation | Bistable luminal graft endoprostheses |
US5609605A (en) | 1994-08-25 | 1997-03-11 | Ethicon, Inc. | Combination arterial stent |
US5843170A (en) | 1994-09-02 | 1998-12-01 | Ahn; Sam Seunghae | Apparatus and method for performing aneurysm repair |
US6015429A (en) | 1994-09-08 | 2000-01-18 | Gore Enterprise Holdings, Inc. | Procedures for introducing stents and stent-grafts |
US5653743A (en) | 1994-09-09 | 1997-08-05 | Martin; Eric C. | Hypogastric artery bifurcation graft and method of implantation |
JP2911763B2 (en) | 1994-10-27 | 1999-06-23 | 三桜子 布川 | Artificial blood vessel |
CA2134997C (en) | 1994-11-03 | 2009-06-02 | Ian M. Penn | Stent |
US5549662A (en) | 1994-11-07 | 1996-08-27 | Scimed Life Systems, Inc. | Expandable stent using sliding members |
NL9500094A (en) | 1995-01-19 | 1996-09-02 | Industrial Res Bv | Y-shaped stent and method of deployment. |
US5755770A (en) | 1995-01-31 | 1998-05-26 | Boston Scientific Corporatiion | Endovascular aortic graft |
US5683449A (en) | 1995-02-24 | 1997-11-04 | Marcade; Jean Paul | Modular bifurcated intraluminal grafts and methods for delivering and assembling same |
WO1996036297A1 (en) | 1995-05-19 | 1996-11-21 | Kanji Inoue | Transplantation instrument, method of bending same and method of transplanting same |
US5902311A (en) | 1995-06-15 | 1999-05-11 | Perclose, Inc. | Low profile intraluminal suturing device and method |
US5769882A (en) | 1995-09-08 | 1998-06-23 | Medtronic, Inc. | Methods and apparatus for conformably sealing prostheses within body lumens |
US6071300A (en) | 1995-09-15 | 2000-06-06 | Sub-Q Inc. | Apparatus and method for percutaneous sealing of blood vessel punctures |
US6689162B1 (en) | 1995-10-11 | 2004-02-10 | Boston Scientific Scimed, Inc. | Braided composite prosthesis |
US6287315B1 (en) | 1995-10-30 | 2001-09-11 | World Medical Manufacturing Corporation | Apparatus for delivering an endoluminal prosthesis |
US6348066B1 (en) | 1995-11-07 | 2002-02-19 | Corvita Corporation | Modular endoluminal stent-grafts and methods for their use |
US6576009B2 (en) | 1995-12-01 | 2003-06-10 | Medtronic Ave, Inc. | Bifurcated intraluminal prostheses construction and methods |
US5824040A (en) | 1995-12-01 | 1998-10-20 | Medtronic, Inc. | Endoluminal prostheses and therapies for highly variable body lumens |
US6042605A (en) | 1995-12-14 | 2000-03-28 | Gore Enterprose Holdings, Inc. | Kink resistant stent-graft |
ATE290832T1 (en) | 1996-01-05 | 2005-04-15 | Medtronic Inc | EXPANDABLE ENDOLUMINAL PROSTHESES |
CA2199890C (en) | 1996-03-26 | 2002-02-05 | Leonard Pinchuk | Stents and stent-grafts having enhanced hoop strength and methods of making the same |
FR2748199B1 (en) | 1996-05-02 | 1998-10-09 | Braun Celsa Sa | TRANSCUTANEOUS SURGICAL ANASTOMOSABLE VASCULAR PROSTHESIS |
US5769884A (en) | 1996-06-27 | 1998-06-23 | Cordis Corporation | Controlled porosity endovascular implant |
US5676697A (en) | 1996-07-29 | 1997-10-14 | Cardiovascular Dynamics, Inc. | Two-piece, bifurcated intraluminal graft for repair of aneurysm |
US5755781A (en) | 1996-08-06 | 1998-05-26 | Iowa-India Investments Company Limited | Embodiments of multiple interconnected stents |
WO1998006355A1 (en) | 1996-08-09 | 1998-02-19 | Edoga John K | Endoluminal graft replacement of abdominal aortic aneurysms |
US6325819B1 (en) | 1996-08-19 | 2001-12-04 | Cook Incorporated | Endovascular prosthetic device, an endovascular graft prothesis with such a device, and a method for repairing an abdominal aortic aneurysm |
US5728134A (en) | 1996-09-17 | 1998-03-17 | Barak; Shlomo | Method and apparatus for hemostasis |
US6086610A (en) | 1996-10-22 | 2000-07-11 | Nitinol Devices & Components | Composite self expanding stent device having a restraining element |
US6599316B2 (en) | 1996-11-04 | 2003-07-29 | Advanced Stent Technologies, Inc. | Extendible stent apparatus |
US7341598B2 (en) | 1999-01-13 | 2008-03-11 | Boston Scientific Scimed, Inc. | Stent with protruding branch portion for bifurcated vessels |
US6325826B1 (en) | 1998-01-14 | 2001-12-04 | Advanced Stent Technologies, Inc. | Extendible stent apparatus |
US6036702A (en) | 1997-04-23 | 2000-03-14 | Vascular Science Inc. | Medical grafting connectors and fasteners |
US5976178A (en) | 1996-11-07 | 1999-11-02 | Vascular Science Inc. | Medical grafting methods |
WO1998020810A1 (en) | 1996-11-12 | 1998-05-22 | Medtronic, Inc. | Flexible, radially expansible luminal prostheses |
US6015431A (en) | 1996-12-23 | 2000-01-18 | Prograft Medical, Inc. | Endolumenal stent-graft with leak-resistant seal |
US6406420B1 (en) | 1997-01-02 | 2002-06-18 | Myocor, Inc. | Methods and devices for improving cardiac function in hearts |
US6152956A (en) | 1997-01-28 | 2000-11-28 | Pierce; George E. | Prosthesis for endovascular repair of abdominal aortic aneurysms |
US5827321A (en) | 1997-02-07 | 1998-10-27 | Cornerstone Devices, Inc. | Non-Foreshortening intraluminal prosthesis |
US5911732A (en) | 1997-03-10 | 1999-06-15 | Johnson & Johnson Interventional Systems, Co. | Articulated expandable intraluminal stent |
US6048360A (en) | 1997-03-18 | 2000-04-11 | Endotex Interventional Systems, Inc. | Methods of making and using coiled sheet graft for single and bifurcated lumens |
US5824055A (en) | 1997-03-25 | 1998-10-20 | Endotex Interventional Systems, Inc. | Stent graft delivery system and methods of use |
US6159228A (en) | 1997-05-20 | 2000-12-12 | Frid; Noureddine | Applicator for luminal endoprostheses |
CA2424551A1 (en) | 1997-05-27 | 1998-11-27 | Schneider (Usa) Inc. | Stent and stent-graft for treating branched vessels |
US5906641A (en) | 1997-05-27 | 1999-05-25 | Schneider (Usa) Inc | Bifurcated stent graft |
BE1011180A6 (en) | 1997-05-27 | 1999-06-01 | Medicorp R & D Benelux Sa | Luminal endoprosthesis AUTO EXPANDABLE. |
US5855600A (en) | 1997-08-01 | 1999-01-05 | Inflow Dynamics Inc. | Flexible implantable stent with composite design |
US5984955A (en) | 1997-09-11 | 1999-11-16 | Wisselink; Willem | System and method for endoluminal grafting of bifurcated or branched vessels |
US6520988B1 (en) | 1997-09-24 | 2003-02-18 | Medtronic Ave, Inc. | Endolumenal prosthesis and method of use in bifurcation regions of body lumens |
US6074416A (en) | 1997-10-09 | 2000-06-13 | St. Jude Medical Cardiovascular Group, Inc. | Wire connector structures for tubular grafts |
US6231516B1 (en) | 1997-10-14 | 2001-05-15 | Vacusense, Inc. | Endoluminal implant with therapeutic and diagnostic capability |
US6132457A (en) | 1997-10-22 | 2000-10-17 | Triad Vascular Systems, Inc. | Endovascular graft having longitudinally displaceable sections |
US6033435A (en) | 1997-11-03 | 2000-03-07 | Divysio Solutions Ulc | Bifurcated stent and method for the manufacture and delivery of same |
US6030414A (en) | 1997-11-13 | 2000-02-29 | Taheri; Syde A. | Variable stent and method for treatment of arterial disease |
US6049824A (en) | 1997-11-21 | 2000-04-11 | Adc Telecommunications, Inc. | System and method for modifying an information signal in a telecommunications system |
WO1999034748A1 (en) | 1998-01-07 | 1999-07-15 | Boston Scientific, Limited | Implantable band and stent graft for treating a vessel aneurysm |
US6395018B1 (en) | 1998-02-09 | 2002-05-28 | Wilfrido R. Castaneda | Endovascular graft and process for bridging a defect in a main vessel near one of more branch vessels |
US6623521B2 (en) | 1998-02-17 | 2003-09-23 | Md3, Inc. | Expandable stent with sliding and locking radial elements |
US5938697A (en) | 1998-03-04 | 1999-08-17 | Scimed Life Systems, Inc. | Stent having variable properties |
US6099497A (en) | 1998-03-05 | 2000-08-08 | Scimed Life Systems, Inc. | Dilatation and stent delivery system for bifurcation lesions |
JP4801838B2 (en) * | 1998-03-05 | 2011-10-26 | ボストン サイエンティフィック リミテッド | Intraluminal stent |
US6224609B1 (en) | 1998-03-16 | 2001-05-01 | Teramed Inc. | Bifurcated prosthetic graft |
US6129756A (en) | 1998-03-16 | 2000-10-10 | Teramed, Inc. | Biluminal endovascular graft system |
US20020099438A1 (en) | 1998-04-15 | 2002-07-25 | Furst Joseph G. | Irradiated stent coating |
US6206914B1 (en) | 1998-04-30 | 2001-03-27 | Medtronic, Inc. | Implantable system with drug-eluting cells for on-demand local drug delivery |
US6168615B1 (en) | 1998-05-04 | 2001-01-02 | Micrus Corporation | Method and apparatus for occlusion and reinforcement of aneurysms |
US20050283188A1 (en) | 1998-05-29 | 2005-12-22 | By-Pass, Inc. | Vascular closure device |
EP1083835A4 (en) | 1998-05-29 | 2004-06-02 | By Pass Inc | Methods and devices for vascular surgery |
WO2000015144A1 (en) | 1998-06-10 | 2000-03-23 | Advanced Bypass Technologies, Inc. | Aortic aneurysm treatment systems |
US6036725A (en) | 1998-06-10 | 2000-03-14 | General Science And Technology | Expandable endovascular support device |
US6129738A (en) | 1998-06-20 | 2000-10-10 | Medtronic Ave, Inc. | Method and apparatus for treating stenoses at bifurcated regions |
US6099548A (en) | 1998-07-28 | 2000-08-08 | Taheri; Syde A. | Apparatus and method for deploying an aortic arch graft |
US6156064A (en) | 1998-08-14 | 2000-12-05 | Schneider (Usa) Inc | Stent-graft-membrane and method of making the same |
US6325820B1 (en) | 1998-11-16 | 2001-12-04 | Endotex Interventional Systems, Inc. | Coiled-sheet stent-graft with exo-skeleton |
US20010049554A1 (en) | 1998-11-18 | 2001-12-06 | Carlos E. Ruiz | Endovascular prosthesis and method of making |
US6733523B2 (en) | 1998-12-11 | 2004-05-11 | Endologix, Inc. | Implantable vascular graft |
US6692520B1 (en) | 1998-12-15 | 2004-02-17 | C. R. Bard, Inc. | Systems and methods for imbedded intramuscular implants |
US6059824A (en) | 1998-12-23 | 2000-05-09 | Taheri; Syde A. | Mated main and collateral stent and method for treatment of arterial disease |
CA2329214A1 (en) | 1999-01-22 | 2000-07-27 | Gore Enterprise Holdings, Inc. | A biliary stent-graft |
US7914564B2 (en) | 1999-02-09 | 2011-03-29 | Innercool Therapies, Inc. | System and method for patient temperature control employing temperature projection algorithm |
US6077298A (en) | 1999-02-20 | 2000-06-20 | Tu; Lily Chen | Expandable/retractable stent and methods thereof |
US6200339B1 (en) | 1999-02-23 | 2001-03-13 | Datascope Investment Corp. | Endovascular split-tube bifurcated graft prosthesis and an implantation method for such a prosthesis |
US6261316B1 (en) | 1999-03-11 | 2001-07-17 | Endologix, Inc. | Single puncture bifurcation graft deployment system |
US6273911B1 (en) | 1999-04-22 | 2001-08-14 | Advanced Cardiovascular Systems, Inc. | Variable strength stent |
US6287335B1 (en) | 1999-04-26 | 2001-09-11 | William J. Drasler | Intravascular folded tubular endoprosthesis |
AU757744B2 (en) | 1999-07-16 | 2003-03-06 | Cook Medical Technologies Llc | Stent adapted for tangle-free deployment |
US6544279B1 (en) | 2000-08-09 | 2003-04-08 | Incept, Llc | Vascular device for emboli, thrombus and foreign body removal and methods of use |
US20020173809A1 (en) | 1999-09-01 | 2002-11-21 | Fleischman Sidney D. | Sutureless anastomosis system deployment concepts |
US7662161B2 (en) | 1999-09-13 | 2010-02-16 | Rex Medical, L.P | Vascular hole closure device |
EP1211983B1 (en) | 1999-09-13 | 2007-03-07 | Rex Medical, LP | Vascular closure |
US6344056B1 (en) | 1999-12-29 | 2002-02-05 | Edwards Lifesciences Corp. | Vascular grafts for bridging a vessel side branch |
US20020198585A1 (en) | 1999-10-05 | 2002-12-26 | Willem Wisselink | System and method for edoluminal grafting of bifurcated or branched vessels |
WO2001026584A1 (en) | 1999-10-14 | 2001-04-19 | United Stenting, Inc. | Stents with multilayered struts |
US6325823B1 (en) | 1999-10-29 | 2001-12-04 | Revasc Corporation | Endovascular prosthesis accommodating torsional and longitudinal displacements and methods of use |
US6652567B1 (en) | 1999-11-18 | 2003-11-25 | David H. Deaton | Fenestrated endovascular graft |
US6280466B1 (en) | 1999-12-03 | 2001-08-28 | Teramed Inc. | Endovascular graft system |
US6663667B2 (en) | 1999-12-29 | 2003-12-16 | Edwards Lifesciences Corporation | Towel graft means for enhancing tissue ingrowth in vascular grafts |
US6537311B1 (en) | 1999-12-30 | 2003-03-25 | Advanced Cardiovascular Systems, Inc. | Stent designs for use in peripheral vessels |
US6312458B1 (en) | 2000-01-19 | 2001-11-06 | Scimed Life Systems, Inc. | Tubular structure/stent/stent securement member |
US6692513B2 (en) | 2000-06-30 | 2004-02-17 | Viacor, Inc. | Intravascular filter with debris entrapment mechanism |
US6652571B1 (en) | 2000-01-31 | 2003-11-25 | Scimed Life Systems, Inc. | Braided, branched, implantable device and processes for manufacture thereof |
US6296661B1 (en) | 2000-02-01 | 2001-10-02 | Luis A. Davila | Self-expanding stent-graft |
GB0003387D0 (en) | 2000-02-14 | 2000-04-05 | Angiomed Ag | Stent matrix |
US6808534B1 (en) | 2000-02-16 | 2004-10-26 | Endovascular Technologies, Inc. | Collapsible jacket guard |
US6814752B1 (en) | 2000-03-03 | 2004-11-09 | Endovascular Technologies, Inc. | Modular grafting system and method |
US6929658B1 (en) | 2000-03-09 | 2005-08-16 | Design & Performance-Cyprus Limited | Stent with cover connectors |
WO2001067993A2 (en) | 2000-03-14 | 2001-09-20 | Cook Incorporated | Endovascular stent graft |
US6942691B1 (en) | 2000-04-27 | 2005-09-13 | Timothy A. M. Chuter | Modular bifurcated graft for endovascular aneurysm repair |
US6616689B1 (en) | 2000-05-03 | 2003-09-09 | Advanced Cardiovascular Systems, Inc. | Intravascular stent |
US6846321B2 (en) | 2000-06-21 | 2005-01-25 | Cardiodex, Ltd. | Mechanical method and apparatus for enhancing hemostatis following arterial catheterization |
US6613078B1 (en) | 2000-08-02 | 2003-09-02 | Hector Daniel Barone | Multi-component endoluminal graft assembly, use thereof and method of implanting |
US6773454B2 (en) | 2000-08-02 | 2004-08-10 | Michael H. Wholey | Tapered endovascular stent graft and method of treating abdominal aortic aneurysms and distal iliac aneurysms |
US6695833B1 (en) | 2000-09-27 | 2004-02-24 | Nellix, Inc. | Vascular stent-graft apparatus and forming method |
US7616997B2 (en) | 2000-09-27 | 2009-11-10 | Kieval Robert S | Devices and methods for cardiovascular reflex control via coupled electrodes |
AU2001296716A1 (en) | 2000-10-13 | 2002-04-22 | Rex Medical, Lp | Covered stents with side branch |
US6770086B1 (en) | 2000-11-02 | 2004-08-03 | Scimed Life Systems, Inc. | Stent covering formed of porous polytetraflouroethylene |
US7029481B1 (en) | 2000-11-06 | 2006-04-18 | Abbott Laboratories | Systems, devices and methods for suturing patient tissue |
US6506211B1 (en) | 2000-11-13 | 2003-01-14 | Scimed Life Systems, Inc. | Stent designs |
US7229472B2 (en) | 2000-11-16 | 2007-06-12 | Cordis Corporation | Thoracic aneurysm repair prosthesis and system |
CA2428836A1 (en) | 2000-11-17 | 2002-05-23 | Evysio Medical Devices Ulc | Endovascular prosthesis |
US6648911B1 (en) | 2000-11-20 | 2003-11-18 | Avantec Vascular Corporation | Method and device for the treatment of vulnerable tissue site |
US20040106972A1 (en) | 2000-11-20 | 2004-06-03 | Deaton David H. | Fenestrated endovascular graft |
US6645242B1 (en) | 2000-12-11 | 2003-11-11 | Stephen F. Quinn | Bifurcated side-access intravascular stent graft |
US8870946B1 (en) | 2000-12-11 | 2014-10-28 | W.L. Gore & Associates, Inc. | Method of deploying a bifurcated side-access intravascular stent graft |
US8192484B2 (en) | 2000-12-12 | 2012-06-05 | Cardiatis S.A. | Stent for blood flow improvement |
BE1013757A6 (en) | 2000-12-12 | 2002-07-02 | Frid Noureddine | Luminal endoprosthesis MODULAR. |
US6929660B1 (en) | 2000-12-22 | 2005-08-16 | Advanced Cardiovascular Systems, Inc. | Intravascular stent |
CN2453960Y (en) | 2000-12-26 | 2001-10-17 | 微创医疗器械(上海)有限公司 | Celianeurysm tuncile carriage and tansfering device thereof |
US20020123791A1 (en) | 2000-12-28 | 2002-09-05 | Harrison William J. | Stent design with increased vessel coverage |
US6673080B2 (en) | 2001-01-08 | 2004-01-06 | Scimed Life Systems, Inc. | Retrieval basket with releasable tip |
US6445953B1 (en) | 2001-01-16 | 2002-09-03 | Kenergy, Inc. | Wireless cardiac pacing system with vascular electrode-stents |
WO2002062250A1 (en) | 2001-02-07 | 2002-08-15 | Synthes Ag Chur | Device and method for intraoperative navigation |
JP4673987B2 (en) | 2001-02-27 | 2011-04-20 | 株式会社トップ | Stent and stent member |
US20030057156A1 (en) | 2001-03-08 | 2003-03-27 | Dean Peterson | Atrial filter implants |
US6743195B2 (en) | 2001-03-14 | 2004-06-01 | Cardiodex | Balloon method and apparatus for vascular closure following arterial catheterization |
FR2822370B1 (en) | 2001-03-23 | 2004-03-05 | Perouse Lab | TUBULAR ENDOPROSTHESIS COMPRISING A DEFORMABLE RING AND REQUIRED OF INTERVENTION FOR ITS IMPLANTATION |
EP1372534B1 (en) | 2001-03-28 | 2006-11-29 | Cook Incorporated | Set of sections for a modular stent graft assembly |
US6761733B2 (en) | 2001-04-11 | 2004-07-13 | Trivascular, Inc. | Delivery system and method for bifurcated endovascular graft |
US7175651B2 (en) | 2001-07-06 | 2007-02-13 | Andrew Kerr | Stent/graft assembly |
US20040215322A1 (en) | 2001-07-06 | 2004-10-28 | Andrew Kerr | Stent/graft assembly |
US6716238B2 (en) | 2001-05-10 | 2004-04-06 | Scimed Life Systems, Inc. | Stent with detachable tethers and method of using same |
US20020183783A1 (en) | 2001-06-04 | 2002-12-05 | Shadduck John H. | Guidewire for capturing emboli in endovascular interventions |
US6824560B2 (en) | 2001-06-13 | 2004-11-30 | Advanced Cardiovascular Systems, Inc. | Double-butted superelastic nitinol tubing |
US6635083B1 (en) | 2001-06-25 | 2003-10-21 | Advanced Cardiovascular Systems, Inc. | Stent with non-linear links and method of use |
US6554855B1 (en) | 2001-07-03 | 2003-04-29 | Scimed Life Systems, Inc. | Low profile, high stretch, low dilation knit prosthetic device |
EP1427469A4 (en) | 2001-08-22 | 2007-03-28 | Hasan Semih Oktay | Flexible mems actuated controlled expansion stent |
US6953469B2 (en) | 2001-08-30 | 2005-10-11 | Ethicon, Inc, | Device and method for treating intraluminal tissue |
AUPR748801A0 (en) | 2001-09-04 | 2001-09-27 | Stentco Llc | A stent |
US7912554B2 (en) | 2001-09-26 | 2011-03-22 | Medtronic Cryocath Lp | Method for treatment of aneurysms |
US20030065386A1 (en) | 2001-09-28 | 2003-04-03 | Weadock Kevin Shaun | Radially expandable endoprosthesis device with two-stage deployment |
US20030074055A1 (en) | 2001-10-17 | 2003-04-17 | Haverkost Patrick A. | Method and system for fixation of endoluminal devices |
US7749243B2 (en) | 2001-10-19 | 2010-07-06 | Boston Scientific Scimed, Inc. | Embolus extractor |
AUPR847201A0 (en) | 2001-10-26 | 2001-11-15 | Cook Incorporated | Endoluminal graft |
US8740973B2 (en) | 2001-10-26 | 2014-06-03 | Icon Medical Corp. | Polymer biodegradable medical device |
US6776794B1 (en) | 2001-11-28 | 2004-08-17 | Advanced Cardiovascular Systems, Inc. | Stent pattern with mirror image |
US20090112302A1 (en) | 2001-11-28 | 2009-04-30 | Josh Stafford | Devices, systems, and methods for endovascular staple and/or prosthesis delivery and implantation |
WO2003049600A2 (en) | 2001-12-06 | 2003-06-19 | Stx Medical, Inc. | Medical device |
US20030114061A1 (en) | 2001-12-13 | 2003-06-19 | Kazuhisa Matsuda | Adhesion preventive membrane, method of producing a collagen single strand, collagen nonwoven fabric and method and apparatus for producing the same |
US6752826B2 (en) | 2001-12-14 | 2004-06-22 | Thoratec Corporation | Layered stent-graft and methods of making the same |
AUPR969201A0 (en) | 2001-12-20 | 2002-01-24 | White, Geoffrey H. | A device for use in intraluminal grafting |
CA2470824A1 (en) | 2001-12-21 | 2003-08-28 | Cardiovasc, Inc. | Composite stent with polymeric covering and bioactive coating |
US20030212449A1 (en) | 2001-12-28 | 2003-11-13 | Cox Daniel L. | Hybrid stent |
US20030130720A1 (en) | 2002-01-08 | 2003-07-10 | Depalma Donald F. | Modular aneurysm repair system |
EP1336392A1 (en) | 2002-02-14 | 2003-08-20 | John S. Geis | Body vessel support and catheter system |
US7918883B2 (en) | 2002-02-25 | 2011-04-05 | Boston Scientific Scimed, Inc. | Non-invasive heating of implanted vascular treatment device |
US7708771B2 (en) | 2002-02-26 | 2010-05-04 | Endovascular Technologies, Inc. | Endovascular graft device and methods for attaching components thereof |
US7192434B2 (en) | 2002-03-08 | 2007-03-20 | Ev3 Inc. | Vascular protection devices and methods of use |
JP4208075B2 (en) | 2002-03-25 | 2009-01-14 | クック インコーポレイティド | Bifurcated / branched vascular prosthesis |
US7789903B2 (en) | 2002-04-04 | 2010-09-07 | Boston Scientific Scimed, Inc. | Stent-graft with adjustable length |
US7131991B2 (en) | 2002-04-24 | 2006-11-07 | Medtronic Vascular, Inc. | Endoluminal prosthetic assembly and extension method |
US7655036B2 (en) | 2002-04-24 | 2010-02-02 | Medtronic Vascular, Inc. | Bifurcated endoluminal prosthetic assembly and method |
US6676699B2 (en) | 2002-04-26 | 2004-01-13 | Medtronic Ave, Inc | Stent graft with integrated valve device and method |
US7105031B2 (en) | 2002-04-26 | 2006-09-12 | Medtronic Vascular, Inc. | Balloon-tipped, multi-lumen catheter for endoluminal repair of endoluminal leaks in aortic or aorto-iliac endoluminal grafts |
US7270675B2 (en) | 2002-05-10 | 2007-09-18 | Cordis Corporation | Method of forming a tubular membrane on a structural frame |
US7887575B2 (en) | 2002-05-22 | 2011-02-15 | Boston Scientific Scimed, Inc. | Stent with segmented graft |
CA2486363A1 (en) | 2002-05-28 | 2003-12-04 | The Cleveland Clinic Foundation | Minimally invasive treatment system for aortic aneurysms |
US7399313B2 (en) | 2002-06-07 | 2008-07-15 | Brown Peter S | Endovascular graft with separable sensors |
US7261733B1 (en) | 2002-06-07 | 2007-08-28 | Endovascular Technologies, Inc. | Endovascular graft with sensors design and attachment methods |
US6748953B2 (en) | 2002-06-11 | 2004-06-15 | Scimed Life Systems, Inc. | Method for thermal treatment of type II endoleaks in arterial aneurysms |
US7717934B2 (en) | 2002-06-14 | 2010-05-18 | Ev3 Inc. | Rapid exchange catheters usable with embolic protection devices |
EP1374799A1 (en) | 2002-06-18 | 2004-01-02 | F.R.I.D. R&D Benelux Sprl | Hemodynamic luminal endoprosthesis |
US7044962B2 (en) | 2002-06-25 | 2006-05-16 | Scimed Life Systems, Inc. | Implantable prosthesis with displaceable skirt |
US7611529B2 (en) | 2002-06-28 | 2009-11-03 | Cook Incorporated | Thoracic introducer |
US20040015229A1 (en) | 2002-07-22 | 2004-01-22 | Syntheon, Llc | Vascular stent with radiopaque markers |
US20040034407A1 (en) | 2002-08-16 | 2004-02-19 | John Sherry | Covered stents with degradable barbs |
US8043365B2 (en) | 2002-08-19 | 2011-10-25 | Jeffery Thramann | Methods for placement of vascular stent grafts and vascular stents |
US7550004B2 (en) | 2002-08-20 | 2009-06-23 | Cook Biotech Incorporated | Endoluminal device with extracellular matrix material and methods |
WO2004017868A1 (en) | 2002-08-23 | 2004-03-04 | William A. Cook Australia Pty. Ltd. | Asymmetric stent graft attachment |
AU2003262754B2 (en) | 2002-08-23 | 2007-06-21 | Cook Incorporated | Composite prosthesis |
US8518096B2 (en) | 2002-09-03 | 2013-08-27 | Lifeshield Sciences Llc | Elephant trunk thoracic endograft and delivery system |
DE60326000D1 (en) | 2002-12-04 | 2009-03-12 | Cook Inc | METHOD AND DEVICE FOR TREATMENT IN AORTASE ACTION |
US7371256B2 (en) | 2002-12-16 | 2008-05-13 | Poly-Med, Inc | Composite vascular constructs with selectively controlled properties |
CA2512610C (en) | 2003-01-14 | 2008-12-23 | The Cleveland Clinic Foundation | Branched vessel endoluminal device |
US8080026B2 (en) | 2003-01-21 | 2011-12-20 | Angioscore, Inc. | Apparatus and methods for treating hardened vascular lesions |
US7223266B2 (en) | 2003-02-04 | 2007-05-29 | Cardiodex Ltd. | Methods and apparatus for hemostasis following arterial catheterization |
US7115127B2 (en) | 2003-02-04 | 2006-10-03 | Cardiodex, Ltd. | Methods and apparatus for hemostasis following arterial catheterization |
US8157810B2 (en) | 2003-02-26 | 2012-04-17 | Cook Medical Technologies Llc | Prosthesis adapted for placement under external imaging |
US7025779B2 (en) | 2003-02-26 | 2006-04-11 | Scimed Life Systems, Inc. | Endoluminal device having enhanced affixation characteristics |
US7220274B1 (en) | 2003-03-21 | 2007-05-22 | Quinn Stephen F | Intravascular stent grafts and methods for deploying the same |
US7537606B2 (en) | 2003-04-03 | 2009-05-26 | Cook Incorporated | Branch stent graft deployment and method |
US8109987B2 (en) | 2003-04-14 | 2012-02-07 | Tryton Medical, Inc. | Method of treating a lumenal bifurcation |
US7279003B2 (en) | 2003-04-24 | 2007-10-09 | Medtronic Vascular, Inc. | Stent graft tapered spring |
US7438721B2 (en) | 2003-04-25 | 2008-10-21 | Medtronic Vascular, Inc. | Universal modular stent graft assembly to accommodate flow to collateral branches |
ATE531338T1 (en) * | 2003-04-28 | 2011-11-15 | Kips Bay Medical Inc | ELASTIC VENOUS IMPLANT |
US20040254628A1 (en) | 2003-06-13 | 2004-12-16 | Patrice Nazzaro | One-branch stent-graft for bifurcated lumens |
US7105015B2 (en) | 2003-06-17 | 2006-09-12 | Medtronic Vascular, Inc. | Method and system for treating an ostium of a side-branch vessel |
US8021418B2 (en) | 2003-06-19 | 2011-09-20 | Boston Scientific Scimed, Inc. | Sandwiched radiopaque marker on covered stent |
AU2004253375B2 (en) | 2003-07-08 | 2011-07-14 | Ventor Technologies Ltd. | Implantable prosthetic devices particularly for transarterial delivery in the treatment of aortic stenosis, and methods of implanting such devices |
US7201772B2 (en) | 2003-07-08 | 2007-04-10 | Ventor Technologies, Ltd. | Fluid flow prosthetic device |
US20050033406A1 (en) | 2003-07-15 | 2005-02-10 | Barnhart William H. | Branch vessel stent and graft |
WO2005011535A2 (en) * | 2003-07-31 | 2005-02-10 | Cook Incorporated | Prosthetic valve for implantation in a body vessel |
US7763063B2 (en) | 2003-09-03 | 2010-07-27 | Bolton Medical, Inc. | Self-aligning stent graft delivery system, kit, and method |
US7789891B2 (en) | 2003-09-23 | 2010-09-07 | Boston Scientific Scimed, Inc. | External activation of vaso-occlusive implants |
WO2005032340A2 (en) | 2003-09-29 | 2005-04-14 | Secant Medical, Llc | Integral support stent graft assembly |
US7425219B2 (en) | 2003-10-10 | 2008-09-16 | Arshad Quadri | System and method for endoluminal grafting of bifurcated and branched vessels |
JP4846590B2 (en) | 2003-10-10 | 2011-12-28 | ウィリアム・エイ・クック・オーストラリア・プロプライエタリー・リミテッド | Stent graft fenestration |
JP4970944B2 (en) | 2003-10-10 | 2012-07-11 | ウィリアム・エイ・クック・オーストラリア・プロプライエタリー・リミテッド | Stent graft with opening |
EP1673040B1 (en) | 2003-10-10 | 2008-07-30 | Cook Incorporated | Stretchable prosthesis fenestration |
EP3050542B1 (en) | 2003-10-14 | 2022-03-16 | Cook Medical Technologies LLC | Introducer for an iliac side branch device |
WO2005037138A2 (en) | 2003-10-14 | 2005-04-28 | Peacock James C Iii | Aneurysm treatment system and method |
US7998186B2 (en) | 2003-10-14 | 2011-08-16 | William A. Cook Australia Pty. Ltd. | Introducer for a side branch device |
US20070167898A1 (en) | 2003-10-30 | 2007-07-19 | Sunshine Heart Company Pty Ltd. | Methods and devices for tensioning a wrap around a blood vessel |
WO2005041783A1 (en) | 2003-10-30 | 2005-05-12 | Sunshine Heart Company Pty Ltd | A wrap |
US7144421B2 (en) | 2003-11-06 | 2006-12-05 | Carpenter Judith T | Endovascular prosthesis, system and method |
US9974674B2 (en) | 2003-11-08 | 2018-05-22 | Cook Medical Technologies Llc | Branch vessel prothesis with positional indicator system and method |
US7261732B2 (en) | 2003-12-22 | 2007-08-28 | Henri Justino | Stent mounted valve |
ATE434991T1 (en) | 2004-01-20 | 2009-07-15 | Cook Inc | ENDOLUMINAL STENT-GRAFT WITH SEWN ATTACHMENT |
US20050165480A1 (en) | 2004-01-23 | 2005-07-28 | Maybelle Jordan | Endovascular treatment devices and methods |
US7803178B2 (en) | 2004-01-30 | 2010-09-28 | Trivascular, Inc. | Inflatable porous implants and methods for drug delivery |
US7637903B2 (en) | 2004-02-09 | 2009-12-29 | Cryocor, Inc. | Catheter articulation segment with alternating cuts |
US7294145B2 (en) | 2004-02-26 | 2007-11-13 | Boston Scientific Scimed, Inc. | Stent with differently coated inside and outside surfaces |
US20050203606A1 (en) | 2004-03-09 | 2005-09-15 | Vancamp Daniel H. | Stent system for preventing restenosis |
US7959634B2 (en) | 2004-03-29 | 2011-06-14 | Soteira Inc. | Orthopedic surgery access devices |
US7674284B2 (en) | 2004-03-31 | 2010-03-09 | Cook Incorporated | Endoluminal graft |
US8048140B2 (en) | 2004-03-31 | 2011-11-01 | Cook Medical Technologies Llc | Fenestrated intraluminal stent system |
US8715340B2 (en) | 2004-03-31 | 2014-05-06 | Merlin Md Pte Ltd. | Endovascular device with membrane |
US8034096B2 (en) | 2004-03-31 | 2011-10-11 | Cook Medical Technologies Llc | Stent-graft with graft to graft attachment |
US8377110B2 (en) | 2004-04-08 | 2013-02-19 | Endologix, Inc. | Endolumenal vascular prosthesis with neointima inhibiting polymeric sleeve |
US8628564B2 (en) | 2004-05-25 | 2014-01-14 | Covidien Lp | Methods and apparatus for luminal stenting |
US20050266042A1 (en) | 2004-05-27 | 2005-12-01 | Medtronic Vascular, Inc. | Methods and apparatus for treatment of aneurysmal tissue |
EP1765222B1 (en) | 2004-06-15 | 2012-10-31 | Cook Medical Technologies LLC | Stent graft with internal tube |
US8043354B2 (en) | 2004-06-16 | 2011-10-25 | William A. Cook Australia Pty. Ltd. | Thoracic deployment device and stent graft |
US7955373B2 (en) | 2004-06-28 | 2011-06-07 | Boston Scientific Scimed, Inc. | Two-stage stent-graft and method of delivering same |
US20060015170A1 (en) | 2004-07-16 | 2006-01-19 | Jones Ryan A | Contrast coated stent and method of fabrication |
GB0417078D0 (en) | 2004-07-30 | 2004-09-01 | Angiomed Ag | Flexible implant |
US20060030921A1 (en) | 2004-08-03 | 2006-02-09 | Medtronic Vascular, Inc. | Intravascular securement device |
BRPI0514553A (en) | 2004-08-23 | 2008-06-17 | Lilly Co Eli | a compound or a pharmaceutically acceptable salt thereof, pharmaceutical composition, methods for inhibiting the h3 histamine receptor in a mammal, for treating a nervous system disorder, for treating obesity and for treating a disorder or disease, and , use of a compound or a salt thereof |
DE602005005495T2 (en) | 2004-09-02 | 2009-04-16 | Med Institute, Inc., West Lafayette | MODULAR PROSTHESIS AND METHOD FOR BRANCHED VESSELS |
AU2005286730B2 (en) | 2004-09-21 | 2010-08-12 | Cook Incorporated | Stent graft connection arrangement |
US8226706B2 (en) | 2004-09-22 | 2012-07-24 | Cook Medical Technologies Llc | Stent graft with integral side arm |
US20060069426A1 (en) | 2004-09-27 | 2006-03-30 | Weinberger Judah Z | Methods and devices for extravascular intervention |
US20060106406A1 (en) | 2004-09-27 | 2006-05-18 | Judah Weinberger | Methods and devices for extravascular intervention |
US8287583B2 (en) | 2005-01-10 | 2012-10-16 | Taheri Laduca Llc | Apparatus and method for deploying an implantable device within the body |
US20070150051A1 (en) | 2005-01-10 | 2007-06-28 | Duke Fiduciary, Llc | Vascular implants and methods of fabricating the same |
US8128680B2 (en) | 2005-01-10 | 2012-03-06 | Taheri Laduca Llc | Apparatus and method for deploying an implantable device within the body |
US20060155366A1 (en) | 2005-01-10 | 2006-07-13 | Laduca Robert | Apparatus and method for deploying an implantable device within the body |
US7306623B2 (en) | 2005-01-13 | 2007-12-11 | Medtronic Vascular, Inc. | Branch vessel graft design and deployment method |
US20060173530A1 (en) | 2005-01-28 | 2006-08-03 | Das Gladwin S | Flexible cells for interconnecting stent components |
US20060190072A1 (en) | 2005-01-28 | 2006-08-24 | Das Gladwin S | Flexible cells for axially interconnecting stent components |
US7544160B2 (en) | 2005-02-10 | 2009-06-09 | Yossi Gross | Extracardiac blood flow amplification device |
US20060190070A1 (en) | 2005-02-23 | 2006-08-24 | Dieck Martin S | Rail stent and methods of use |
JP2008534108A (en) | 2005-03-30 | 2008-08-28 | ユニバーシティ・オブ・リムリック | Vascular graft |
US20060276882A1 (en) | 2005-04-11 | 2006-12-07 | Cook Incorporated | Medical device including remodelable material attached to frame |
WO2006113501A1 (en) | 2005-04-13 | 2006-10-26 | The Cleveland Clinic Foundation | Endoluminal prosthesis |
CN2817768Y (en) | 2005-05-24 | 2006-09-20 | 微创医疗器械(上海)有限公司 | Tectorium stand and host cage section thereof |
US8974523B2 (en) | 2005-05-27 | 2015-03-10 | Hlt, Inc. | Stentless support structure |
US7846194B2 (en) | 2005-06-01 | 2010-12-07 | William A. Cook Australia Pty. Ltd. | Iliac artery stent graft |
US20080109058A1 (en) | 2005-06-01 | 2008-05-08 | Cook Incorporated | Intraoperative Anastomosis Method |
US7637939B2 (en) | 2005-06-30 | 2009-12-29 | Boston Scientific Scimed, Inc. | Hybrid stent |
CN2817770Y (en) | 2005-07-12 | 2006-09-20 | 北京有色金属研究总院 | Capeline aorta tectorial stand |
US8118852B2 (en) | 2005-07-13 | 2012-02-21 | Cook Medical Technologies Llc | Introducer for self-expandable medical device |
CN102225024B (en) | 2005-07-21 | 2013-05-01 | 泰科医疗集团有限合伙公司 | Systems and methods for treating hollow anatomical structures |
WO2007014088A2 (en) | 2005-07-25 | 2007-02-01 | Cook Incorporated | Intraluminal prosthesis and stent |
US7473272B2 (en) | 2005-08-17 | 2009-01-06 | Medtronic Vascular, Inc. | Recapturable stent with minimum crossing profile |
US9504555B2 (en) | 2005-08-18 | 2016-11-29 | Cook Medical Technologies Llc | Assembly of stent grafts |
WO2007024964A1 (en) | 2005-08-22 | 2007-03-01 | Incept, Llc | Flared stents and apparatus and methods for making and using them |
US20070050011A1 (en) | 2005-08-26 | 2007-03-01 | Medlogics Device Corporation | Lumen-supporting stents and methods for creating lumen-supporting stents with various open/closed designs |
EP1928512B1 (en) | 2005-09-01 | 2012-11-14 | Cook Medical Technologies LLC | Attachment of material to an implantable frame by cross-linking |
ES2360185T3 (en) | 2005-09-01 | 2011-06-01 | Medtronic Vascular, Inc. | METHODS AND APPARATUS FOR THE TREATMENT OF AORTA TORÁCICA ANEURISMS. |
US7955374B2 (en) | 2005-09-02 | 2011-06-07 | Medtronic Vascular, Inc. | Modular branch vessel stent-graft assembly |
US8911491B2 (en) | 2005-09-02 | 2014-12-16 | Medtronic Vascular, Inc. | Methods and apparatus for treatment of aneurysms adjacent branch arteries including branch artery flow lumen alignment |
EP1933764A2 (en) | 2005-09-02 | 2008-06-25 | Medtronic Vascular, Inc. | Methods and apparatus for treatment of aneurysms adjacent to branch arteries |
CA2621535A1 (en) | 2005-09-07 | 2007-03-15 | The Foundry, Inc. | Apparatus and method for disrupting subcutaneous structures |
US20070067014A1 (en) | 2005-09-22 | 2007-03-22 | Microport Medical Co., Ltd. | Method for aortic graft installation |
EP1940316B1 (en) | 2005-09-26 | 2015-10-21 | AttenueX Technologies, Inc. | Pressure attenuation device |
US8562666B2 (en) | 2005-09-28 | 2013-10-22 | Nitinol Development Corporation | Intraluminal medical device with nested interlocking segments |
EP1769774A1 (en) | 2005-10-03 | 2007-04-04 | Noureddine Frid | Radiopaque endoprostheses |
US7670369B2 (en) | 2005-10-13 | 2010-03-02 | Cook Incorporated | Endoluminal prosthesis |
WO2007053592A2 (en) | 2005-10-31 | 2007-05-10 | Cook Incorporated | Composite stent graft |
US20080275540A1 (en) | 2005-11-09 | 2008-11-06 | Ning Wen | Artificial Heart Valve Stent and Weaving Method Thereof |
US8251963B2 (en) | 2005-12-08 | 2012-08-28 | Boston Scientific Scimed, Inc. | Flexible needle |
US7540881B2 (en) | 2005-12-22 | 2009-06-02 | Boston Scientific Scimed, Inc. | Bifurcation stent pattern |
US8900287B2 (en) | 2006-01-13 | 2014-12-02 | Aga Medical Corporation | Intravascular deliverable stent for reinforcement of abdominal aortic aneurysm |
AU2007207612B2 (en) | 2006-01-18 | 2012-02-23 | Cook Incorporated | Endoluminal delivery device |
US20090227997A1 (en) | 2006-01-19 | 2009-09-10 | The Regents Of The University Of Michigan | System and method for photoacoustic imaging and monitoring of laser therapy |
US20070168013A1 (en) | 2006-01-19 | 2007-07-19 | Myles Douglas | Vascular graft and deployment system |
US20070179598A1 (en) | 2006-02-01 | 2007-08-02 | Duerig Thomas W | Method and system of attaching vessels to grafts |
WO2007095283A2 (en) | 2006-02-13 | 2007-08-23 | Willam A. Cook Australia Pty. Ltd. | Side branch stent graft construction |
ATE526914T1 (en) | 2006-02-17 | 2011-10-15 | Invatec Spa | ENDOLUMINAL PROSTHESIS |
WO2007098234A2 (en) | 2006-02-21 | 2007-08-30 | Med Institute, Inc. | Graft material for prostheses |
US8585753B2 (en) | 2006-03-04 | 2013-11-19 | John James Scanlon | Fibrillated biodegradable prosthesis |
US8801777B2 (en) | 2007-04-18 | 2014-08-12 | David Elmaleh | Intravascular device with netting system |
US9155641B2 (en) | 2006-03-09 | 2015-10-13 | Cook Medical Technologies Llc | Expandable stent grafts |
US7955380B2 (en) | 2006-03-17 | 2011-06-07 | Medtronic Vascular, Inc. | Prosthesis fixation apparatus and methods |
US20070219610A1 (en) | 2006-03-20 | 2007-09-20 | Israel Henry M | Stent with flap |
US20070239256A1 (en) | 2006-03-22 | 2007-10-11 | Jan Weber | Medical devices having electrical circuits with multilayer regions |
US20070225797A1 (en) | 2006-03-24 | 2007-09-27 | Medtronic Vascular, Inc. | Prosthesis With Adjustable Opening for Side Branch Access |
US7678141B2 (en) | 2006-04-18 | 2010-03-16 | Medtronic Vascular, Inc. | Stent graft having a flexible, articulable, and axially compressible branch graft |
US20070244547A1 (en) | 2006-04-18 | 2007-10-18 | Medtronic Vascular, Inc., A Delaware Corporation | Device and Method for Controlling the Positioning of a Stent Graft Fenestration |
US8066760B2 (en) | 2006-04-18 | 2011-11-29 | Medtronic Vascular, Inc. | Stent with movable crown |
EP2007313B1 (en) | 2006-04-19 | 2018-05-16 | Cook Medical Technologies, LLC | Stent graft |
EP1849440A1 (en) | 2006-04-28 | 2007-10-31 | Younes Boudjemline | Vascular stents with varying diameter |
US7867270B2 (en) | 2006-06-02 | 2011-01-11 | William A. Cook Australia Pty. Ltd. | Multi-port delivery device |
US7771465B2 (en) | 2006-06-23 | 2010-08-10 | Gore Enterprise Holdings, Inc. | Branched stent delivery system |
AU2007269117A1 (en) | 2006-07-07 | 2008-01-10 | Endotronix, Inc. | Methods and systems for monitoring an endoprosthetic implant |
WO2008008291A2 (en) | 2006-07-13 | 2008-01-17 | Icon Medical Corp. | Stent |
EP1882465B1 (en) | 2006-07-24 | 2009-01-07 | Cardiatis Société Anonyme | Reversible-action endoprosthesis delivery device |
US7708704B2 (en) | 2006-07-31 | 2010-05-04 | Codman & Shurtleff, Pc | Interventional medical device component having an interrupted spiral section and method of making the same |
US8080053B2 (en) | 2006-08-01 | 2011-12-20 | Merit Medical Systems, Inc. | Stent, stent removal and repositioning device, and associated methods |
JP5392655B2 (en) | 2006-08-18 | 2014-01-22 | クック・メディカル・テクノロジーズ・リミテッド・ライアビリティ・カンパニー | Stent grafting system |
WO2008021557A1 (en) | 2006-08-18 | 2008-02-21 | William A. Cook Australia Pty. Ltd. | Stent graft |
US20080064957A1 (en) | 2006-09-07 | 2008-03-13 | Spence Paul A | Ultrasonic implant, systems and methods related to diverting material in blood flow away from the head |
US8414643B2 (en) | 2006-09-19 | 2013-04-09 | Medtronic Ventor Technologies Ltd. | Sinus-engaging valve fixation member |
JP5109193B2 (en) | 2006-09-28 | 2012-12-26 | クック・メディカル・テクノロジーズ・リミテッド・ライアビリティ・カンパニー | Intravascular delivery device |
US20080082154A1 (en) | 2006-09-28 | 2008-04-03 | Cook Incorporated | Stent Graft Delivery System for Accurate Deployment |
GB0620495D0 (en) | 2006-10-16 | 2006-11-22 | Anson Medical Ltd | Apparatus and method for positioning a stent graft |
US8784478B2 (en) | 2006-10-16 | 2014-07-22 | Medtronic Corevalve, Inc. | Transapical delivery system with ventruculo-arterial overlfow bypass |
WO2008051543A2 (en) | 2006-10-24 | 2008-05-02 | Cook Incorported | Stent member |
US20100070019A1 (en) | 2006-10-29 | 2010-03-18 | Aneuwrap Ltd. | extra-vascular wrapping for treating aneurysmatic aorta and methods thereof |
WO2008057568A1 (en) | 2006-11-07 | 2008-05-15 | William A. Cook Australia Pty. Ltd | Fenestrations for stent graft arrangements and stent graft including the same |
US20080114444A1 (en) | 2006-11-09 | 2008-05-15 | Chun Ho Yu | Modular stent graft and delivery system |
US20090099648A1 (en) | 2006-11-09 | 2009-04-16 | Chun Ho Yu | Modular stent graft and delivery system |
US8211158B2 (en) | 2006-11-21 | 2012-07-03 | The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center | Branch stent graft for aortic aneurysm repair |
EP2088969B1 (en) | 2006-11-30 | 2014-08-20 | Cook Medical Technologies LLC | Implant release mechanism |
US20080147173A1 (en) | 2006-12-18 | 2008-06-19 | Medtronic Vascular, Inc. | Prosthesis Deployment Apparatus and Methods |
US8216298B2 (en) | 2007-01-05 | 2012-07-10 | Medtronic Vascular, Inc. | Branch vessel graft method and delivery system |
WO2008089282A2 (en) | 2007-01-16 | 2008-07-24 | Silver James H | Sensors for detecting subtances indicative of stroke, ischemia, infection or inflammation |
US7704275B2 (en) | 2007-01-26 | 2010-04-27 | Reva Medical, Inc. | Circumferentially nested expandable device |
WO2008109041A2 (en) | 2007-03-02 | 2008-09-12 | William A. Cook Australia Pty. Ltd. | Vascular band |
ES2624595T3 (en) | 2007-03-05 | 2017-07-17 | Endospan Ltd | Bifurcated, supportive, expandable endoluminal grafts with multiple components and methods for use |
US20080228256A1 (en) | 2007-03-13 | 2008-09-18 | Medtronic Vascular, Inc. | Braided Flange Branch Graft for Branch Vessel |
US8715336B2 (en) | 2007-04-19 | 2014-05-06 | Medtronic Vascular, Inc. | Methods and apparatus for treatment of aneurysms adjacent to branch arteries |
US8273115B2 (en) | 2007-04-24 | 2012-09-25 | W. L. Gore & Associates, Inc. | Side branched endoluminal prostheses and methods of delivery thereof |
US20090171448A1 (en) | 2007-04-27 | 2009-07-02 | Uri Eli | Implantable device with miniature rotating portion for energy harvesting |
WO2008140796A1 (en) | 2007-05-11 | 2008-11-20 | William A. Cook Australia Pty. Ltd. | Stent grafts for the thoracic aorta |
DE102007025921A1 (en) | 2007-06-02 | 2008-12-04 | Biotronik Vi Patent Ag | Medical implant, in particular stent |
WO2008151204A1 (en) | 2007-06-04 | 2008-12-11 | Sequent Medical Inc. | Methods and devices for treatment of vascular defects |
CN201058061Y (en) | 2007-06-12 | 2008-05-14 | 中国人民解放军第二军医大学 | Implant in vascellum cavity of aortic arch with branch |
US20080319528A1 (en) | 2007-06-25 | 2008-12-25 | Abbott Laboratories | Modular endoprosthesis with flexible interconnectors between modules |
US8048147B2 (en) | 2007-06-27 | 2011-11-01 | Aga Medical Corporation | Branched stent/graft and method of fabrication |
US8092510B2 (en) | 2007-07-25 | 2012-01-10 | Cook Medical Technologies Llc | Retention wire for self-expanding stent |
US20090030502A1 (en) | 2007-07-26 | 2009-01-29 | Jichao Sun | Socket For Fenestrated Tubular Prosthesis |
WO2009020653A1 (en) | 2007-08-08 | 2009-02-12 | Cleveland Clinic Foundation | Branched stent graft system |
US7731732B2 (en) | 2007-08-31 | 2010-06-08 | Ken Christopher G M | Closure medical device |
US7959669B2 (en) | 2007-09-12 | 2011-06-14 | Boston Scientific Scimed, Inc. | Bifurcated stent with open ended side branch support |
US20090082841A1 (en) | 2007-09-26 | 2009-03-26 | Boston Scientific Corporation | Apparatus for securing stent barbs |
US20090082847A1 (en) | 2007-09-26 | 2009-03-26 | Boston Scientific Corporation | System and method of securing stent barbs |
US8066755B2 (en) | 2007-09-26 | 2011-11-29 | Trivascular, Inc. | System and method of pivoted stent deployment |
CA2701096A1 (en) | 2007-10-04 | 2009-04-09 | Trivascular, Inc. | Modular vascular graft for low profile percutaneous delivery |
WO2009051607A1 (en) | 2007-10-19 | 2009-04-23 | Medlogics Device Corporation | Implantable and lumen-supporting stents and related methods of manufacture and use |
US20090112233A1 (en) | 2007-10-30 | 2009-04-30 | Medtronic Vascular, Inc. | Prosthesis Fixation Apparatus and Methods |
US20090125096A1 (en) | 2007-11-12 | 2009-05-14 | Medtronic Vascular, Inc. | Stent Graft With Pins |
US8551128B2 (en) | 2007-12-06 | 2013-10-08 | Cardiovascular Systems, Inc. | Rotational atherectomy device with pre-curved drive shaft |
CA2709278A1 (en) | 2007-12-15 | 2009-06-25 | Endospan Ltd. | Extra-vascular wrapping for treating aneurysmatic aorta in conjunction with endovascular stent-graft and methods thereof |
US9440058B2 (en) | 2007-12-17 | 2016-09-13 | Cook Medical Technologies, LLC | Device for enabling repeated access to a vessel |
US20090164001A1 (en) | 2007-12-21 | 2009-06-25 | Biggs David P | Socket For Fenestrated Tubular Prosthesis |
US9180030B2 (en) | 2007-12-26 | 2015-11-10 | Cook Medical Technologies Llc | Low profile non-symmetrical stent |
US8574284B2 (en) | 2007-12-26 | 2013-11-05 | Cook Medical Technologies Llc | Low profile non-symmetrical bare alignment stents with graft |
CN101969883B (en) | 2007-12-26 | 2014-07-30 | 梅德学会公司 | Stent and method of making a stent |
CN101909554A (en) * | 2008-02-13 | 2010-12-08 | 耐利克斯股份有限公司 | Graft endoframe having axially variable characteristics |
US8221494B2 (en) | 2008-02-22 | 2012-07-17 | Endologix, Inc. | Apparatus and method of placement of a graft or graft system |
US8197475B2 (en) | 2008-03-17 | 2012-06-12 | Medtronic Vascular, Inc. | Method and structure for ameliorating side-effects of performing in situ fenestration using a plasma RF catheter |
US8696689B2 (en) | 2008-03-18 | 2014-04-15 | Medtronic Ventor Technologies Ltd. | Medical suturing device and method for use thereof |
US8313525B2 (en) | 2008-03-18 | 2012-11-20 | Medtronic Ventor Technologies, Ltd. | Valve suturing and implantation procedures |
US8100960B2 (en) | 2008-03-20 | 2012-01-24 | Medtronic Vascular, Inc. | Bloused stent-graft and fenestration method |
IL190438A0 (en) | 2008-03-25 | 2008-12-29 | K M B Y Ltd | A method of setting a drill for drilling a hole in a bone coaxial to the hole in the nail and aiming device for realizing this method |
US7806919B2 (en) | 2008-04-01 | 2010-10-05 | Medtronic Vascular, Inc. | Double-walled stent system |
US7806923B2 (en) | 2008-04-11 | 2010-10-05 | Medtronic Vascular, Inc. | Side branch stent having a proximal split ring |
US8236040B2 (en) | 2008-04-11 | 2012-08-07 | Endologix, Inc. | Bifurcated graft deployment systems and methods |
US20090259290A1 (en) | 2008-04-14 | 2009-10-15 | Medtronic Vascular, Inc. | Fenestration Segment Stent-Graft and Fenestration Method |
US7655037B2 (en) * | 2008-04-17 | 2010-02-02 | Cordis Corporation | Combination barb restraint and stent attachment deployment mechanism |
US8292885B2 (en) | 2008-04-21 | 2012-10-23 | Medtronic Vascular, Inc. | Family of electrodes for use in performing in situ fenestration using a plasma RF catheter |
US20090287145A1 (en) | 2008-05-15 | 2009-11-19 | Altura Interventional, Inc. | Devices and methods for treatment of abdominal aortic aneurysms |
CN101283937B (en) | 2008-05-21 | 2010-08-18 | 微创医疗器械(上海)有限公司 | Overlay film frame with an opening and bonding method of the overlay film frame |
AU2009286062B2 (en) | 2008-08-26 | 2013-07-18 | Cook Medical Technologies Llc | Thoracic aorta stent graft with access region |
US8911488B2 (en) | 2008-08-26 | 2014-12-16 | The Cleveland Clinic Foundation | Thoracic introducer |
AU2009286139B2 (en) | 2008-08-27 | 2013-04-04 | Cleveland Clinic Foundation | Stent graft fixation coupling |
US8353943B2 (en) | 2008-08-29 | 2013-01-15 | Cook Medical Technologies Llc | Variable weave graft with metal strand reinforcement for in situ fenestration |
US8998981B2 (en) | 2008-09-15 | 2015-04-07 | Medtronic, Inc. | Prosthetic heart valve having identifiers for aiding in radiographic positioning |
US8137398B2 (en) | 2008-10-13 | 2012-03-20 | Medtronic Ventor Technologies Ltd | Prosthetic valve having tapered tip when compressed for delivery |
GB2464977B (en) | 2008-10-31 | 2010-11-03 | William Cook Europe As | Introducer for deploying a stent graft in a curved lumen and stent graft therefor |
JP5701776B2 (en) | 2009-02-09 | 2015-04-15 | エビーシオ・メディカル・デバイセズ・ユーエルシー | Stent |
CN101836911A (en) | 2009-03-18 | 2010-09-22 | 微创医疗器械(上海)有限公司 | Collateral filmed stent |
US8052741B2 (en) | 2009-03-23 | 2011-11-08 | Medtronic Vascular, Inc. | Branch vessel prosthesis with a roll-up sealing assembly |
WO2010111583A1 (en) | 2009-03-26 | 2010-09-30 | Cook Incorporated | Stent graft |
GB2469297B (en) | 2009-04-07 | 2011-05-25 | Cook Inc | Introducer assembly and implantable medical device |
US8506622B2 (en) | 2009-04-17 | 2013-08-13 | Medtronic Vascular, Inc. | Mobile external coupling for branch vessel connection |
US8292941B2 (en) | 2009-04-23 | 2012-10-23 | Medtronic Vascular, Inc. | Delivery system for deployment of a one-piece iliac-branch device |
US8876877B2 (en) | 2009-04-23 | 2014-11-04 | Medtronic Vascular, Inc. | Centering for a TAA |
US8876883B2 (en) | 2009-04-24 | 2014-11-04 | Medtronic Vascular, Inc. | Self-flaring active fixation element for a stent graft |
GB2470083A (en) | 2009-05-08 | 2010-11-10 | Nat Univ Ireland | Closed loop stent |
WO2010132707A1 (en) | 2009-05-14 | 2010-11-18 | Orbusneich Medical, Inc. | Self-expanding stent with polygon transition zone |
DE102009042150A1 (en) | 2009-05-29 | 2010-12-02 | Aesculap Ag | Surgical instrument to be used in combination with a trocar or something similar has proximal and distal ends as well as an end section with an articulated zone |
US20100318180A1 (en) | 2009-06-15 | 2010-12-16 | Boston Scientific Scimed, Inc. | Multi-layer stent assembly |
US8409269B2 (en) | 2009-12-21 | 2013-04-02 | Covidien Lp | Procedures for vascular occlusion |
US8771333B2 (en) | 2009-06-23 | 2014-07-08 | Cordis Corporation | Stent-graft securement device |
EP2445444B1 (en) | 2009-06-23 | 2018-09-26 | Endospan Ltd. | Vascular prostheses for treating aneurysms |
CA2767596C (en) | 2009-07-09 | 2015-11-24 | Endospan Ltd. | Apparatus for closure of a lumen and methods of using the same |
CN102470031B (en) | 2009-07-14 | 2015-11-25 | 恩多斯潘有限公司 | For the Ce Kou engaged and sealing mechanism of pipe Endovascular stent-graft |
WO2011008989A2 (en) | 2009-07-15 | 2011-01-20 | Endologix, Inc. | Stent graft |
WO2011017123A2 (en) * | 2009-07-27 | 2011-02-10 | Endologix, Inc. | Stent graft |
US20110093002A1 (en) | 2009-10-20 | 2011-04-21 | Wilson-Cook Medical Inc. | Stent-within-stent arrangements |
CA2780048A1 (en) | 2009-11-04 | 2011-05-12 | Endospan Ltd. | Treatment of a main body lumen in the vicinity of a branching body lumen |
CN102740807B (en) | 2009-11-30 | 2015-11-25 | 恩多斯潘有限公司 | For implantation into the multi-part overlay film frame system had in the blood vessel of multiple branch |
US20120330399A1 (en) | 2009-12-02 | 2012-12-27 | Endospan Ltd. | Endovascular fenestrated stent-grafting |
US8475513B2 (en) | 2009-12-02 | 2013-07-02 | Nedunchezian Sithian | Stent graft apparatus and method |
WO2011070576A1 (en) | 2009-12-08 | 2011-06-16 | Endospan Ltd. | Endovascular stent-graft system with fenestrated and crossing stent-grafts |
EP2519166A4 (en) | 2009-12-31 | 2017-06-14 | Endospan Ltd | Endovascular flow direction indicator |
US9468517B2 (en) | 2010-02-08 | 2016-10-18 | Endospan Ltd. | Thermal energy application for prevention and management of endoleaks in stent-grafts |
WO2011100367A2 (en) * | 2010-02-10 | 2011-08-18 | Trivascular, Inc. | Fill tube manifold and delivery methods for endovascular graft |
US10433956B2 (en) | 2010-02-24 | 2019-10-08 | Medtronic Ventor Technologies Ltd. | Mitral prosthesis and methods for implantation |
US9414914B2 (en) | 2010-02-24 | 2016-08-16 | Medtronic Ventor Technologies Ltd. | Catheter assembly with valve crimping accessories |
US20110208289A1 (en) | 2010-02-25 | 2011-08-25 | Endospan Ltd. | Flexible Stent-Grafts |
US8764811B2 (en) | 2010-04-20 | 2014-07-01 | Medtronic Vascular, Inc. | Controlled tip release stent graft delivery system and method |
US20110257725A1 (en) | 2010-04-20 | 2011-10-20 | Medtronic Vascular, Inc. | Blood Inflating Prosthesis |
EP2380526B1 (en) | 2010-04-23 | 2019-01-02 | Biotronik AG | Implant and method for producing the same |
US20110264184A1 (en) | 2010-04-26 | 2011-10-27 | Paul Heltai | Sleeve and tubing device for restricting and constricting aneurysms and a system and method for using such a device |
US8333800B2 (en) | 2010-04-29 | 2012-12-18 | Medtronic Vascular, Inc. | Mobile external coupling with internal sealing cuff for branch vessel connection |
US8292951B2 (en) | 2010-04-29 | 2012-10-23 | Medtronic Vascular, Inc. | Tethered pop up branch structure stent graft and method |
US8337546B2 (en) | 2010-04-29 | 2012-12-25 | Medtronic Vascular, Inc. | Mobile external coupling for branch vessel connection |
US9402754B2 (en) | 2010-05-18 | 2016-08-02 | Abbott Cardiovascular Systems, Inc. | Expandable endoprostheses, systems, and methods for treating a bifurcated lumen |
US9561102B2 (en) | 2010-06-02 | 2017-02-07 | Medtronic, Inc. | Transcatheter delivery system and method with controlled expansion and contraction of prosthetic heart valve |
CA2814136A1 (en) | 2010-10-12 | 2012-04-19 | Endospan Ltd. | Accelerated bench-testing of medical devices |
US8915950B2 (en) | 2010-12-06 | 2014-12-23 | Covidien Lp | Vascular remodeling device |
WO2012087277A1 (en) | 2010-12-20 | 2012-06-28 | Empire Technology Development Llc | Implantable apparatus for facilitating imaging-based diagnoses |
WO2012099731A1 (en) | 2011-01-19 | 2012-07-26 | Cook Medical Technologies Llc | Rotary and linear handle mechanism for constrained stent delivery system |
CA2826022A1 (en) | 2011-02-03 | 2012-08-09 | Endospan Ltd. | Implantable medical devices constructed of shape memory material |
US9855046B2 (en) | 2011-02-17 | 2018-01-02 | Endospan Ltd. | Vascular bands and delivery systems therefor |
AU2011200858B1 (en) | 2011-02-28 | 2012-04-05 | Cook Medical Technologies Llc | Stent graft with valve arrangement |
US9486341B2 (en) | 2011-03-02 | 2016-11-08 | Endospan Ltd. | Reduced-strain extra-vascular ring for treating aortic aneurysm |
US9839542B2 (en) | 2011-04-19 | 2017-12-12 | Medtronic Ardian Luxembourg S.A.R.L. | Mobile external coupling for branch vessel connection |
US8574287B2 (en) | 2011-06-14 | 2013-11-05 | Endospan Ltd. | Stents incorporating a plurality of strain-distribution locations |
WO2012176187A1 (en) | 2011-06-21 | 2012-12-27 | Endospan Ltd. | Endovascular system with circumferentially-overlapping stent-grafts |
EP2729095B1 (en) | 2011-07-07 | 2016-10-26 | Endospan Ltd. | Stent fixation with reduced plastic deformation |
US9839510B2 (en) | 2011-08-28 | 2017-12-12 | Endospan Ltd. | Stent-grafts with post-deployment variable radial displacement |
EP2750635A4 (en) | 2011-09-01 | 2015-05-20 | Endospan Ltd | Cross-reference to related applications |
US9427339B2 (en) | 2011-10-30 | 2016-08-30 | Endospan Ltd. | Triple-collar stent-graft |
US8771341B2 (en) | 2011-11-04 | 2014-07-08 | Reverse Medical Corporation | Protuberant aneurysm bridging device and method of use |
WO2013084235A2 (en) | 2011-12-04 | 2013-06-13 | Endospan Ltd. | Branched stent-graft system |
WO2013171730A1 (en) | 2012-05-15 | 2013-11-21 | Endospan Ltd. | Stent-graft with fixation elements that are radially confined for delivery |
WO2014020609A1 (en) | 2012-08-01 | 2014-02-06 | Endospan Ltd. | Stent-grafts configured for post-implantation expansion |
CN105007860B (en) | 2013-01-08 | 2017-05-10 | 恩多斯潘有限公司 | Minimization of stent-graft migration during implantation |
EP2967830B1 (en) | 2013-03-11 | 2017-11-01 | Endospan Ltd. | Multi-component stent-graft system for aortic dissections |
WO2014188412A2 (en) | 2013-05-23 | 2014-11-27 | Endospan Ltd. | Ascending aorta stent-graft system |
-
2012
- 2012-04-04 US US14/240,600 patent/US9839510B2/en active Active
- 2012-04-04 WO PCT/IL2012/000148 patent/WO2013030818A2/en active Application Filing
Cited By (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11090148B2 (en) | 2009-06-23 | 2021-08-17 | Endospan Ltd. | Vascular prosthesis for treating aneurysms |
US9918825B2 (en) | 2009-06-23 | 2018-03-20 | Endospan Ltd. | Vascular prosthesis for treating aneurysms |
US9855046B2 (en) | 2011-02-17 | 2018-01-02 | Endospan Ltd. | Vascular bands and delivery systems therefor |
US9486341B2 (en) | 2011-03-02 | 2016-11-08 | Endospan Ltd. | Reduced-strain extra-vascular ring for treating aortic aneurysm |
US9839510B2 (en) | 2011-08-28 | 2017-12-12 | Endospan Ltd. | Stent-grafts with post-deployment variable radial displacement |
US9427339B2 (en) | 2011-10-30 | 2016-08-30 | Endospan Ltd. | Triple-collar stent-graft |
WO2013084235A2 (en) | 2011-12-04 | 2013-06-13 | Endospan Ltd. | Branched stent-graft system |
US9770350B2 (en) | 2012-05-15 | 2017-09-26 | Endospan Ltd. | Stent-graft with fixation elements that are radially confined for delivery |
WO2014108895A2 (en) | 2013-01-08 | 2014-07-17 | Endospan Ltd. | Minimization of stent-graft migration during implantation |
US9668892B2 (en) | 2013-03-11 | 2017-06-06 | Endospan Ltd. | Multi-component stent-graft system for aortic dissections |
US9179998B2 (en) | 2013-03-12 | 2015-11-10 | Cook Medical Technologies Llc | Device and method for treating vascular dissections |
EP2777609A1 (en) * | 2013-03-12 | 2014-09-17 | Cook Medical Technologies LLC | Device for treating vascular dissections |
US20210077283A1 (en) * | 2013-04-24 | 2021-03-18 | Vascular Dynamics, Inc. | Implantable vascular device having longitudinal struts |
US10603197B2 (en) | 2013-11-19 | 2020-03-31 | Endospan Ltd. | Stent system with radial-expansion locking |
WO2016098113A1 (en) | 2014-12-18 | 2016-06-23 | Endospan Ltd. | Endovascular stent-graft with fatigue-resistant lateral tube |
US11419742B2 (en) | 2014-12-18 | 2022-08-23 | Endospan Ltd. | Endovascular stent-graft with fatigue-resistant lateral tube |
US10485684B2 (en) | 2014-12-18 | 2019-11-26 | Endospan Ltd. | Endovascular stent-graft with fatigue-resistant lateral tube |
WO2016113731A1 (en) | 2015-01-12 | 2016-07-21 | Endospan Ltd. | Self-curving stent-graft |
EP3632376A1 (en) | 2015-01-12 | 2020-04-08 | Endospan Ltd. | Self-curving stent graft |
WO2016125137A1 (en) | 2015-02-02 | 2016-08-11 | Endospan Ltd. | Self-orienting endovascular delivery system |
US10426593B2 (en) | 2015-03-11 | 2019-10-01 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Expansible cardiovascular graft system |
WO2016145391A1 (en) * | 2015-03-11 | 2016-09-15 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Expansible cardiovascular graft system |
WO2017081679A1 (en) | 2015-11-12 | 2017-05-18 | Endospan Ltd. | Stent-grafts systems with skirt |
CN108712891A (en) * | 2016-02-29 | 2018-10-26 | 爱德华兹生命科学公司 | Compliance based on vacuum is restored |
WO2018173056A1 (en) | 2017-03-21 | 2018-09-27 | Endospan Ltd. | Stent-grafts for sealing around external disturbances |
Also Published As
Publication number | Publication date |
---|---|
WO2013030818A3 (en) | 2015-06-18 |
US9839510B2 (en) | 2017-12-12 |
US20140324154A1 (en) | 2014-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9839510B2 (en) | Stent-grafts with post-deployment variable radial displacement | |
US11801129B2 (en) | Vascular prosthesis with fenestration ring and methods of use | |
AU2003200089B2 (en) | Covered segmented stent | |
JP4825665B2 (en) | Lumen device with enhanced mounting characteristics | |
EP1696828B1 (en) | Interconnected leg extensions for an endoluminal prostehsis | |
US9056001B2 (en) | Method of producing low profile stent and graft combination | |
US20130204343A1 (en) | Endovascular system with circumferentially-overlapping stent-grafts | |
EP3946171A1 (en) | Oval stent | |
JP6333278B2 (en) | Vascular implant with side branch | |
JP2003515386A (en) | Endovascular graft system | |
WO2006069094A1 (en) | Intraluminal support frame and medical devices including the support frame | |
US9956070B2 (en) | Percutaneous endovascular apparatus for repair of aneurysms and arterial blockages | |
WO2015061669A1 (en) | Branched vessel prosthesis for repair of a failed stent graft | |
EP4125738A1 (en) | Expandable devices and associated systems and methods | |
WO2024030794A1 (en) | Vascular flow management | |
US20220096221A1 (en) | Endovascular stent graft having an oblique feature | |
US20150112418A1 (en) | Segmented Balloon Expandable Stent Graft With Reduced Foreshortening | |
US20210121180A1 (en) | Endovascular fixation device | |
WO2024158949A1 (en) | Compliant lobe-shaped implant devices |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12826996 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 14240600 Country of ref document: US |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12826996 Country of ref document: EP Kind code of ref document: A2 |